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Abstract
Abstract
The objectives of the present study were to identify genes that enable the opportunistic
pathogen P. aeruginosa TB to survive intracellularly in polymorphonuclear granulocytes
(PMNs). A signature-tagged mutant (STM) library made up of 2304 mutants was screened
for intracellular survival in PMNs. Out of the identified 44 mutants, 35 mutants which have
reduced survival significantly, while 9 mutants which survived even better as compared to the
TB wild type. The genes identified encode elements of oxidative stress response, flagella
and type IV pili biogenesis. Most of them are belong to the class of conserved hypotheticals
of unknown function. Almost all genes that are needed by TB are present in the sequenced
PAO1 core genome, only very few are strain-or clone-specific. This indicates that subtle
shifts in the genetic repertoire are sufficient to cause a smooth transition from extracellular
lifestyle to intracellular survival and growth in the major antipseudomonal host defense cell. 
The genome wide transcriptional profile of P. aeruginosa against paraquat was performed
using PAO1 GeneChips which uncovered one operon (PA0939-PA0942) encoding four
proteins of previously unknown function being 20-200 fold up-regulated in all three analyzed
P. aeruginosa strains TB, 892 and PAO1. It confers most resistance to paraquat-induced
superoxide stress in addition to constitutively highly expressed genes sodB, katA and ahpC.
The transcriptional profile of the three P. aeruginosa strains against hydrogen peroxide
stress identified significantly more number of genes up-regulated in TB as compared to 892
and PAO1. 
The GeneChip experiments with the P. aeruginosa TB mutants harboring transposon
insertions in strain specific genes revealed that there were virtually no interference with the
expression of the PAO1 defined core genome under standard growth conditions. Murine
infection experiments indicated that the analyzed mutants are even more virulent than the TB
wild type. 
The transcriptome data together with murine infection model described in this study could be
useful for experiments to dissect the intracellular survival mechanisms in P. aeruginosa TB
and the biochemical function of the strain specific genes.   
Key-words: Pseudomonas aeruginosa, Polymorphonuclear granulocytes, GeneChip 
Zusammenfassung
Zusammenfassung
Das Ziel dieser Arbeit war die Identifizierung von Genen, die es dem opportunistischen
Pathogen P. aeruginosa TB ermöglichen, intrazellulär in polymorphonukleären Granulozyten
(PMNs) zu überleben. 2304 Transposonmutanten einer STM- Bibliothek wurden auf ihre
intrazelluläre Überlebensfähigkeit in PMNs untersucht. Hierbei wurden 44 Mutanten mit
deutlichen Veränderungen des Phänotyps identifiziert. 35 hatten eine deutlich verringerte
intrazelluläre Überlebensfähigkeit, wogegen 9 Mutanten sogar besser überlebten als der TB-
Wildtyp. Die Funktionen der identifizierten Gene beinhalten die Abwehr von oxidativem
Stress, den Aufbau von Flagellen und Typ IV Pili. Die meisten der identifizierten Gene haben
aber bisher eine unbekannte Funktion. Es war auffällig, daß die meisten Gene, die von P.
aeruginosa TB zum intrazellulären Überleben benötigt werden, aus dem sequenzierten
PAO1 – Genom bekannt sind und nur sehr wenige Gene Stamm- oder Klon- spezifisch sind.
Dies ist ein Hinweis darauf, daß nur geringste Veränderungen im genetischen Hintergrund
ausreichend sind, um einen Übergang von einer extrazellulären Lebensweise zu einer
intrazellulären auszulösen, bei der die P. aeruginosa Bakterien sogar in der Lage sind, sich
in der wichtigsten Abwehrzelle des Menschen gegenüber Pseudomonas-Infektionen zu
vermehren.
In PAO1 GeneChips wurde das genomweite Transkriptionsprofil von P. aeruginosa nach
Exposition mit Paraquat analysiert. Ein Operon aus vier Genen (PA0939-PA0942) mit bisher
unbekannter Funktion wurde in den drei analysierten Stämmen TB, 892 und TB 20-200fach
stärker exprimiert. Es verleiht neben den konstitutiv hoch exprimierten Gene sodB, katA und
ahpC den größten Anteil an Resistenz gegen Paraquat-induzierten Superoxid Stress. Das
transkriptionelle Profil der drei P. aeruginosa Stämme während Wasserstoffperoxid-
induziertem Stress zeigte signifikant mehr hochregulierte Gene bei TB als bei 892 und
PAO1. 
GeneChip Experimente mit zwei P. aeruginosa TB Mutanten, die Transposon-Insertionen in
non-PAO1 Genen beherbergen, zeigten praktisch keine Interferenz mit der globalen
Expression des PAO1 Kerngenoms unter Standard-Wachstumsbedingungen. Die Produkte
dieser beiden Gene schützen P. aeruginosa TB vor dem bakteriziden Zugriff durch PMNs,,
attenuieren aber gleichzeitig die Virulenz im Mäuseinfektionsversuch. 
Die Transkriptom-Daten können zusammen mit den in dieser Studie beschriebenen
Mausinfektions-Versuchen nützlich für gezielte Experimente sein, um die intrazellulären
Überlebensmechanismen von P. aeruginosa TB sowie die biochemischen Funktionen der
Stamm-spezifischen Gene aufzuklären. 
Schlüsselwörter: Pseudomonas aeruginosa, polymorphnukleäre Granulozyten, GeneChip
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1
1. INTRODUCTION
1.1. Pseudomonas aeruginosa
Pseudomonas aeruginosa is a Gram-negative polarly flagellated rod which is a
member of the γ-proteobacteria group (Olsen et al., 1994), that is noted for its
environmental versatility. Unlike many environmental bacteria, P. aeruginosa has a
remarkable capacity to cause disease in susceptible hosts. It has the ability to adapt
to and thrive in many ecological niches, from water and soil to plant and animal
tissues (Hardalo and Edberg, 1997). The bacterium is capable of utilizing a wide
range of organic compounds as food sources, thus giving it an exceptional ability to
colonize ecological niches where nutrients are limited. P. aeruginosa can produce a
number of toxic proteins which not only cause extensive tissue damage, but also
interfere with the human immune system's defense mechanisms. These proteins
range from potent toxins that enter and kill host cells at or near the site of
colonization to degradative enzymes that permanently disrupt the cell membranes
and connective tissues in various organs. The emergence of P. aeruginosa as a
major opportunistic human pathogen during the past century may be a consequence
of its resistance to the antibiotics and disinfectants that eliminate other environmental
bacteria. P. aeruginosa is now a significant source of bacteraemia in burn victims,
urinary-tract infections in catheterized patients, and hospital-acquired pneumonia in
patients on respirators (Bodey et al., 1983). It is also the predominant cause of
morbidity and mortality in cystic fibrosis (CF) patients, whose abnormal airway
epithelia allow long-term colonization of the lungs by P. aeruginosa. These infections
are impossible to eradicate, in part because of the natural resistance of the bacterium
to antibiotics, and ultimately lead to pulmonary failure and death (Stover et al., 2000).
Recently, Stover et al. (2000) has sequenced and published the complete genome of
P. aeruginosa strain PAO1 (available on http://pseudomonas.com). The P.
aeruginosa genome is markedly larger (6.3 million base pairs) than most of the 140
sequenced bacterial genomes. In fact, with 5,570 predicted open reading frames
(ORFs), the genetic complexity of P. aeruginosa approaches that of the simple
eukaryote Saccharomyces cerevisiae, whose genome encodes about 6,200 proteins
(Ball et al., 2000). In contrast, P. aeruginosa has only 30-40 % of the number of
predicted genes present in the simple metazoans Caenorhabditis elegans and
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Drosophila melanogaster (Ewing and Green, 2000). Consistent with its larger
genome size and environmental adaptability, P. aeruginosa contains the highest
proportion of regulatory genes observed for a bacterial genome and a large number
of genes involved in the catabolism, transport and efflux of organic compounds as
well as four potential chemotaxis systems (Stover et al., 2000). These regulatory
genes presumably modulate the diverse genetic and biochemical capabilities of this
bacterium in changing environmental conditions.
1.1.1. P. aeruginosa and cystic fibrosis
P. aeruginosa typically causes disease only in individuals with impaired host
defenses and is thus referred to as an opportunistic pathogen. Such compromised
individuals include patients undergoing immunosuppressive therapies (e.g., cancer
treatment), those receiving treatment for traumatic skin damage (burn wounds), those
with human immunodeficiency virus infections, and those with cystic fibrosis (Govan
and Deretic, 1996). CF arises from mutations in the cystic fibrosis transmembrane
conductance regulator (CFTR) gene which interferes with chloride ion transport in CF
patients. The gene defect results in a myriad of medical problems for the patient, the
most prominent clinical feature being chronic pulmonary infection with P. aeruginosa,
allows the basic pathologic process in CF to be designated as an infectious disease.
Ultimately, 80 to 95 % of patients with CF succumb to respiratory failure brought on
by chronic bacterial infection and concomitant airway inflammation. The discovery in
1989 of the genetic defect causing CF sparked an explosion of research efforts,
which have led to a greater understanding of the molecular mechanisms underlying
the various phenotypic manifestations of the disease. Yet the breadth of the link
between mutant forms of the CF gene product, CFTR, and chronic bacterial
respiratory infections, particularly by P. aeruginosa, remains elusive. Deciphering this
link is critical, since this infection and the ensuing inflammation accounts for the
majority of the morbidity and mortality in the disease. Chronic P. aeruginosa airway
infection and the accompanying inflammatory response are clearly the major clinical
problems for CF patients today. While antibiotic chemotherapy and chemoprophylaxis
have reduced the morbidity and early mortality of CF patients from this infection, the
intrinsic ability of P. aeruginosa to develop resistance to many commonly used
antibiotics (Kobayashi et al., 1972; Richmond et al., 1971) probably underlies the
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inability to eradicate P. aeruginosa from the CF patient's lung and ultimately allows
this microbe to be highly problematic for these patients . 
The abnormal composition of the airway secretions of the CF lung is frequently cited
as the host factor that predisposes CF patients to chronic colonization by P.
aeruginosa. One of the most striking and clinically important features of infection by
P. aeruginosa is the tendency of this bacterium to change to a mucoid phenotype,
probably initiating the chronic-infection stage of the disease. The mucoid phenotype
results from bacterial production of a polysaccharide known as both alginate and
mucoid exopolysaccharide (MEP) and plays an important role in bacterial evasion of
the host immune response. The mucoid phenotype is often unstable, with a large
percentage of isolates reverting to a nonmucoid phenotype during in vitro culture
(Pugashetti et al., 1982). This instability has been genetically mapped to changes in
the one of the gene known as mucA (Boucher et al., 1997). Production of MucA
protein inhibits the activity of the alternative sigma factor (sigma E), which is required
for the mucoid phenotype. Mutations in the mucA gene leading to a premature
termination of the coding sequence are found in mucoid isolates (Schurr et al., 1994).
Accompanying the onset of alginate production is the initiation of the microcolony
mode of growth within the lungs of CF patients, representing a bacterial biofilm
composed of cells embedded within an alginate matrix (Costerton et al., 1983). With
the emergence of mucoid P. aeruginosa within the lungs, there are cell surface
changes with respect to LPS phenotype (Fomsgaard et al., 1988).
1.1.2. Pathogenesis of P. aeruginosa infections 
P. aeruginosa is able to grow and survive in almost any environment, lives primarily
in water, soil, and vegetation. It produces several cell associated and extracellular
virulence factors ( Van Delden and Iglewski, 1998). 
1.1.2.1. Role of cell-associated virulence factors 
To initiate infection, P. aeruginosa usually requires a substantial break in first-line
defenses. Such a break can result from breach or bypass of normal cutaneous or
mucosal barriers (e.g., trauma, surgery, serious burns, or indwelling devices),
disruption of the protective balance of normal mucosal flora by broad-spectrum
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antibiotics, or alteration of the immunological defense mechanisms (e.g., in
chemotherapy-induced neutropenia, mucosal clearance defects from cystic fibrosis,
AIDS, and diabetes mellitus). The first step in P. aeruginosa infections is the
colonization of the altered epithelium. The pathogen colonizes the oropharynx of up
to 6 % and is recovered from the feces of 3 % to 24 % of healthy persons (Pollack et
al., 1995). In contrast, up to 50 % of hospitalized patients are at high risk for P.
aeruginosa colonization (Pollack et al., 1995). Adherence of P. aeruginosa to
epithelium is probably mediated by type 4 pili similar to those of Neisseria
gonorrhoeae (de Bentzmann et al., 1996). Several other nonpilus adhesins
responsible for the binding to mucin have been described, but their role in the
infection process remains unclear (Gilboa-Garber, 1996). Flagella, which are
primarily responsible for motility, may also act as adhesins to epithelial cells
(Feldman et al., 1998). The ability of P. aeruginosa to attach to abiotic surfaces, to
host tissues, or to each other, and the subsequent differentiation of the
microorganisms into biofilm, can be considered a major virulence trait in a variety of
infections (Watnik and Kolter, 2000). Biofilm formation can take place on a variety of
surfaces, such as medical instruments, leading to many types of nosocomial
infections, and P. aeruginosa has been shown to persist in biofilm in the lungs of
cystic fibrosis patients (Singh et al., 2000). Biofilms are characterized by a complex,
highly structured, bacterial organization (Costerton et al., 1999). They are initiated by
the attachment of a single planktonic cell on a surface. The chaperone-usher
pathway has been identified in P. aeruginosa as one of the mechanisms that are
involved in the attachment to the abiotic surfaces (Vallet et al., 2001). The gene
cluster was named as cup gene cluster. This suggest that multiple factors are
available to P. aeruginosa to facilitate its binding to various surfaces and for
interbacterial adhesion as well. The wide variety of such attachment mechanisms
may reflect the complex needs of this organism during the colonization of widely
diverse environmental niches.
1.1.2.2. Role of extracellular virulence factors 
P. aeruginosa produces several extracellular products that after colonization can
cause extensive tissue damage, bloodstream invasion, and dissemination. In vivo
studies have shown that mutants defective in the production of exotoxin A,
exoenzyme S, elastase, or alkaline protease are essential for minimum virulence of
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P. aeruginosa; however, the relative contribution of a given factor may vary with the
type of infection (Nicas and Iglewski, 1985). Many of these factors are controlled by
regulatory systems involving cell-to-cell signaling. Exotoxin A is produced by most P.
aeruginosa strains that cause clinical infections. Exotoxin A is responsible for local
tissue damage, bacterial invasion (Lyczak et al., 2000), and (possibly)
immunosuppression (Vidal et al., 1993). Purified exotoxin A is highly lethal for mice
which supports its role as a major systemic virulence factor of P. aeruginosa.
Exoenzyme S is responsible for direct tissue destruction in lung infection (Nicas et
al., 1985a) and may be important for bacterial dissemination (Nicas et al., 1985b).
Two hemolysins, phospholipase C and rhamnolipid, produced by P. aeruginosa, may
act synergistically to breakdown lipids and lecithin. Both may contribute to tissue
invasion by their cytotoxic effects. Rhamnolipid, a rhamnose-containing glycolipid
biosurfactant, has a detergentlike structure and is believed to solubilize the
phospholipids of lung surfactant, making them more accessible to cleavage by
phospholipase C (Liu, 1974). Rhamnolipid also inhibits the mucociliary transport and
ciliary function of human respiratory epithelium (Read et al., 1992). Proteases are
assumed to play a major role during acute P. aeruginosa infection. P. aeruginosa
produces several proteases including LasB elastase, LasA elastase, and alkaline
protease (Passador et al., 1993). The ability of P. aeruginosa to destroy the protein
elastin is a major virulence determinant during acute infection. Elastin is a major part
of human lung tissue and is responsible for lung expansion and contraction. The
concerted activity of two enzymes, LasB elastase and LasA elastase, is responsible
for elastolytic activity (Galloway, 1991). Both LasB elastase and LasA elastase have
been found in the sputum of CF patients during pulmonary exacerbation (Jaffar-
Bandjee et al., 1995). LasB elastase not only destroys tissue components but also
interferes with host defense mechanisms (Galloway 1991; Hong and Ghebrehiwet,
1992). Studies in animal models show that mutants defective in LasB elastase
production are less virulent than their parent strains (Nicas et al., 1985b; Tamura et
al., 1992; Tang et al., 1996), which supports the role of LasB elastase as a virulence
factor.
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1.2. Type III secretion system 
Interaction of bacterial pathogens with host cells is particularly characterized by
factors that are located on the bacterial surface or are secreted into the extracellular
space. Although the secreted bacterial proteins are numerous and diverse and exhibit
a wide variety of functions that include proteolysis, haemolysis, cytotoxicity, and
protein phosphorylation and dephosphorylation, only a few pathways exist by which
these proteins are transported from the bacterial cytoplasm to the extracellular space.
Thus, four pathways of protein secretion (types I to IV) have been described in Gram-
negative bacteria (Fath and Kolter, 1993; Finlay and Falkow, 1997; Salmond and
Reeves, 1993). Type I, exemplified by the hemolysin secretion system of Escherichia
coli, is a rather simple exporter that is based on only three proteins, one of which
belongs to the ABC transporters. Type II is a very complex apparatus that extends
the general secretary pathway and transfers fully folded enzymes or toxins from the
periplasm to the extracellular medium, across the outer membrane. Type IV, another
complex system that transfers pertussis toxin among others, is related to the
apparatus of Agrobacterium spp. that transfers DNA to plant cells. Finally, type III, is
a sophisticated apparatus that couples secretion with pathogenesis.
In bacteria that are pathogenic for animals, type III secretion systems allow
extracellular bacteria adhering to the surface of a host cell to inject specialized
proteins across the plasma membrane. This system probably also allows bacteria
residing in vacuoles to inject proteins across the vacuolar membrane. The injected
proteins subvert the functioning of the aggressed cell or destroy its communications,
favoring the entry or survival of the invading bacteria. Type III secretion has been
extensively studied in Yersinia spp. (Cornelis et al., 1998), in Salmonella spp. (Galan
and Collmer, 1999; Hensel et al., 1997), in Shigella spp. (Van Nhieu et al., 1997),
and in enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli (EHEC)
(Frankel et al., 1998; Goosney et al., 1999; Jarvis et al., 1995). It has also been
described in P. aeruginosa (Yahr et al., 1998), Chlamydia trachomatis and
Chlamydia pneumoniae (Subtil et al., 2000), Bordetella bronchiseptica (Yuk et al.,
1998), Bordetella pertussis (Kerr et al., 1999) and in Burkholderia pseudomallei
(Rainbow et al., 2002). It is surprising that Salmonella typhimurium and Yersinia spp.
have not only one type III system but two (Hensel et al., 1998; Ochman et al., 1996),
presumably playing their role at different stages of the infection (figure 1.1).
Introduction
7
Fig. 1.1. Type III systems in animal pathogens. Illustrated are the various bacterial pathogens
endowed with type III secretion, injecting effectors into the cytosol of a eukaryotic target cell (Cornelis
and Gijsegem, 2000).
1.2.1. Proteins secreted by P. aeruginosa type III pathway 
As mentioned above, P. aeruginosa secretes several proteins with high similarity to
Yersinia type III secreted factors. The two related ADP-ribosyltransferases ExoS (453
aa) and ExoT (457 aa), which have 75% aa sequence identity, both carry an amino-
terminal half similar to YopE, while the catalytic domain of the proteins resides in the
carboxy terminus (Frank, 1997). Another secreted factor which is associated with
epithelial cell damage is the 687-aa ExoU (Finck-Barbancon et al., 1997). ExoU is
coregulated with other type III secreted proteins and is highly similar in its first 6 aa to
ExoS and ExoT, suggesting that ExoU might also be secreted via the type III
secretion pathway. Furthermore, proteins which show 40 to 60% sequence identity to
Yersinia LcrV (PcrV, 294 aa), YopB (PopB, 392 aa), YopD (PopD, 295 aa), and YopN
(PopN, 288 aa) are secreted by P. aeruginosa (Yahr et al., 1997) and may be
involved in protein translocation by P. aeruginosa as their homologs are in Yersinia
spp (Hueck, 1998). 
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1.2.2. P. aeruginosa type III secretion system genes 
The chromosomal type III secretion system in P. aeruginosa has been discovered by
characterization of ExoS secretion-deficient mutants. The part of the secretory
apparatus which has been identified so far is encoded by 12 genes, 11 of which are
arranged colinear to the Yersinia yscB to yscL genes. Except for their homologs in
Yersinia spp., the pscB-, pscE-, and pscGH-encoded proteins do not have homologs
in other type III secretion systems. In P. aeruginosa, the exsD-pscB to pscL genes
are transcribed as a single operon (Yahr et al., 1996). The exsD-encoded protein is
unique to P. aeruginosa, but the preceding operon (exsCBA) (Yahr and Frank, 1994)
encodes homologs of Yersinia VirG (ExsB) and VirF (ExsA). Like the Yersinia VirF,
the ExsA protein is a positive regulatory factor of the exsD-pscB to pscL operon
(Yahr and Frank, 1994), which belongs to the AraC family of transcriptional regulators
(Frank and Iglewski, 1991). Yahr et al. (1997) reported that transposon insertions
located immediately upstream of the exsCBA operon also led to an ExoS secretion-
deficient phenotype, and by homology to Yersinia spp., it is likely that this region
contains additional genes of the P. aeruginosa type III secretion system. A number of
P. aeruginosa type III secretion genes homologous to respective Yersinia sp. genes
have recently been described (Frank, 1997). 
1.2.3. Transcriptional regulation in P. aeruginosa 
As mentioned above, the P. aeruginosa type III secretion system is highly similar to
the Yersinia system. Accordingly, the P. aeruginosa type III gene cluster contains a
trans-regulatory locus encoding an AraC-type regulator (ExsA) which exhibits 56%
sequence identity to Yersinia VirF. ExsA activates P. aeruginosa type III secretion
gene transcription by specifically binding to promoters upstream of pscN, the popN to
pcrR operon, the exsD to pscB to pscL operon, and the exsC to exsA operon. In
addition, ExsA activates transcription of genes encoding the secreted proteins ExoS,
ExoT, and ExoU (Frank, 1997; Hovey and Frank, 1995). As like in Yersinia spp.,
expression of P. aeruginosa secreted proteins is activated under low-Ca2+ conditions
(Frank, 1997). The ExsA binding site has been determined for several promoters and
comprises the core consensus sequence TNAAAANA, located 51 or 52 bp upstream
of the transcriptional start site (Hovey and Frank, 1995).
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1.3. Quorum sensing in Gram-negative bacteria
1.3.1. What is quorum sensing
Bacteria were considered for a long time to exist as independent single cells rather
than collectively as co-ordinate members of an organized community. Emerging
evidence demonstrate that bacteria can behave not only as individual cells, under
appropriate conditions when their numbers have reached a critical value (approx. 107
cfu/ml in liquid medium), bacteria can modify and co-ordinate their behaviour to act
uniformly as a multicellular group. The phenomenon is initiated when the bacterial
cell density was achieved to a threshold value (that means a quorum has been
reached), then the whole bacterial population responds to the high cell density via
signal molecules by modifying its behaviour collectively for the synthesis of virulence
factors which could not be executed by the individual cell. Hence the population of
bacterial cells exhibit a new characteristic, which is dependent on cell density. Most
Gram-negative bacteria can sense, integrate and process information from the
environment via intercellular communication after a critical population has been
achieved, the phenomenon was originally termed “autoinduction“, now most
frequently called quorum-sensing (QS), a “symphony of bacterial voices“, and it can
also be named “cell to cell communication“ (Van Delden and Iglewski, 1998). The
vast majority of gram-negative quorum-sensing systems that have been studied thus
far utilize N-acyl homoserine lactones (AHL) as signaling molecules. When in high
enough concentration, these molecules can bind to and activate a transcriptional
activator, or R protein, which in turn induces expression of target genes (figure 1.2).
Fig.1.2. Quorum sensing in gram-negative organisms
involves 2 regulatory components: the transcriptional
activator protein (R protein) and the AI molecule.
Accumulation of AI occurs until a threshold level is
reached.  Then AI binds to and activates the R
protein, which in turn induces gene expression. The
R protein consists of two domains: the N terminus of
the protein that interacts with AI and the C terminus
that is involved in DNA binding. Typically, gram-
negative AI molecules are N-acyl-HSLs; however,
other types of signal molecules do exist (Van Delden
and Iglweski, 1998).
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In the past decade quorum sensing circuits have been identified in over 25 species of
Gram-negative bacteria (Bassler, 1999; de Kievit and Iglewski, 2000; Fuqua et al.,
1996; Parsek and Greenberg, 2000). In every case except those of Vibrio harveyi
and Myxococcus xanthus the quorum sensing circuits identified in Gram-negative
bacteria resemble the canonical quorum sensing circuit of the symbiotic bacterium
Vibrio fischeri. Specifically, these Gram-negative bacterial quorum sensing circuits
contain, at a minimum, homologues of two V. fischeri regulatory proteins called LuxI
and LuxR. The LuxI-like proteins are responsible for the biosynthesis of a specific
acylated homoserine lactone signaling molecule (HSL) known as an autoinducer.
The LuxR-like proteins bind cognate HSL autoinducers that have achieved a critical
threshold concentration, and the LuxR-autoinducer complexes also activate target
gene transcription (Engebrecht and Silverman, 1987). Using this quorum sensing
mechanism, Gram-negative bacteria can efficiently couple gene expression to
fluctuations in cell-population density. Among the 25 species of bacteria that mediate
quorum sensing by means of a LuxI/LuxR-type circuit, the V. fischeri, P. aeruginosa,
Agrobacterium tumefaciens, and Erwinia carotovora systems are the best
understood. 
1.3.2. Quorum sensing systems in P. aeruginosa 
In the opportunistic human pathogen P. aeruginosa, a hierarchical LuxI/LuxR circuit
regulates quorum sensing. Two pairs of LuxI/LuxR homologues, LasI/LasR
(Passador et al., 1993) and RhlI/RhlR (Brint and Ohman, 1995), exist in P.
aeruginosa. Both LasI and RhlI are autoinducer syntheses that catalyze the formation
of the HSL autoinducers N-(3-oxododecanoyl)-homoserine lactone (Pearson et al.,
1994) and N-(butyryl)-homoserine lactone (Pearson et al., 1995), respectively. The
two regulatory circuits act in tandem to control the expression of a number of P.
aeruginosa virulence factors. The P. aeruginosa quorum sensing circuit functions as
follows. At high cell density, LasR binds to its cognate HSL autoinducer, and together
they bind at promoter elements immediately preceding the genes encoding a number
of secreted virulence factors that are responsible for host tissue destruction during
initiation of the infection process. These pathogenicity determinants include elastase,
encoded by lasB; a protease encoded by lasA; exotoxinA, encoded by toxA; and
alkaline phosphatase, which is encoded by the aprA gene (Parsek et al., 1999; Miller
and Bassler, 2001). Analogous to the V. fischeri LuxI/LuxR circuit, LasR bound to
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autoinducer also activates lasI expression, which establishes a positive feedback
loop (Seed et al., 1995). The LasR-autoinducer complex also activates the
expression of the second quorum sensing system of P. aeruginosa (Ochsner and
Reiser, 1995). Specifically, expression of rhlR is induced. RhlR binds the autoinducer
produced by RhlI; this complex induces the expression of two genes that are also
under the control of the LasI/LasR system, lasB and aprA. Additionally, the RhlR-
autoinducer complex activates a second class of specific target genes. These genes
include rpoS, which encodes the stationary phase sigma factor; rhlAB, which
encodes rhamnosyltransferase and is involved in the synthesis of the
biosurfactant/hemolysin rhamnolipid; genes involved in pyocyanin antibiotic
synthesis; the lecA gene, which encodes a cytotoxic lectin; and the rhlI gene (Miller
and Bassler, 2001). Again, similar to LasI/LasR and LuxI/LuxR, activation of rhlI
establishes an autoregulatory loop. As mentioned above, the LasR-autoinducer
complex activates rhlR expression to initiate the second signaling cascade. However,
the LasR-dependent autoinducer, N-(3-oxododecanoyl)-homoserine lactone, also
prevents the binding of the RhlI-dependent autoinducer, N-(butyryl)-homoserine
lactone, to its cognate regulator RhlR (Pesci et al., 1997). Presumably, this second
level of control of RhlI/RhlR autoinduction by the LasI/LasR system ensures that the
two systems initiate their cascades sequentially and in the appropriate order.
A novel, additional autoinducer has recently been demonstrated to be involved in
quorum sensing in P. aeruginosa. This signal is noteworthy because it is not of the
homoserine lactone class. Rather, it is 2-heptyl-3-hydroxy-4-quinolone (denoted PQS
for Pseudomonas quinolone signal) (Pesci et al., 1999). PQS partially controls the
expression of the elastase gene lasB in conjunction with the Las and Rhl quorum
sensing systems. The expression of PQS requires LasR, and PQS in turn induces
transcription of rhlI. These data indicate that PQS is an additional link between the
Las and Rhl circuits. The notion is that PQS initiates the Rhl cascade by allowing the
production of the RhlI-directed autoinducer only after establishment of the LasI/LasR
signaling cascade. Following is the model (figure 1.3) showing quorum sensing circuit
and its regulation in P. aeruginosa.  
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Fig. 1.3. The quorum-sensing circuitry of P. aeruginosa is illustrated. Expression of the lasR gene is
subject to at least two levels of control: the global regulators Vfr and GacA and the las quorum-
sensing system, which regulates expression of both lasR and lasI. The latter creates an autoinduction
feedback loop. Regulation of the rhl system is similar to las in that GacA affects expression of rhlR,
and the rhlR and rhlI genes are controlled to some degree by the las system. Interestingly, the las
quorum-sensing system was shown to elicit an additional level of control over the rhl system; the las
signal molecule, 3-oxo-C12-HSL, can act posttranslationally to block RhlR activation by C4-HSL. The
las and rhl quorum-sensing systems regulate expression of numerous genes that contribute to the
virulence of P. aeruginosa. In addition, the las signal molecule, 3-oxo-C12-HSL, is required for biofilm
differentiation and exhibits immunomodulatory activity (de Kievit and Iglewski, 2000).
1.4. Intracellular lifestyle of bacterial pathogens 
The majority of bacteria (including many bacterial pathogens) that are phagocytosed
by macrophages and polymorphonuclear leukocytes (PMNs) are killed. PMN-
mediated phagocytosis and killing is the most important host defense mechanism
against P. aeruginosa (Döring et al., 1995). The PMN is a small cell, about 9-10 µm
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in diameter, and is the most abundant leukocyte. It is referred to as a first line of
defense, as it is the first defensive cell type to be recruited to a site of inflammation
(König et al., 1992). It is present in the bloodstream as well as attached to the
epithelium, especially close to inflammation sites (Smith, 2000). Furthermore, PMN
can enter tissues upon stimulation and move towards an inflammation site (Lala et
al., 1992). PMN possess an extensive array of antibacterial weaponary, both within
its granules and by generating reactive oxygen species (Elsbach, 1998;
Gudmundson and Agerberth, 1999). Prior to adherence to the target micro-organism,
the phagocyte begins to consume oxygen (oxidative burst). In the phagolysosome,
mainly superoxide anions are formed, which spontaneously or catalytically dismutate
into hydrogen peroxide and dioxygen (Superoxide dismutase, SOD). Hydrogen
peroxide is only slightly cytotoxic but due to its chemical properties can also act
within the bacterium, for example inflicting damages upon the DNA after permeation
of the bacterial cell wall. 
However, several pathogens have devised successful strategies that enable them to
survive and replicate within potentially lethal, phagocytic host cells. Successful
bacterial multiplication plays the pivotal role in causation of infection and disease.
Thus, many intracellular bacterial pathogens have devised strategies to grow within
host cells (intracellular multiplication). Bacteria use a variety of strategies to avoid
engulfment and degradation by phagocytes and facilitate proliferation and spread
among host tissues (Underhill and Ozinsky, 2002). Examples are the inhibition of
phagocytosis by capsule formation or toxin-mediated cellular destruction and
necrosis. In contrast, induction of apoptosis avoids the release of pro-inflammatory
signals (Weinrauch and Zychlinsky, 1999). Host-induced apoptosis of lung epithelial
cells during infection with P. aeruginosa plays an important role in reducing leukocyte
infiltration and maintaining the essential function of the lung: the oxygenation of blood
(Grassme et al., 2000). In contrast, Salmonella and Shigella both actively stimulate
pro-apoptotic pathways in order to paralyze phagocytic defense: SipB from S.
enterica Typhimurium and the similar IpaB from S. flexneri are translocated via a type
III secretion apparatus into the host cytosol. These proteins bind to caspase-1, which
activates downstream caspases and induces apoptosis (Hersh et al., 1999;
Zychlinsky et al., 1994). The observation that caspase-1–deficient mice are resistant
to infection with wild-type Salmonella suggests that this mechanism may contribute to
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the pathogenesis of this bacterium (Monack et al., 2000). Yersinia enterocolitica
YopP (like its homolog Yersinia pseudotuberculosis YopJ) can also inhibit anti-
apoptotic signals via the repression of NF- B activation as well as stimulation of pro-
apoptotic signals through LPS-mediated activation of the TLR4 pathway
(Ruckdeschel et al., 2002). Y. enterocolitica and Y. pseudotuberculosis can inhibit
phagocytosis by the translocation of bacterial mediators that specifically disorganize
the host cell cytoskeleton preventing bacterial uptake by macrophages and
polymorphonuclear leukocytes (Black and Bliska, 2000; Fallman et al., 1995). Once
internalization has occurred, some bacteria such as the food-borne pathogen Listeria
monocytogenes, which is responsible for serious infections in immunocompromised
individuals: manage to survive, persist and even proliferate in host phagocytes. To
avoid degradation in the phagolysosome, L. monocytogenes is able to escape into
the host cell cytosol by means of a bacterial toxin, listeriolysin, which disrupts the
endosomal membrane (Dramsi and Cossart, 2002). Other pathogens such as
Salmonella are able to manipulate endosomal trafficking and recruit defense factors
to the maturing vacuole (Eriksson et al., 2000). S. enterica Typhimurium, for
example, is able to reduce the recruitment of NADPH oxidase and inducible nitric
oxide synthase (iNOS) to the vacuole through interference with vacuolar trafficking,
thereby preventing oxygen radical production and bacterial killing in macrophages
(Uchiya et al., 1999; Vazquez-Torres et al., 2000; Chakravortty et al., 2002). The fact
that many different Salmonella mutants that are able to down-regulate host iNOS
activity could be isolated in a screen of macrophage-adapted bacteria suggests that
Salmonella use several strategies for interfering with the host NO response (Eriksson
et al., 2000). And like many other bacteria, Salmonella is able to detoxify oxygen
radicals enzymatically (Fang et al., 1999). M. tuberculosis inhibits phagosomal
maturation by depleting H+ ATPase molecules from the vacuolar membrane (Sturgill-
Koszycki et al., 1994). This leads to reduced acidification and allows intracellular
survival and growth.
Although the PMN is considered to be the host’s most proficient antipseudomonal
weapon, at least some P. aeruginosa isolates seem to be able to surmount even this
defense mechanism. About 20% of  tested CF clinical isolates have been shown to
induce the oncosis of macrophages and PMNs as indicated by cellular and nuclear
swelling, disintegration of the plasma membrane, and absence of DNA fragmentation
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(Dacheux et al., 2000). Cell death results from a pore-forming activity that requires
the intact pcrGVHpopBD operon of the type III secretion system (Dacheux et al.,
2001). A P. aeruginosa strain that combats PMNs by other, type III-independent
mechanisms has been detected (Tümmler, 1987). The highly virulent CF clinical
isolate TB (TBCF10839) is able to constitutively survive and replicate in PMNs.
TBCF10839 grows in human neutrophils irrespective of whether they were isolated
from patients with CF or healthy donors (Tümmler, 1987). Intracellular survival in host
defense cells is the typical lifestyle of a few obligatory pathogens but has so far not
been attributed to the ubiquitous P. aeruginosa.
1.4.1. P. aeruginosa TB: Survival in PMN
The P. aeruginosa strain TB was isolated in 1983 from the sputum of a CF patient
who had been rapidly deteriorating within three years after acquisition of airways with
P. aeruginosa and who was severely ill at the time of strain isolation (Tümmler,
1987). After strain TBCF10839 had been eradicated from the patient’s airways by
high-dose antipseudomonal chemotherapy the patient recovered and since then has
remained in a stable state. Macrorestriction fragment pattern analysis of sequential
isolates over the last 18 years verified that the patient was not re-infected by the
TBCF10839 clone after this episode (Tümmler, 1987). Strain TBCF10839 was
clinically the most virulent strain amongst clone TB isolates which were frequently
isolated from CF patients and burnt patients treated at the Medizinische Hochschule
Hannover in the 80s (Tümmler et al., 1991; Kiewitz and Tümmler, 2000).
Phagocytosis assays with freshly isolated PMNs uncovered the putative reason for
the virulence of strain TBCF10839. Whereas the genetic reference strain PAO1 was
efficiently phagocytosed and lysed under standard conditions, the CFU of
TBCF10839 initially declined within the first 30 minutes but continuously increased
thereafter indicating cell growth (Miethke, 1985).  
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Fig. 1.4. Electron micrograph of P. aeruginosa (PAO1, or SG17M or C) (A) and TB (B) incubated with
granulocytes. Bacteria were added at a multiplicity of  infection (MOI) 20 and incubated at 37 oC for 30
min.
Electron microscopy revealed that after 30 minutes only cell debris remained from P.
aeruginosa PAO1 in the phagolysosomes (figure 1.4A). In contrast, phagocytosed
bacteria of strain TBCF10839 were still intact (figure 1.4B). Viable P. aeruginosa
TBCF10839 and bacterial cell debris were often found in one and the same vacuole,
thus implicating that the uptake of the bacteria by the PMN does not hinder the fusion
of the phagosome with lysosomes (figure 1.5). TBCF10839 bacteria resided in the
extracellular space and the cytosolic and lysosomal compartments of the PMNs. At
higher magnification lysis of the phagolysosomal membrane was observed, thus
allowing the bacteria direct access to the cytosol of the PMN. By 60 minutes and
thereafter the TBCF10839 bacteria multiplied in the phagolysosomes (Wiehlmann,
2001). In summary, internalized P. aeruginosa TBCF10839 are far more resistant to
the conditions in the PMN phagolysosome than common P. aeruginosa strains.
A B
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Intracellular growth in PMNs is extremely rare amongst bacteria and has yet not been
reported for P. aeruginosa, although a related type III-secretion dependent
phenomenon in macrophages called oncosis has been detected in virulent clinical
isolates (Dacheux et al., 2001; Dacheux et al., 2000). P. aeruginosa TBCF10839 is
not only able to survive in PMN but also replicates after less than one hour.
Intracellular pathogens typically undergo a lag phase, which is used for adaptation to
the conditions in the phagosome as well as to eliminate the lytic processes of the
phagocyting cell (Aldridge and Hughes, 2001; Ernst, 2000; Galan, 2001; Philpott et
al., 2001). Only after the completion of this phase, further cell divisions can be seen.
P. aeruginosa TBCF10839 does not need such an adaptation. After 2 hours PMNs
are starting to die, the bacteria are released and are growing fast in the nutrient-rich
sludge. The enhanced resistance of P. aeruginosa TBCF10839 towards PMNs is not
limited to those of CF patients. PMNs from 40 tested healthy donors consistently
showed all the same phenotype of bacterial growth in the phagocytosis assay under
standard conditions of a tenfold excess of bacteria over PMNs. This shows that the
opportunistic pathogen P. aeruginosa can convert into a highly virulent micro-
organism. The dominant-negative selection by signature-tagged mutagenesis (STM)
(Hensel et al., 1995) has been applied to unravel the etiology of this uncommon
virulence trait (Wiehlmann et al., 2002). 
Fig. 1.5. Electron micrograph of P.
aeruginosa TB (CF10839) incubated with
granulocytes. Bacteria were added at a
multiplicity of  infection (MOI) 20 and
incubated at 37 oC for 1 h.
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1.5. Methods for functional genome analysis
Microbial responses during the infection process cannot be discerned from in vitro
studies alone. Host microenvironments are much more complex, and change as the
infection proceeds due to inflammation, tissue breakdown, and immune responses of
the host. Smith (1998) has distilled three implications from the fact that environmental
conditions in vivo are not the same as those in vitro: (i) some candidate virulence
determinants produced in vitro may not be produced during infection, (ii) some
virulence determinants produced during infection may not be produced in vitro, and
(iii) the repertoire of virulence determinants changes as the infection proceeds.
There are many fundamentally different methods for identifying in vivo expressed
genes (Hautefort and Hinton, 2000; Heithoff et al., 1997). All approaches benefit from
the recent availability of microbial whole genome sequences, as often a short
nucleotide sequence from any gene selected by these methods will suffice for
database identification. The following methods have been used to investigate gene
expression in various infections. 
1.5.1. In vivo expression technology 
In vivo expression technology (IVET) is a promoter trap strategy that selects bacterial
promoters driving the expression of a gene required for growth within the host.
Complementation in the animal demands elevated levels of gene expression
compared to growth on laboratory medium (Mahan et al., 1993; Mahan et al., 1995).
Modification of the selection/reporter system allows the study of bacterial gene
expression in animals and within cultured cells. In addition, lac gene fusions have
been used to identify co-ordinately regulated genes that are preferentially expressed
during infection (Heithoff et al., 1999a) as well as the regulatory parameters that
govern their expression (Heithoff et al., 1999b). The recombinase-based IVET
system, RIVET (Camilli and Mekalanos, 1995), is designed to monitor spatial and
temporal patterns of gene expression during infection. Because RIVET is
independent of selection parameters such as innate auxotrophic requirements in the
animal, bacterial genes can be identified that are weakly and/or transiently expressed
during infection. 
Introduction
19
1.5.2. Differential fluorescence induction 
Differential fluorescence induction (DFI) is a promoter trap strategy that takes
advantage of the high throughput and semi-automation of fluorescence activated cell
sorting (FACS) to measure intracellular fluorescence in individual bacterial cells
(Cirillo et al., 1998; Valdivia and Falkow, 1997). FACS can be used to identify either
fluorescent bacteria or host cells containing fluorescent bacteria through the use of a
green fluorescent protein (GFP) reporter. GFP facilitates real-time measurements of
gene expression in vivo, including the analysis of large cell populations. Like RIVET,
DFI screens are not influenced by selection parameters, and thus genes can be
identified that are weakly and/or transiently expressed during infection. Moreover,
DFI has identified genes encoding elusive functions involved in bacterial persistence
within host granulomas (Ramakrishnan et al., 2000). DFI may be best exploited in an
approach that integrates high throughput screening and genomics (Strauss and
Falkow, 1997). 
1.5.3. Signature tagged mutagenesis 
Signature tagged mutagenesis (STM) is a negative selection strategy in which an
animal host is infected with a pool of sequence-tagged insertion mutants. Mutations
represented in the initial inoculum but not recovered from the host are required for
infection (Hensel et al., 1995). The major advantage of STM is that it directly
identifies genes involved in virulence rather than indirectly by in vivo expression. Like
RIVET and DFI, it does not depend on selection parameters and can be used to
identify genes that are expressed transiently or at low levels. STM is relatively easy
to adapt to many host-pathogen systems and, unlike IVET methods, it is not
dependent on preferential transcription in host tissues. Rather, its principal operating
strategy is to identify functions required for survival within the host. However, mutants
that are slow-growing, inviable, contain mutations in genes encoding redundant
functions, or that can be complemented in a mixed population (e.g. by secreted
factors), may be underrepresented.
Recently, Lehoux et al. (2002) adapted PCR-based signature-tagged mutagenesis to
P. aeruginosa and a collection of 1056 mutants was screened in a chronic lung
infection rat model. STM is also used successfully in identification of factors involved
in virulence/colonization in many pathogenic bacteria, such as Staphylococcus
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aureus (Coulter et al., 1998; Mei et al., 1997; Schwan et al., 1998), Salmonella
typhimurium (Shea et al., 1996), Vibrio cholerae (Chiang and Mekalanos, 1998),
Neisseria meningitidis (Claus et al., 1998), Streptococcus pneumoniae (Polissi et al.,
1998), Legionella pneumophila (Edelstein et al., 1999), Yersinia enterocolitica
(Darwin and Miller, 1999), Proteus mirabilis (Zhao et al., 1999), Mycobacterium
tuberculosis (Camacho et al., 1999) Brucella abortus (Hong et al., 2000), Brucella
melitensis (Lestrate et al., 2000), and Streptococcus agalactiae (Jones et al., 2000)
including P. aeruginosa (Lehoux et al., 2002). The strength of STM is that it
combines the power of insertional mutagenesis with in vivo negative selection of
attenuated strains in an animal model. The presence or loss of each mutant from an
animal model can be assessed by following the unique signature tags present on the
insertional element. Thus, with STM, one can screen many different mutants in a
single assay to identify those factors that are essential for intracellular survival in the
host cells.
Modifications of the STM method include the use of pre-selected tagged transposons
to construct the mutant library, which simplifies the screening significantly (Mei et al.,
1997). STM screenings of a mutant library in more than one infection model have
been performed (Coulter et al., 1998; Tsolis et al., 1999; Bispham et al., 2001; Lau et
al., 2001). Such screenings provide valuable knowledge of whether the same
virulence factors are involved in different types of infections. By use of the traditional
STM methodology, screenings in more than one infection model are, however, very
laborious.
1.5.4. Differential display 
Differential Display (DD) is a subtractive hybridization strategy in which bacterial
cDNAs from infected tissue are hybridized against a cDNA library constructed from
laboratory-grown bacteria (Abu Kwaik and Pederson, 1996; Plum and Clarke-Curtiss,
1994). The resulting host-specific cDNAs are used as probes to isolate genes that
are preferentially expressed in host tissues. DD can be used in pathogens lacking
well-developed genetic tools, can be applied to two or more conditions
simultaneously, and has the added advantage of being able to detect both up- and
down-regulation of in vivo expressed genes. Disadvantages include the instability of
bacterial mRNA for the construction of cDNA libraries, the low abundance of
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messages from transiently expressed genes, and the difficulty in isolation of sufficient
high-quality mRNA from small populations of bacteria in vivo. PCR-based
modifications may allow representation of low-abundance mRNAs, but the
concomitant concern is the generation of false-positives.
1.5.5. DNA microarray technology
A main characteristic of pathogenic micro-organisms is their ability to cause tissue
damage and consequently disease in their host. For decades, scientists have used a
wide variety of methods to study how micro-organisms interact with the host to cause
damage and the mechanisms by which the host protects itself from micro-organisms.
This information has been invaluable in the design of safe and effective diagnostics,
therapeutics and vaccines. We are currently in the midst of an explosive increase in
the availability of genomic sequence information, with 144 genomes having been fully
sequenced and published, and more than 344 prokaryotic genomes are in the
process of being sequenced (http://www.tigr.org/tdb/). The availability of the complete
sequence of both host and pathogen is promising in developing novel insights into
the host-pathogen relationship. However, extracting biological knowledge from
sequence data is the essential challenge of this post-genome era. DNA microarray
(GeneChip) based approaches have gained rapid acceptance in a variety of fields for
studying the roles of genes in the pathogenesis of infectious disease.
The theory and background of microarray technology, as well as the technology
itself, have been described in detail elsewhere (Ferea and Brown, 1999; Lipshutz et
al., 1999). In brief, a DNA microarray is a microscopic chequerboard representing
thousands of different DNA sequences. There are several methods of producing
microarrays, but the two most commonly used techniques: spotted glass slide
microarray and high-density oligonucleotide array technology. In the spotted
microarray, presynthesized single-stranded or double-stranded DNA is bound or
'printed' onto glass slides. The DNA can be generated from cloned, synthesized or
polymerase chain reaction (PCR)-amplified material. Because of the technical
simplicity of this approach, spotted microarrays can be produced in house as well as
purchased from commercial providers. High-density oligonucleotide arrays are
constructed by synthesizing short ( 25-mer) oligonucleotides in situ on glass wafers
using a photolithographic manufacturing process and are thus available only from
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commercial vendors (Lipshutz et al., 1999). Both types of DNA microarrays are used
to measure the relative abundance of DNA or RNA in order to compare genomes or
gene expression profiles.
Microarray-based approaches have several advantages over other systems that
have been used previously to study pathogens and their interaction with hosts, such
as those that measure the expression of a small number of genes in individual
experiments. The major advantage of microarrays is their ability to measure
simultaneously the presence of tens of thousands of different nucleic acid
sequences. Thus, this technique permits the quantification of specific genes and their
expression patterns in a comprehensive genome-wide framework. Although
expensive relative to other quantitative hybridization and amplification methods, the
high-throughput capacity makes it a cost-effective technique for a variety of
applications. 
Microarray technology has been used in variety of applications such as to study the
genetic polymorphism of pathogens (Fitzgerald et al., 2003; Kato-Maeda et al., 2001;
Salama et al., 2000; Troesch et al., 1999; Hacia and Collins, 1999; Gingeras et al.,
1998), host-pathogen interactions (Ren et al., 2003; Brooks et al., 2003; Ng et al.,
2003; Boyce et al., 2002; Schoolnik, 2002; Detweiler et al., 2001; Eckmann et al.,
2000; Cummings and Relman, 2000; Manger and Relman, 2000), the gene
expression profiles of pathogens (Minagawa et al., 2003; Lobner-Olesen, et al., 2003;
Schembri et al., 2003; Phadtare et al., 2002; de Saizieu et al., 2000; Eckmann et al.,
2000; Tao et al., 1999) and drug target identification (Anzick and Trent, 2002;
Debouck and Goodfellow, 1999; Braxton and Bedilion, 1998).
1.6. P. aeruginosa pathogenicity in murine infection
model 
A pathogenesis model in which both the pathogen and the host are genetically
tractable would greatly facilitate our understanding of some of the universal
mechanisms underlying host-pathogen interactions. In 1979, Cash et al. enmeshed
different concentration of P. aeruginosa in agar beads and installed the inocula
intratracheally into the lungs of normal rats in order to mimic the chronic P.
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aeruginosa infection in CF. The immobilized bacteria were not cleared and
proliferated within 3 days, and high dose of bacteria was still persisted in the lungs
after 35 days (Cash et al., 1979). The histopathologic and serologic changes were
similar to what observed in the chronic lungs of CF patients, i.e. Inflammation
reactions with many PMNs surrounding a bead containing bacteria and small
microcolonies formed at the periphery of the bead, and strong antibodies against P.
aeruginosa could be detected in the serum (Cash et al., 1979). Since then, several
chronic models of lung P. aeruginosa infection have been established in animal
species including rat (Pedersen et al., 1990), guinea pig (Pennington et al., 1981),
cats (Thomassen et al., 1984), inbred mice (Morissette et al., 1995; Stevenson et al.,
1995), outbreed mice (Starke et al., 1987) and monkeys (Cheung et al., 1992;
Cheung et al.,1993). P. aeruginosa must be entrapped into immobilizing agents such
as agar, agarose or seaweed alginate to limit bacterial clearance in order to achieve
a chronic infection lasting for a longer period of time. 
Several groups have tried to use different variants of transgenic CF mice for the
study of P. aeruginosa lung infection since the CFTR gene was found in 1989, and
first CF mouse model was generated by Snouwaert et al. (1992) and Clarke et al.
(1992). Rahme et al. (1995) introduced a multihost system by showing that several
strains of the human opportunistic pathogen P. aeruginosa cause disease in both
plants and animals. P. aeruginosa virulence has been tested in several pathogenicity
models such as  Arabidopsis leaves (Rahme et al., 1995), wax moth caterpillar
Galleria mellonella (Jander et al., 2000), mouse full-skin-thickness burn model
(Rahme et al., 1995), and nematode Caenorhabditis elegans (Mahajan-Miklos et al.,
1999). 
1.7. Objectives of the present investigation
 One of the challenges of the future is the functional analysis of putative ORFs
identified in genome sequencing projects and their integration into regulatory
networks and metabolic pathways.  This thesis applies the up-to-date technology of
functional genomics to unravel virulence factors and pathogenicity mechanisms of
the opportunistic pathogen  P. aeruginosa.
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Phagocytosis and lysis of P. aeruginosa by PMNs is the most important
antipseudomonal host defense mechanism in man. The supervisor’s laboratory
identified one of the most virulent P. aeruginosa strains known to date. This strain TB
(TBCF10839) from the lung of a cystic fibrosis patient (Miethke, 1985) survives and
multiplies both in the phagolysosomal compartment and the cytosol of
polymorphonuclear granulocytes. A minitransposon Tn5 library of non-auxotrophic
isogenic mutants has been constructed in the laboratory to identify the encoded
phenotypic traits that are responsible for the transition from the typical extracellular
lifestyle of the ubiquitous P. aeruginosa to intracellular growth in the most hostile
environment the bacterium can encounter. The transposon mutants carry specific
single-copy oligonucleotides. These tags allow to test numerous mutants
simultaneously for changes in phenotype compared to the wild type strain. Hence,
multiple mutants each carrying a different signature tag can be tested for differential
survival in PMNs. A previous Ph. D. student of the group  constructed this so-called
STM library of strain TB and screened one third of the mutants for differential survival
in PMNs (Wiehlmann et al., 2002).
It is the major objective of the thesis to search within the remaining pool of two-thirds
of non-screened mutants for key genes that are essential for intracellular growth of P.
aeruginosa TB and thereafter to characterize the role of the inactivated  gene for
virulence and lifestyle by whole-genome gene expression profiling and specific
phenotypic assays. In other words, the objectives of the present investigation are to
identify genes which contribute for the survival and growth of P. aeruginosa TB in
PMNs and to understand the genetic mechanism as how P. aeruginosa TB can
become an intracellular pathogen.
For this, the following tasks need to be accomplished:
1. Screening of the STM library for mutants with differential intracellular survival in
granulocytes and quorum-sensing mediated virulence. 
2. Identification of the transposon inactivated genes by sequencing. 
3. Phenotypic comparison of wild type strain and isogenic mutant in various
bioassays such as sensitivity towards hydrogen peroxide, cytotoxicity and quorum
sensing.
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4. Whole genome gene expression profiling (transcriptome) of the subset of mutants
carrying the transposon in regulatory genes or novel genes that are not present in
the completely sequenced genetic reference strain PAO1, under conditions
mimicking differential aspects of the PMN habitat and standard growth conditions. 
5. Comparison of the global transcriptional pattern of P. aeruginosa TB, its less
virulent clonal variant  892 and the genetic reference strain PAO1 under paraquat
mediated superoxide stress and hydrogen peroxide mediated oxidative stress.
6. Global impact of the identified genes on inflammation and pathogenicity by
comparison of wild type TB and isogenic transposon mutants in a murine P.
aeruginosa lung infection model.
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2. MATERIALS AND METHODS
2.1. Materials
2.1.1. Equipments
Balance        BP3100S
                     BP210  S Sartorius
Centrifuge Hettich Universal
Eppendorf centrifuge 5415C Eppendorf
Eppendorf centrifuge 5417R Eppendorf
Heating block DR-block DB-3 Techne
Hybridization oven 400 HY Bachofer
Hybridization oven Biometra
Incubator Heraeus
Minifold I Vacuum blotter Schleicher and Schuell
pH meter 766 Calimatic Knick
Spectrophotometer U3000 Hitachi
Thermocycler Landgraf
Thermomixer Eppendorf
UV- Transilluminator Bachofer
UV Stratalinker 1800 Stratagene
Vacuum concentrator Bachofer
Voltage supply power pack 300 Bio-Rad
2.1.2. Consumables 
Eppendorf tubes (0.5 ml, 1.5 ml, 2 ml) Sarstedt
Filter Cellulose ester HA 0.45 µM pore size Millipore
Filter Cellulose acetate 0.2 & 5 µM poresize Sartorius
Filter paper GB003 Schleicher and Schuell
Pasteurpipette Sarstedt
Petri plates 9 cm Ø Sarstedt
Pipette tips (1 ml, 200 µl, 10 µl) Sarstedt
Plastic tubes (50 ml, 15 ml) Greiner
Polaroid film 667 Polaroid
TLC plate Merck
X-ray film Kodak, AGFA
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2.1.3. Chemicals and enzymes
Affymetrix Enzo BioArray Terminal Labeling Kit, Oligonucleotide B2, P.
aeruginosa GeneChip
Amersham Pharmacia
Biotech 
Deoxynucleotides, Hybond N+ nylon membrane, OnePhorAll-buffer,
RNase-free DNase l, TEMED
Ambion SUPERaseIn (RNase Inhibitor)
Blood bank MHH AB serum
Biozym SeaKem GTG Agarose
Die & Bernsten (DK) Formalin buffer
Difco Agar, Bacto-Peptone, Beef extract
Gibco BRL Agar, Agarose, DMEM medium, FCS, Fetal calf serum, Lymphocyte
separation medium, PBS Tablets, RPMI 1640 medium
In ViTeK Taq-Polymerase + buffer system
Invitrogen Bromophenol blue, Bovine serum albumin, Gentamicin, MOPS buffer,
Random Primers, RNA-standard, Serva Blau G-250, SuperScript II
Reverse Transcriptase, Xylene cyanol FF
Janssen, Denmark Hypnorm
KVL, Denmark Pentobarbital
Leo Pharma, Denmark Heparin
Merck Formaldehyde 35 %, Hydrogen peroxide (30 %), Liquemin (Heparin),
Uranylacetate
Molecular Probes Streptavidine-Phycoerythrine, SYBRGreen 
MWG-Biotech Oligodeoxynucleotides, Primers
New England Biolabs DNA-ladder standards, Restriction enzymes + buffer system, T4-DNA-
Ligase
Pierce Chemical Streptavidine
Promega Herring-Sperm DNA, RNase Inhibitor
Proton A/S, Norway Protonal
Qiagen Plasmid Spin Kit, Qia- Mini Prep plasmid kit, QIAquick Gel Extraction
Kit, RNeasy Kit, RNase A
Roche Molecular
Biochemicals
Alkaline Phosphatase, Anti-Dioxigenin AP fab fragment, DNA Labeling
and Detection Kit, Klenow Polymerase I, Midazolam, RNase-free
DNase I, Terminal Transferase + Buffer system, Blocking reagent
Roth Acrylamide solution (Rotiphorese-Gel 40), Ethidium bromide, Phenol
(Rotiphenol), DPEC
Schleicher & Schuell Nitrocellulose membrane
Serva Gentamicin
Sigma Chelex-100 (iminodiacetic acid), Ethidium bromide, Proteinase K,
paraquat, Propidium iodide, Tween 20, H2SO4
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Tropix CDP- Star, DEA
Vector Laboratories Biotin anti-Streptavidine
2.1.4. Media and solutions
2.1.4.1. Media
(1)  LB Medium:
Peptone 15  g/l
Yeast Extract 5  g/l 
NaCl (10g/l) 0.17  M
 LB-GM: LB medium with 25 µg/l Gentamicin
 LB- Agar: LB medium was solidified by adding 15 g/l agar and
                                          autoclaved.
(2)  M9- Medium (10X):
Na2HPO4 (68.14 g/l) 0.48  M 
KH2PO4 (30 g/l) 0.22  M
NaCl (5 g/l) 85  mM
NH4Cl (10 g/l) 0.18  M
Casein 0.5 % (w/v)
                 M9- Agar: The M9 (10x) medium and agar (15 g/l water) were
                                          autoclaved separately. Casein was warmed in M9 medium
                                          and mixed with the melted agar when the temperature
                                          was about 50 oC.
(3) M8- Medium:
Na2HPO4 (68.14 g/l) 0.48  M
KH2PO4 (30 g/l) 0.22  M
NaCl (5 g/l) 85  mM
Aspartate 0.05 % (w/v)
Glucose 0.2 % (w/v)
M8- Agar: The M8 medium was supplemented with 0.5 % agar for
                                the solidification.
(4)  SOB:
Bactotryptone 20  g/l
Yeast Extract 5  g/l
NaCl (0.58 g/l) 10  mM
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KCl (0.185 g/l) 2.5  mM
pH 7.0
after autoclaving, the following filter sterilized stock
solutions were added
MgCl2 (1 g/l) 10  mM
MgSO4 (1.2 g/l) 10  mM
(5)  SOC:
SOB + 20 mM Glucose (3.6 g/l)
(6)  ABC minimal medium:
A: (NH4)2SO4 (20 g/l) 0.15  M
Na2HPO4 ·2H2O (60 g/l) 0.33  M
KH2PO4 (30 g/l) 0.22  M
NaCl (29 g/l) 0.5  M
B: MgCl2 ·6H2O (0.4 g/l) 2  mM
CaCl2 ·2H2O (0.014 g/l) 0.1  mM
FeCl3 ·6H2O (0.008 g/l) 0.003  mM
C: Sodium citrate 10  mM
All the components were separately sterilized and mixed
with water at the above mentioned final concentration.
Components A & C were autoclaved, while the component
B was filter sterilized. 
2.1.4.2. Solutions for DNA work
(1) TBE-Buffer (10X): 
Tris (108 g/l ) 0.9  M
Boric Acid (55 g/l) 0.9  M
EDTA (7.7 g/l) 0.02  M
pH 8.3-8.5
(2)  Loading Buffer (6X):
Ficoll 400 15 % (v/v)
Bromophenol Blue 0.25 % (w/v)
Xylene cyanol 0.25 % (w/v)
EDTA (146 g/l) 0.5  M 
pH 8.0
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(3)  PBS (10X):
NaCl (80 g/l) 1.37  M
KCl (2 g/l) 27  mM
Na2HPO4 ·7H2O (11.5 g/l) 4.3  mM
KH2PO4 (2 g/l) 1.4  mM
pH 7.3
(4)  TB Buffer:
PIPES (3 g/l) 10  mM
CaCl2 (1.6 g/l) 15  mM
KCl (18.6 g/l) 250  mM
pH adjusted to 6.7 with KOH, then MnCl2 (50 mM-9.58 g/l)
was added, sterilized by filtration and stored at 4 oC.
(5)  TE Buffer:
Tris-HCl (1.2 g/l) 10  mM
EDTA (0.38 g/l) 1  mM
pH 8.0 
(6)  Plasmid DNA isolation:
       Solution I:
Tris-Cl (6 g/l) 50  mM
EDTA (3.8 g/l) 10  mM
DNase free RNase A 100  µg/ml
pH 8.0
       Solution II:
NaOH (16 g/l) 0.4  M 
SDS 1 % (w/v)
      Solution III:
Potassium acetate (294 g/l) 3  M
Acetic acid (115 ml/l) 2  M
(7)  Lysis Buffer:
Tris-acetate (4.84 g/l) 40  mM
Sodium acetate 20  mM
EDTA (0.38 g/l) 1  mM
SDS 1 % (w/v)
pH 7.8
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(8)  Fixation solution:
PBS 1x
Paraformaldehyde 1 % (v/v)
CaCl2 (0.11 g/l) 1  mM
pH 7.2-7.4
(9)  Colour solution for gel filtration:
Dextran Blue (2 x 106 g/mol) 0.8 % (w/v)
Phenol red (376 g/mol) 0.5 % (w/v)
(10)  Blot buffer:
NaOH (16 g/l) 0.4  M
(11)  Blot wash buffer:
NaH2PO4 ·2H2O (7.8 g/l) 50  mM
pH 6.5 with NaOH
(12)  Pre-hybridization buffer:
SDS 7 % (w/v)
NaH2PO4 ·2H2O (78 g/l) 0.5  M
EDTA (0.38 g/l) 1  mM
pH 7.2
Blocking reagent 0.5 % (w/v)
Blocking reagent was dissolved by heating the solution
to 50-70 oC.
(13)  Non radioactive detection:
        Hybridization wash buffer:
NaH2PO4 ·2H2O (6.3 g/l) 40  mM
SDS 1 % (w/v)
EDTA (0.38 g/l) 1  mM
pH 7.2
        Buffer I:
Tris-HCl (12 g/l) 100  mM
NaCl (8.7 g/l) 150  mM
pH 7.5
        Buffer II:
Buffer I + 0.5 % (w/v) Blocking reagent 
Materials and methods
32
       Antibody solution:
1:5000 dilution of Anti- Digoxigenin AP Fab- alkaline
phosphatase conjugate in buffer II.
       Buffer III:
Tris-HCl (12 g/l) 100  mM
NaCl (5.8 g/l) 100  mM
MgCl2 (4.8 g/l) 50  mM
pH 9.5
(14)  Wash solution:
NaOH (8 g/l) 0.2  M
SDS 0.1 % (w/v)
(15) Sucrose solution:
Sucrose (171 g/l) 0.5  M
Tris-HCl (12 g/l) 0.1  M
pH 8.0
(16) TET buffer:
Tris-HCl (1.2 g/l) 10  mM 
EDTA (1.9 g/l) 5  mM
Triton-X100 0.1 % (v/v)
pH 8.0
2.1.4.3. Solutions for RNA work
(1) RNA Lysis buffer:
SDS 2 % (w/v)
Sodium acetate 3  mM      
EDTA 0.1 %  (w/v)
pH 5.5
(2) DNase buffer (10 x):
Sodium acetate 500  mM  
MgCl2 ·6H2O (20.3 g/l) 100  mM
CaCl2 ·2H2O (2.94 g/l) 20  mM
pH  6.5
(3) MOPS buffer (10 x):
MOPS (41.8 g/l) 200  mM  
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Sodium acetate 100  mM
EDTA (2.9 g/l) 10  mM
pH 7.0
(4) RNA loading buffer:
Glycerol 50 % (v/v)
EDTA (0.29 g/l) 1  mM      
Bromophenol blue 0.25 % (w/v)
pH 6.0
(5) SSC buffer (20 x):
NaCl (175 g/l) 3  M
Sodium citrate 0.3 M
pH 7.0
(6) Northern hybridization solutions:
       Pre-hybridization buffer:
Formamide 50 % (v/v)
Denhardt’s solution 5x
SSC 5x
SDS 1 % (w/v)
Herring sperm DNA 100 µg/ml
The Herring sperm DNA was fragmented by the
ultrasound sonication treatment and then denatured (10
min at 95 oC) before adding it to the hybridization solution. 
       Denhardt’s solution:
Ficoll (Type 400) 2 % (v/v)
Polyvinylpyrrolidine (PVP-40) 2 % (v/v)
Cattle serum albumin 2 % (v/v)
       Buffer I:
NaCl (175 g/l) 3  M
Tris-HCl (12 g/l) 0.1  M      
Tween 20 0.3 % (v/v)
pH 8.0
       Buffer II:
Buffer I + 0.5 % (w/v) Blocking reagent 
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       Buffer III:
Tris-HCl (12 g/l) 100  mM  
NaCl (5.8 g/l) 100  mM
MgCl2 (4.8 g/l)  50  mM
pH  9.5
(7)  cDNA Reaction mixture:
1st Strand buffer 5 x
DTT 10  mM
dNTPs 0.5  mM
SUPERaseIn 0.5  U/µl
SuperScript II 25  U/µl 
(8)  MES hybridization buffer: 
MES 100  mM
NaCl (58 g/l) 1  M
EDTA (5.84) 20  mM
Tween 20 0.01 % (v/v)
(protected from light and stored at 2-8 oC)
(9)  Non-stringent buffer:
SSPE 6 x
Tween 20 0.01 % (v/v)
(filtered through a 0.2 µM filter)
(10)  Stringent wash buffer:
MES 100  mM
NaCl (5.8 g/l) 0.1  M
Tween 20 0.01 % (v/v)
(filtered through a 0.2 µM filter, shielded from light and
stored at 2-8 oC)
(11) Streptavidin solution mix:
MES 100  mM
NaCl (58 g/l) 1  M
Streptavidin 10  µg/ml
BSA 2  mg/ml
Tween 20 0.05 % (v/v)
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(12) Antibody solution mix (secondary stain):
MES 100  mM
NaCl (58 g/l) 1  M
Biotin Anti-streptavidin 5  µg/ml
Goat IgG 0.1  mg/ml
BSA 2  mg/ml
Tween 20 0.05 % (v/v)
(13) SAPE solution mix (Tertiary stain):
MES 100  mM
NaCl (58 g/l) 1  M
Streptavidin-Phycoerythrin 10  µg/ml
BSA 2  mg/ml
Tween 20 0.05 % (v/v)
2.1.4.4. Solutions for animal experiments
(1) Alginate solution:
Protonal 11  mg/ml
NaCl 0.9 % (w/v)
(autoclaved)
(2) Tris- calcium chloride buffer:
Tris-HCl (12 g/l) 0.1  M
CaCl2. 2H2O (14.7 g/l) 0.1  M
pH 7.0
(3) Hypnorm & Midazolam mixture:
Hypnorm 2.5  mg/ml
Midazolam 1.25  mg/ml
2.1.5. Bacterial cultures
2.1.5.1. Escherichia coli DH5α:
F -,ϕ80, m80lacZ∆M1S, ∆(lacYZA-argF)U169, recA1, endA1, hsdR17(rK-;mK+),
supE44,λ-,thi-, gyrA, relA1
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2.1.5.2. Pseudomonas aeruginosa
The following P. aeruginosa strains were used during the present investigation.
TB:
           Serotype: 4 
Pyocin type: 1h
Phage lysotype: F8, M4, PS2, PS24, PS31, 352, 46b/2, 
1214, Col21,F7, F10, PS21, PS73, no plasmids
(Tümmler, 1987).
892:
Serotype: 4 
Pyocin type: 1h 
Phage lysotype: F8, M4, PS2, PS24, PS31 
no plasmids, the strain 892 is a clonal
    variant of the strain TB (Tümmler et al., 1991).
PAO1: wound isolate, genetic reference strain (Holloway et al., 1994)
SG17M: clone C, environmental isolate (river) (Römling et al., 1994)
CSGB8: clone C, CF airways isolate (Römling et. al., 1994)
CHA: CF airways isolate (Dacheux et. al., 2000)
2.1.5.3. Pseudomonas putida
KT2440: soil isolate, plasmid-free derivative of strain mt-2 (Bagdasarian et al.,
1981).
2.2. Methods
The following part represents the basic methods that were used to carry out this
work. 
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2.2.1. Microbiological methods
2.2.1.1. Bacterial growth conditions 
All bacterial cultures were grown in the LB medium unless and otherwise specified
other growth conditions. For this, a single colony was inoculated in a glass tube
containing 5 ml of LB medium with or without antibiotic depending on the experiment
and incubated at 37 oC (250 rpm) for 12-16 h. If large volumes were required, 1-2 ml
of bacteria were inoculated in Erlenmeyer flasks containing 400 ml LB medium and
incubated at 37 oC (250 rpm) for 12-16 h.  
LB agar with appropriate antibiotic was used as selection media.
Selection medium:
E.coli DH5α pTnMod-OGm LB + 25 µg/ml Gentamicin
P. aeruginosa  LB + 30 µg/ml Gentamicin 
2.2.1.2. Determination of bacterial cell density
The optical density (OD) for all the bacteria was measured on the photometer at a
wavelength of 600 nm (OD600). The correlation between optical density and cell
density in terms of colony forming units (cfu) is given as follows. 
Pseudomonas aeruginosa:  0.6 OD ≈    1 x 109 cfu/ml
Escherichia coli: 1.0 OD ≈    0,8 x 109 cfu/ml
2.2.1.3. Maintenance of bacterial cultures
All bacterial cultures were maintained in LB medium containing 15 % glycerol (v/v)
and stored at -80 oC. LB medium with 2.5 % (w/v) agar was used to store cultures at
4 oC. 
2.2.2. Separation of DNA
2.2.2.1. Agarose gel electrophoresis
The DNA was mixed with 1/5th volume of loading buffer and loaded on an 1 % (w/v)
precasted agarose gel. 1x TBE buffer was used as running buffer and 2.0 V/cm (run
for overnight) to 8.5 V/cm field strength was applied. The gel was run until the front
line of the dye crossed 2/3rd of the total gel length. After the run, the agarose gel was
stained with 0.5 µg/ml ethidium bromide for 30 min, destained in water for 30 min and
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photographed on a UV transilluminator (312 nm). Lambda phage DNA digested with
BstEII was used as molecular size standard. 
2.2.2.2. Polyacrylamide gel electrophoresis
Polyacrylamide gel electrophoresis was used for the isolation of small DNA
fragments. For this, the DNA fragments were loaded on a 10 % gel (19+1
acrylamide/bis-acrylamide) in TBE buffer and separated with a field strength of 6.5
V/cm. The gel was stained with 0.5 µg/ml ethidium bromide for 5 min and destained
in water for 5-10 min and photographed on a UV transilluminator (312 nm). Longer
destaining should be avoided due to substantial loss of the signal strength since the
DNA fragments are very small (40 bp).  
2.2.3. Transformation 
2.2.3.1. Generation of transformation competent cells
Competent cells from E. coli DH5α were prepared according to Inoue et al. (1990).
10-12 colonies from LB agar plate were inoculated in a 1 l Erlenmeyer flask
containing 250 ml of SOB medium and grown at 18-20 oC on a rotary shaker (200
rpm) up to an optical density of 0.6-0.8. After the appropriate cell density, flasks were
chilled on ice and the cells were harvested by centrifugation (2500 x g, 10 min, 4 oC).
The pellet was resuspended in 80 ml of ice-cold TB buffer. After 10 min incubation on
ice, the cells were centrifuged again (2500 x g, 10 min, 4 oC) and the pellet
completely resuspended in 20 ml of ice cold TB buffer and 1.4 ml of DMSO (approx..
7 %, v/v) was added. The cells were incubated on ice for 10 min, aliquoted and
immediately frozen in liquid nitrogen. The aliquots were stored at -80 oC.  
2.2.3.2. Transformation by heat shock method
Transformation was carried out by heat shock method as described previously
(Dagert and Ehrlich, 1979). Competent cells were thawed on ice, 20 µl cells were
aliquoted in reaction tubes and 40-60 ng of DNA were added to the cells. After 30
min incubation on ice, the cells were heat shocked at 42 oC for 40 s and immediately
placed on ice for 2 min. Then 80 µl of LB medium was added to the mixture and the
cells were incubated at 37 oC for 1 h. After the incubation period, the whole mixture
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was plated on LB agar containing an appropriate antibiotic and incubated at 37 oC.
The colonies harboring plasmids were visible after 16-24 h of incubation.
2.2.4. DNA isolation
2.2.4.1. Isolation of genomic DNA from Gram-negative bacteria
The genomic DNA from P. aeruginosa was isolated by a method that is described for
Gram-negative bacteria (Chen and Kuo, 1993). DNA isolated by this method was
used as template in PCR reactions or for the preparation of Southern blots. The
bacterial cells from 1.5 ml of overnight grown culture were harvested by
centrifugation (14,000 x g, 3 min). The pellet was resuspended in 300 µl of Lysis
buffer, 100 µl of 5 M NaCl were added and mixed thoroughly. Cell debris was
separated by centrifugation (14,000 x g, 60 min, 4 oC). The supernatant was
transferred in another eppendorf tube and the RNA was digested (37 oC, 30 min) by
addition of 3 µl of RNase (10 mg/ml). To remove proteins and lipids, the DNA solution
was successively treated with equal volumes of phenol, phenol:chloroform:isoamyl
alcohol (25:24:1, v/v), and chloroform:isoamyl alcohol (24:1, v/v). The mixture was
thoroughly mixed every time and phases were separated by centrifugation (14,000 x
g, 15 min) at every step. DNA was precipitated by addition of equal volume of
isopropanol to the supernatant and centrifuged (14,000 x g, 15 min). The pellet was
washed with 70 % (v/v) ethanol, dried in a vacuum concentrator and resuspended in
50 µl TE buffer.  
2.2.4.2. Isolation of plasmid DNA
The plasmid DNA from the transformed E. coli was isolated by the modified alkaline
lysis method (Birnboim & Doly, 1979). 3 ml of the overnight grown culture in LB
medium was centrifuged (5000 x g, 5 min) and resuspended in 300 µl solution I.
Then 300 µl solution II was added and mixed properly by inverting the eppendorf
tube. After 5 min incubation period, 300 µl solution III was added, thoroughly mixed
and incubated on ice for 15 min. The precipitate was centrifuged (10,000 x g, 10 min,
4 oC) and the supernatant was transferred into a fresh eppendorf tube. To remove
proteins and lipids, an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1,
v/v) mixture was added to the above supernatant, thoroughly mixed and centrifuged
(14000 x g, 2 min, 4 oC) for phase separation. The aqueous phase was pipetted into
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a fresh eppendorf tube, chloroform:isoamyl alcohol (24:1, v/v) was added to the
above solution, mixed thoroughly and centrifuged (10,000 x g, 10 min, 4 oC). After
centrifugation, an equal volume of isopropanol was added to the supernatant for the
precipitation of plasmid DNA and centrifuged (14,000 x g, 15 min, at room
temperature). The pellet was washed with 70 % (v/v) ethanol and dried in a vacuum
concentrator. The dried pellet was resuspended in 50 µl TE buffer and stored at -20
oC until further use. 
  
For sequencing, the extra pure plasmid DNA was isolated by using Qiagen Mini and
Maxi Prep kit according to the manufacture’s procedure. 
2.2.4.3. Quantitation of DNA and RNA
The nitrogenous bases in DNA or RNA molecules absorb UV light.
Spectrophotometric measurement of UV absorbance by nucleic acids in solution is a
simple and fast method of determining concentration, but is accurate only if the
preparations are relatively free of contaminants such as proteins, phenol or
particulate matter. The concentration of DNA and RNA was determined
photometrically (Ausubel et al., 1988; Sambrook et al., 1989) by measuring the
absorption at 260 nm in a quartz cuvette with 1 cm thickness. Double distilled water
was used as a control. Based on extinction coefficients, an optical density (OD) of 1.0
at 260 nm, corresponds to approximately:
for double stranded DNA: 50 µg/ml
for single stranded  DNA: 33 µg/ml 
                           for RNA: 40 µg/ml
The ratio of OD260 / OD280 provides the estimate for purity of DNA. A typically pure
preparation of DNA and RNA has a ratio of 1.8 and 2.0 respectively. The
concentration of the DNA and RNA can be calculated from the following formula:
Concentration of DNA (µg/ml) = OD260  X 50 X dilution factor
Concentration of RNA (µg/ml) = OD260  X 40 X dilution factor
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2.2.5. Polymerase chain reaction 
Polymerase chain reaction (PCR) developed by Mullis et al. 1986, is one of the
important standard technique used in molecular biology for the amplification of DNA
(Mullis and Faloona, 1987). PCR is based on the features of the semi conservative
DNA replication carried out in prokaryotic and eukaryotic cells by DNA polymerases.
All the polymerases can catalyze the addition of bases to the 3' hydroxyl end and can
extend a primer, if a template is provided. PCR is based on these principles and is
used to amplify the segment of DNA that lies between two regions of known
sequence. PCR technology has revolutionized the field of molecular biology and finds
tremendous applications in gene isolation, genomic DNA amplification, biodiversity
analysis, DNA fingerprinting and tagging of important genes.
This technique was used for the following purposes in this study. 
- amplification of specific sequence of a transposons and P. aeruginosa gene
for probe preparation for Southern and Northern hybridization.
- amplification of the signal sequences from PTnMod-OGm plasmid. 
2.2.5.1. Construction of primers
A critical factor for yield and purity of the PCR product is the construction of correct
primers. The following criteria were used to construct primers (Spangenberg, 1997).
• Length of the primer was kept to approximately 20 base pairs.
• Primer should end with at least two guanine/cytosine residues to ensure stable
hybridization during PCR.
• Primer should not be complementary with itself or with other primer to form a
hairpin structure above the Tm = 50 oC
• The melting temperature of the primer should be above 60 oC to avoid the non
specific amplification. The melting temperature can be calculated from the rule of
thumb Tm= 4 oC ·Σ(GC) + 2 oC ·Σ(AT). Primers from the one pair should exhibit
the same melting point.
2.2.5.2. PCR reaction
The following protocol was used to amplify the DNA sequences.
2.5 µl 10x Buffer (InViTek)
2.5 µl 8 mM dNTP (2 mM for each nucleotide)
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2.5 µl 5 µM Primer 1
2.5 µl 5 µM Primer 2
                    1.25 µl DMSO
         0.75 µl 50 mM MgCl2
0.2 µl Taq- DNA Polymerase 5 U/µl
10-200 ng Template DNA (depending upon experiment)
Total volume was adjusted up to 25 µl with double distilled water. 
DMSO acts as chaotropic reagent and enhances specificity of binding during
annealing. The hybridization temperature is lowered and formation of secondary
structures is also suppressed. 
2.2.5.3. PCR parameters
During this study, PCR was used for the following applications in order to amplify the
DNA sequence. 
a) Amplification of specific signal sequences from pTnMod-OGM 
For the individual changes of temperature, an interval (temperature ramp) of 10 s
was programmed in each case. This PCR gave high yields over a concentration
range of plasmids and the expected size of the product was 80 bp. Thus all the
temperatures were run only for very short times. TAG-1 and TAG-2 were used as
primers (for sequences, see appendix II) and pTnMod-OGM plasmid as template in
the PCR reaction. Small reaction volumes and short cycle times were used at
moderate temperatures. If necessary, the PCR product from many reactions of small
volume (max. 25 µl), were pooled together.  
b) Amplification of specific signal sequences from P. aeruginosa 
For the individual changes of temperature, an interval (temperature ramp) of 10 s
was programmed in each case. Primers TAG-1 and TAG-2 were used to amplify the
signal sequence from P. aeruginosa genomic DNA. This PCR required the
appropriate amount of template since small inaccuracy leads to substantial loss of
product. 
c) Amplification of genomic sequences from P. aeruginosa
The standard protocol with the change in temperature was used for the amplification
of genomic sequences from P. aeruginosa. The primer sequences are given in the
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appendix (II). The variable parameters of different PCR, depending upon intended
purpose, are given below.
a) b) c)
                   
       300 s 96 oC
20 s    61 oC*
20 s    72 oC*      40 x
30 s    94 oC*
20 s    61 oC*
40 s    72 oC*
  
    ∞ 10 oC
     Primers:
TAG-1; TAG-2
DNA conc.: 5-100 ng
Volume: 25 µl
                   
       300 s 96 oC
20 s    58 oC*
20 s    72 oC*     40 x
30 s    94 oC*
20 s    58 oC*
40 s    72 oC*
  
     ∞ 10 oC
     Primers:
TAG-1; TAG-2
DNA conc.: 3-10 ng
Volume: 25 µl
                   
       300 s 96 oC
20 s   variable
20 s   72 oC*      40 x
30 s   94 oC*
20 s    variable
40 s    72 oC*
 
    ∞ 10 oC
     Primers:
variable
DNA conc.: 10-100 ng
Volume: 25 µl
*: indicate the PCR program steps where changes in temperature (temperature ramp) were
accomplished in 10 s. Program steps without * indicate that the change in temperature was as fast as
possible and it was designed conditionally in the thermocycler.  
2.2.6. Restriction digestion of DNA
The DNA was digested with the appropriate restriction enzyme according to the
manufacturer’s instructions. The restriction enzyme was also used for the digestion of
specific signal sequences, which were amplified by PCR. These sequences which
are relatively small in size were digested with HindIII where several microgram of
DNA was used in each digestion. Signal  sequences (5 µg) were digested with 250 U
of restriction enzyme HindIII in a total volume of 250 µl and the reaction mixture was
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incubated overnight. Because of the high multiplicity of the restriction sites, more
than 50 U/µg signal sequence was added for a complete digestion of the DNA.  
The unit definition of restriction enzyme is defined as the quantity of enzyme required
for the digestion of 1 µg of DNA in 1 h in the assay buffer. 
2.2.7. Plasmid rescue
Plasmid rescue (ligation of digested DNA) was performed to transfer the
minitransposon with its flanking sequences as stable episomal plasmids into E. coli.
The protocol by Dennis and Zylstra (1998) was modified as follows: 10 µg of genomic
DNA from P. aeruginosa attenuated virulence transposon mutants was digested with
40 U of PstI at 37 oC overnight in 40 µl restriction buffer. The restriction enzyme cut
on either end of transposon. Digested DNA was purified by
phenol:chloroform:isoamyl alcohol (25:24:1, v/v) and then by chloroform:isoamyl
alcohol (24:1, v/v) extractions and the DNA was precipitated by ethanol. The pellet
obtained was dried in vacuum concentrator and resuspended in 25 µl of TE buffer.
An aliquot of 500 ng digested genomic DNA was incubated with 1000 cohesive end
ligation units of T4-DNA ligase for 6 h at 16 oC in a total volume of 25 µl ligase buffer.
Forty to sixty ng of ligated DNA were transformed into highly competent E. coli DH5α
(107 transformants/ng DNA) by the heat shock method (see 2.3.3.2) and plasmid
harboring cells were selected on LB agar containing getamycin (30 µg/ml). These
plasmids were sent to Qiagen (Hilden, Germany) for sequencing of the genomic
insertion site of the transposon. Sequence of P. aeruginosa genomic DNA
immediately adjacent to the transposon were determined annealing to both ends of
Tn5. 
2.2.8. Generation of DIG- labeled probe
2.2.8.1. Isolation of DNA fragments from agarose 
The following two methods were used for the isolation of DNA from agarose gels.
1. Method 
The DNA was isolated from agarose gel by the freeze and squeeze method
developed by Walker (1984). This method has two disadvantages, first it is not
applicable for large DNA fragments (5000 bp) and second, the DNA samples are
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always contaminated with agarose. So this interferes with the ligation and
sequencing reactions but it is applicable for DIG labeling. 
After agarose gel electrophoresis, the gel was stained with ethidium bromide,
destained and observed under the UV transilluminator. The DNA bands were located
and cut out of the gel with the help of scalpel. The gel pieces were kept in the
separate eppendorf tubes containing 3-4 layers of muslin cloth which acts as filter.
The eppendorf tubes were kept at -80 oC for 2 h. Then the eppendorf tubes were
thawed and the DNA solution was eluted by centrifugation (14,000 x g, 20 min, 4 oC).
The DNA was precipitated by the addition of 0.5 volume (v/v) of sodium acetate (pH
7.0) and 3.5 volume (v/v) of ethanol and incubated at -80 oC for overnight. The DNA
was pelleted by centrifugation (14,000 x g,15 min, 0 oC), washed, dried and the pellet
was resuspended in small volume of TE buffer. 
2. Method
The DNA was recovered by the method as described by Qiagen (Hilden, Germany).
For this, DNA was separated by agarose gel electrophoresis, stained, destained and
visualized under the UV transilluminator. Then the DNA fragments were excised from
the agarose gel and weighed. 3 volumes of buffer QG was added to 1 volume of gel
and incubated at 50 oC for 10 min or until the gel slice has completely dissolved.
Then 1 gel volume of isopropanol was added to the sample and mixed by inverting
the tube several times. This solution was applied to a MinElute column (Qiagen) and
centrifuged for 1 min. The column was washed with 500 µl of buffer QG and then with
750 µl of buffer PE. The MinElute column was centrifuged for an additional 1 min. 10
µl of buffer EB was applied onto the center of the membrane and kept for 5 min, then
the DNA was eluted by centrifugation for 1 min. All the centrifugation steps were
carried out at more than 10,000 x g at room temperature. The DNA recovered in this
way was used for sequencing or probe generation in Northern Blotting. 
2.2.8.2. Separation of small DNA fragments
The P. aeruginosa transposon mutants contains the specific signal sequence (40 bp)
in the center flanked by non-specific primer (20 bp) sequences on either sides. The
following method was used for the separation of signal sequence from primer
sequence. For this, sephadex G100 column was generated in a 3 ml syringe and
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equilibrated with TE buffer. Then the column was centrifuged (1000 x g, 1 min) and
the 80 bp HindIII digested sequence with dextran blue was loaded on the sephadex
column. Then this column was centrifuged (1000 x g, 2 min). The 40 bp fragments
with dextran blue were eluted & recovered in the fresh eppendorf tube at the bottom
of column and  the 20 bp fragments along with phenol red stayed in the column. The
enriched 40 bp fragments were precipitated with ethanol, pellet dried and then
resuspended in TE buffer. These fragments were used for probe generation.
Unfortunately, the separation of the 40 bp fragments from 20 bp was not complete.
About 5-10 times enrichment was achieved in one procedure by this method, this
was sufficient for the subsequent probe preparation and hybridization.   
2.2.8.3. Random primer labeling by DIG-DNA labeling kit
Random primer labeling, described by Feinberg and Vogelstein (1983) is the most
widely used method for uniform labeling of DNA probes. The method utilizes the
ability of E.coli DNA polymerase (Klenow fragment) to synthesize a new strand
complementary to a template DNA strand starting from a free 3' hydroxyl end in order
to label both the strands simultaneously. Klenow polymerase cannot start synthesis
without primers, therefore, a set of primers was added to the single stranded
template. Random primer labeling leads to a highly efficient reaction giving good
levels of incorporation even with small amount of template DNA. With 1 pg DNA per
assay approx. 10 % of the nucleotides are incorporated into about 250 ng of newly
synthesized labeled DNA within 1 h and approx. 30 % of the nucleotides into about
750 ng after 20 h. The labeled DNA by this method was used as probe in Southern
and Northern hybridizations. 
The DNA was labeled by using the kit supplied by Roche Molecular Biochemicals. 
1 The DNA was denatured in a boiling water bath for 10 min and immediately
chilled on ice. 
2 The following components were added
15 µl Denatured DNA  
  2 µl DIG DNA labeling mix (10x)
  2 µl Hexanucleotide mix (10x)
    1 µl Klenow enzyme
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3 Mix gently by pipetting, then spin briefly in a microcentifuge and incubate the
reaction mixture at 37 oC for overnight.
The labeled DNA was purified by a gel filtration procedure. For this the sephadex
G50 column was prepared in 1 ml syringe until top and equilibrated with TE buffer.
Then this column was dried by centrifugation (1000 x g, 45 s) to remove the excess
buffer. The coloring solution (8 µl) and 72 µl of TE buffer was added in the labeled
DNA mixture so that the final volume achieved was 100 µl. Then this mixture was
loaded on the column and centrifuged (1000 x g, 30 s). The labeled/marked DNA
fragments with dextran blue were eluted & recovered in the fresh eppendorf tube
which was kept at the bottom of column during centrifugation. The DNA labeled in
this way was used immediately or stored at -20 oC until use.
2.2.8.4. DIG- 3’ end labeling of oligonucleotides
The transposon mutants of P. aeruginosa TB harbor a specific 40 bp sequence. This
sequence should be labeled/marked during the procedure for the screening of these
mutants for intracellular survival in polymorphonuclear granulocytes. For this, the
reagents for a Dig- Oligonucleotide 3’ end labeling kit was used. DIG ddUTP
(Digoxigenin-11-2’, 3’ dideoxyuridine 5’ triphosphate) was incorporated into the single
stranded DNA by Terminal transferase. This DIG ddUTP can serve as recognizable
antigen in the immunobiological detection. The manufacturer recommended this
procedure for the labeling of oligonucleotides with a length of 25-100 bps. For the
longer fragments, the signal intensity can decrease. The cleaned specific signal
sequences (see 2.2.8.2) were denatured at 95 oC for 5 min and then immediately
chilled on ice. At least 1 µg of denatured DNA was mixed with the other components
of the labeling kit as described by the manufacturer. Then this mixture was incubated
at 37 oC for 4-8 hours and used directly as a probe without any further treatment in
the pre-hybridization buffer. 
2.2.9. DNA fixation and hybridization
2.2.9.1. Southern Transfer
This method was developed by E. M. Southern in 1975. It involves transfer of single
stranded DNA fragments from an agarose gel to a solid support, usually a nylon
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membrane where the fragments are immobilized. The nylon membrane has a high
binding capacity, physically strengthened DNA fragments can bind rapidly by UV
cross linking or baking, making it ideal for DNA blotting applications. The transfer and
immobilization of the DNA fragments separated by gel electrophoresis can be
achieved by different methods like capillary blotting or vacuum blotting. Capillary
blotting is the most commonly used approach. In this procedure, the agarose gel is
mounted on a porous support which dips into a reservoir containing transfer buffer.
The membrane is sandwiched between the gel and a stack of filter papers which
serves to draw transfer buffer through the gel by capillary action. The DNA molecules
are carried out of the gel by the buffer flow and immobilized on the membrane.
The procedure for Southern blotting is described below.  
1. The agarose gel was destained in sufficient amount of distilled water at room
temperature with gentle shaking.
2. Water was removed and the gel was denatured in 0.4 M NaOH for 30 min at room
temperature with constant shaking. The alkali treatment denatures the fragments
prior to transfer ensuring that they are in single stranded state, latter accessible
for labeling.
3. A Whatman filter paper bridge was prepared on the blotting apparatus and the gel
was kept upside down on the Whatman filter paper. Prewetted nylon (Hybond N+)
membrane with the same size of gel was kept without air bubbles in between gel
and membrane. The 0.4 M NaOH solution was added in the bath.
4. The Whatman filter paper with the size of the gel was placed on top of the
membrane. A stack of ordinary toilette paper with the same size as the gel was
kept on the Whatman filter paper. The glass plate with the weight of
approximately 500 g was kept on the top of the toilet papers.
5. The transfer of DNA was allowed for about 16-24 hours.
6. The membrane was removed, washed with 50 mM phosphate buffer for 5 min
and dried at room temperature for 20 min and then at 65 oC.  
7. DNA on the membrane was cross-linked in UV stratalinker with the program
autocrosslink on both sides of the membrane. The blot was stored at room
temperature till further use. 
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2.2.9.2. Dot- blot preparation
The dot blots were used during the selection experiments carried out for the
screening of STM library for intracellular survival in PMNs. The labeled DNA obtained
from the signal sequences was hybridized specifically on these dot blots. For this, the
signal sequences of the donor plasmids were amplified by PCR (see 2.2.5.3a). The
PCR product (80 µl) from each signal sequence was mixed with 40 µl of 3 M NaOH
and 280 µl of TE buffer and denatured at 65 oC for 30 min. After cooling to ambient
temperature, 400 µl of 2 M ammonium acetate was mixed and after short incubation
period, this denatured DNA solution was aliquoted in a 96 well plate. The DNA
solution (95 µl) was applied to the Minifold-DOT-vacuum-blot- equipment with the
help of a multi-channel pipette. The DNA was sucked and immobilized on the
blot/nylon membrane (Hybond N+) by the vacuum generated in the equipment. The
dot blots were rinsed with the 1 M ammonium acetate solution and dried at room
temperature. DNA on the dot blots was cross-linked in UV stratalinker with the
program autocross link on both sides of the blot and was stored at room temperature
till further use. 
2.2.9.3. Southern and dot blot hybridization
All the hybridization methods are based on the ability of denatured DNA to anneal to
complementary strand at a temperature below their Tm (Church & Gilbert, 1984).
Southern hybridization (Southern, 1975) involves a reaction between denatured DNA
immobilized on the nylon membrane and single stranded DNA probe. It is a function
of a temperature, time, salt concentration, G+C content, probe length and
hybridization volume. All the hybridization protocols are designed to get intense
signals and reduced background for a particular system. Prior to hybridization,
prehybridization is carried out in which potential binding sites for the probe other than
complementary DNA are blocked to avoid background hybridization to the
membrane. The dot blots were also treated in a similar way which were used during
the screening for intracellular survival in PMNs. 
The following protocol was used for the Southern and dot blot hybridization except
that the hybridization temperature for the 3’ labeled 40 bp sequence was 65 oC.
1. The required volume of prehybridization buffer was preheated to 68 oC (65 oC for
40 bp sequence) and the membrane/blot was kept in a large glass tubes
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(Biometra) or in 50 ml plastic Falcon tubes. The membrane was kept in the tube
with the DNA adhered side inward in the tube. Prehybridization buffer (10 ml/100
cm2) was added in the tube and prehybridized at 68 oC (65 oC for 40 bp
sequence) for at least 2-3 hours with constant shaking.
2. The Dig labeled probe was added in 10 ml total volume of prehybridization buffer
and denatured by boiling for 10 min then added in the tube containing blot. 
3. The blot was hybridized for 16-24 hours at 68 oC (65 oC for 40 bp sequence) with
gentle shaking in the hybridization oven.
4. After hybridization, the hybridization buffer was poured in a sterile tube and the
probe was saved for future use at -20 oC. 
5. The blots were rinsed twice with wash solution by adding in the glass tube and
shaking and the solution discarded. 
6. Then 30-40 ml of wash solution was added in the tube and incubated at 68 oC
(65 oC for 40 bp sequence) for 30 min in the hybridization oven. The wash
solution was discarded and the same procedure was repeated for a second time.
2.2.9.4. Immunological detection of the hybridized blot
After hybridization, the hybrids were detected by incubation with an anti-fluorescein
alkaline phosphatase conjugate. The DIG labeled DNA fragments show fluorescence
with the help of an anti Dioxigenin (Fab fragment). The Alkaline Phosphatase
catalyzes a chemo-luminescence reaction with CDP Star(TM), whose light intensity is
constant over several hours. The detection was performed as previously described
by Allefs et al. (1990). In briefly, the protocol is described below.  
1. Following the stringency washes, the blot was equilibrated in buffer I for 5 min.
Then it was saturated in buffer II for 30 min to remove non specific signals by
incubation on a shaker with shaking.
2. Blot was incubated with buffer II containing 5,000 fold (v/v) dilution of  Anti-
fluorescein-AP conjugate (4 ml/100 cm2) with gentle agitation at room
temperature for 30 min.
3. Unbound conjugate was removed by washing for 3 x 15 min in buffer I. 
4. Then the blot was equilibrated in freshly filtered buffer III for 2-5 min, then
incubated with CDP star solution (1:500, v/v) in filtered buffer III for 5-10 min. 
5. After incubation, the excess buffer III was drained off from the blots and wrapped
in plastic foil. After 15-30 min incubation i.e. the maximum chemo-luminescence
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was reached (Bronstein et al., 1989). The X-ray film was kept on the blot in dark
and developed. Different exposures were taken depending upon the signal
intensity. This produced signals with constant intensity over several hours.  
2.2.9.5. Washing of Southern and dot-blots
The labeled and hybridized membranes can be used several times after washing
(stripping) under alkaline conditions. After washing, the membrane did not show any
signals from the previously labeled and bound DANN, because the DIG dUTP is not
stable in an alkaline environment and disintegrates by the release of dioxigenins.  For
washing, the membrane was incubated twice with wash solution for 30 min under
strong shaking conditions. Then the membrane was neutralized by keeping it in
sodium phosphate buffer (pH 6.5) for about 15 min. Then it was wrapped in plastic
foil and stored at -20 oC until the further use. 
2.3. Screening of the STM library for intracellular
survival in PMNs
The following procedure was used for the screening of P. aeruginosa TB transposon
mutant library for intracellular survival in PMNs. 
2.3.1. Growth of transposon mutants
A library of P. aeruginosa TB signature tagged mini Tn5 OGm transposon mutants
was constructed by Lutz Wiehlmann (Ph. D. thesis, 2001) as described previously
(Hensel et al., 1995). The STM library was maintained as glycerol stocks in 96 well
plates at -80 oC. Each transposon mutant inoculated from frozen glycerol stock, was
grown individually in a micro titer plate containing 200 µl of LB medium and incubated
at 37 oC for 16 h. Culture from 48 mutants with different preselected signature tags
were collected, mixed properly and considered as one pool. 
2.3.2. Isolation of granulocytes from human blood
PMNs were isolated from freshly obtained blood of a healthy donor. Approximately
10 ml of fresh blood (with 100 I.U. heparin; 100 µl Liquemin) were used for each
experiment. The blood was added in the glass tube containing 5 ml of 10 %
hydroxyethyl starch (HES) and incubated for 45-60 min at room temperature. Most of
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the erythrocytes were separated by sedimentation and the supernatant was added
into another fresh plastic tube with a pasteur pipette. 2 ml of lymphocyte separation
medium (a Ficoll solution of density = 1.077 g/ml in isotonic saline solution) was
carefully added at the bottom of the blood plasma with a pasteur pipette and
separated by centrifugation (3000 x g, 15 min). The lymphocytes and the
macrophages accumulated at the phase boundary and the granulocytes and
erythrocytes were pelleted. The pellet was resuspended in 1 ml eukaryotic
RPMI1640 media and stored on ice. 
2.3.3. Determination of granulocyte concentration
The erythrocytes were lysed from granulocytes by resuspending the pellet in 1 ml of
autoclaved sterilized double distilled water and incubated for 10 s, then 4 ml of 5x
PBS buffer was added immediately to avoid the lysis of granulocytes. Then this
solution was centrifuged (3000 x g, 5 min) and the granulocyte pellet was
resuspended in 1 ml RMI1640 medium and kept on ice. The granulocyte cell number
was determined by putting a aliquot in a Neubauer chamber and granulocytes were
counted from 10 squares at different locations. 
Following correlation was observed:  
1 Granulocyte/large square = 2.5 x 105 granulocytes/ml
Concentration of granulocytes from 10 ml blood was in the range of 1 x 107-1.5 x 107
cells/ml. 
2.3.4. Phagocytosis assay in granulocytes 
The mutants from one pool were screened for intracellular survival in a phagocytosis
assay that were performed in duplicate. Approximately 1 x 107 freshly isolated
granulocytes were added in the RPMI1640 medium containing AB- blood serum at a
final concentration of 10 % (v/v) and 10 fold excess of bacteria (1 x 108) (determined
by spectrophotometry, 0.6 OD = 109 cfu/ml) added in the 14 ml plastic tube. The
relationship between bacteria and granulocytes was in the range of 10:1 to 20:1
(Miethke, 1985). The final volume was adjusted to 2 ml with the RPMI1640 medium
and this was considered as input pool (selection). The same amount of bacteria were
added in the control experiment except PMNs which was called as output pool
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(without selection). Addition of serum was essential since the granulocytes need a
functional complement system for the recognition of bacteria. Phagocytosis could not
take place without the opsonization of bacteria. The serum with a standard
complement system, from different blood donors (irrespective of blood groups) was
collected. Approximately 300 ml serum was frozen at -80 oC before beginning of the
experiment and same serum was used in all the experiments. 
Fig. 2.1. Schematic representation of phagocytosis assay used during screening of the STM library for
intracellular survival in PMNs.
 
The input and output pools were incubated for 120 min (200 rpm, 37°C). After the
incubation period, the assay mixture was kept on ice for 10 min. Then the tubes were
filled with ice cold RPMI1640 medium until the top and centrifuged (400 x g, 10 min).
The supernatant was discarded and the granulocyte pellet with the internalized
bacteria was resuspended in 200 µl RPMI1640 medium. This suspension was
applied on the nitrocellulose filter paper (pore size 5 µM) and washed with 5 ml PBS
to remove the extracellular adhered bacteria. Then this filter with the adhered
granulocytes was transferred to a fresh tube containing 3 ml distilled water and
vortexed for 5 min. This resulted in the separation of intracellular bacteria from
granulocytes by lysis. The bacterial suspension was transferred in a new tube and
centrifuged (4000 x g, 10 min). The supernatant was discarded and the pelleted
bacteria were resuspended in 100 µl PBS buffer and plated on LB agar. 50-100 µl
aliquot from the output pool was also plated on LB agar. Bacteria were recovered on
+
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the next day from plates, resuspended in the 10 mM MgSO4 solution. Then this
assay was repeated by using the recovered bacteria for input and output pools
separately. According to this protocol, the bacteria were grown on LB- agar overnight
after the second selection assay The schematic representation of phagocytosis
assay is shown in figure 2.1.
 
While doing this experiment, following precaution was taken.
• Experiment was completed within the 6 hours after withdrawing blood to the
filtration of granulocytes. Because granulocytes can stop functioning after 6
hours due to the bacterial selection pressure applied during this procedure.
• Bacteria were not incubated with granulocytes for more than two and half
hours, since apoptosis starts and intracellular bacteria can become free.
Genomic DNA was isolated from the survived mutants after second selection and a
PCR was performed on this genomic DNA to amplify the signature tags. Here, 8 PCR
reactions (each of 25 µl) from one pool were used to get the amount of DNA
sufficient for digestion. The PCR product was digested for 16 h with HindIII and the
specific 40 bp sequences were separated from the unspecific 20 bp sequences and
unused primers by gel filtration and the DNA was precipitated with ethanol. After
resuspending DNA in water, the 40 bp sequences were labeled at 3’ end with Dig-
ddUTP using a terminal transferase as described by manufacture. These labeled
signal sequences from input pool and output pool were hybridized separately at 65
oC on dot-blots which were previously prepared from all 48 pTnModOGm SigTag-
donor plasmids. Then these hybridized dot blots were detected with CDP-Star and
exposed to X-ray films. The developed film was scanned and the optical density
(od/mm2) of the individual dot was quantified by using PCBAS program, version 2.09f
(raytest Isotopenmeßgeräte, GmbH). The signal strength of each dot (input pool) was
compared to the corresponding signal of a probe prepared from pooled bacteria
grown on LB agar without selection (output pool). This evaluation was performed in
MS Excel and the dot blots were washed and could be used 3-4 times.
Signals out of the 95 % confidence interval of the mean were interpreted to be
significantly different from the average signal. These mutants were retested 5 times
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and those mutants with consistently strong differences in their ability to survive were
selected for further examinations.
2.3.5. Cloning, sequencing and analysis of mutated P.
aeruginosa DNA
The plasmid rescue for the virulence attenuated mutants was performed. Then the
DNA sequences obtained were compared with the P. aeruginosa PAO1 genome at
http://www.pseudomonas.com. These sequences were also analyzed with the
BLAST N program for nucleotide-nucleotide homology sequences and BLAST X
program for nucleotide-protein homology sequences on the NCBI
(http://www.ncbi.nlm.nih.gov/BLAST/) database.
2.4. Screening of STM library for mutants defective
in protease secretion 
P. aeruginosa maintains a large genetic capacity (approx. 5500 genes; Stover et al.,
2000), amongst which are encoded a battery of virulence factors localized on the cell
surface or released into the external environment. The expression of many virulence
factors is controlled by quorum sensing (QS), the use of small, diffusible signaling
molecules (acylated homoserine lactones, AHLs) by a bacterial population to monitor
cell density (Fuqua et al., 2001; Whitehead et al., 2001; Erickson et al., 2002). These
virulence factors consist a major fraction of proteases which are secreted in the
extracellular environment. Therefore the whole STM library was screened for
protease secretion on casein agar plates. For this, the frozen mutants from glycerol
stocks were inoculated on casein agar plates with the help of multi-channel pipette.
Then these plates were incubated at 37 oC for 24-48 hours. During this period,
bacterial growth and the zone of clearance was monitored at different time intervals.
The transparent zone was formed around the colony since casein is hydrolyzed by
the proteases that are secreted by bacteria. So the mutants that were unable to grow
or formed small zone of clearance were considered as attenuated for protease
secretion. These mutants were retested 4 times by the similar procedure and those
with consistent in attenuation for protease secretion or growth on casein were
selected for further investigations.
Materials and methods
56
The attenuated mutants from the above assay were also checked for the protease
secretion due to the diffusible products secreted by the wild type. For this, the P.
aeruginosa TB wild type was inoculated in the form of thick line in the center on
casein agar plate. The attenuated mutants were inoculated on the same plate
perpendicular to the wild type (figure 3.7) without touching to wild type. This plate
was incubated for 24-60 h at 37 oC and the zone of clearance due to the induction by
wild type was monitored. A previous student has also screened the un-organized
mutant library  for the defect in protease secretion by the similar method during his
Ph. D. thesis (Wiehlmann, 2001). 
The genomic insertions (plasmid rescue) were determined by the similar procedure
as described previously.
 
2.5. Characterization of STM knockout mutants
2.5.1. In silico analysis
The STM allowed screening of large number of mutants for the intracellular survival
in PMNs in a reasonably less number of experiments. After screening, one can
receive only the information which genes are essential for the intracellular survival in
PMNs. However, the function of most of these genes is still not assigned in the P.
aeruginosa database. So in silico analysis was performed for each identified gene to
get the information about genomic context, structural features and homology. This
information would help to describe the mutant phenotypically and to assign the
function of the identified gene with respect to the intracellular survival in PMNs. The
degree of intracellular survival is also quantified which gives idea about the
intracellular survival ability of mutant with respect to the positive control (P.
aeruginosa 892).
 
2.5.2. Sensitivity towards Hydrogen peroxide
The attenuated virulence mutants from granulocyte selection assays were tested for
sensitivity to hydrogen peroxide (H2O2). For this, hydrogen peroxide with a defined
final concentration was added in the LB agar when the temperature was around 40
oC and plated in the big quadrate plates. After solidification, wild type and mutants
were inoculated in the form of separate dots on agar plates and incubated at 37 oC
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for 24-48 h. The growth pattern was compared at different concentrations of
hydrogen peroxide. 
2.5.3. Motility assay
The swarming and swimming motility was checked for the mutants that have
transposon insertion in the type IV pili and flagella biogenesis genes. The procedure
described by Köhler et al. (2000) was used to check swimming and swarming
motility. 
Swarming: Swarm agar was based on M9 salts (Sambrook et al., 1989) without
NH4Cl (termed here M8 medium, for convenience), supplemented with 0.2% glucose,
2 mM MgSO4, and solidified with 0.5 % (w/v) agar. Aspartate was added as a sole
nitrogen source at a final concentration of 0.05 % (w/v). After solidification, plates
were briefly dried and then 2 µl of an overnight culture of P. aeruginosa were spotted
and observed up to 12-24 h at 37 oC.
Swimming: 2 µl of an overnight grown culture of P. aeruginosa were inoculated
beneath the surface of a 0.2 % (w/v) LB agar plate and observed up to 12-24 h at 37
oC.
2.5.4. Cytotoxicity towards macrophage J774 cells
Cytotoxicity assays were performed using the murine macrophage cell line J774.A1
(ATCC TIB-67) grown in DMEM medium supplemented with 10 % (v/v) heat-
inactivated fetal calf serum. For infection experiments, the macrophages were
seeded in culture plates for 20 h before addition of the bacteria. Each P. aeruginosa
strain was grown in 3 ml of LB medium for overnight and adjusted to an optical
density (OD600) of 1.0-1.5 by dilution in LB medium. Bacteria were then centrifuged,
resuspended in eukaryotic medium, and added to cells at a multiplicity of infection
(MOI) of 5. Cytotoxicity was assayed by measuring the lactate dehydrogenase (LDH)
released into culture supernatants as previously described in Dacheux et al., 2001,
using the cytotoxicity detection kit (Roche Diagnostics). The 100 % value
represented the LDH released from cells lysed by 0.1 % (v/v) TritonX-100.
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2.6. Transcriptional analysis of P. aeruginosa
During the screening for intracellular survival in PMNs, we identified subset of genes
having regulatory function. The other subset of identified genes were not present in
the sequenced genetic reference PAO1 strain. In order to determine the function
these strain specific genes, we decided to use the P. aeruginosa PAO1 microarrays
(GeneChips). The global superoxide and oxidative stress response of the sequenced
reference strain PAO1, a burn wound isolate from the 1950s, was also compared
with that of the two clonal variants TB and 892 isolated from cystic fibrosis lungs that
differ substantially in their resistance to PMNs (Tümmler, 1987).
2.6.1. RNA handling and storage
RNases are found everywhere, including laboratory workers hands and in airborne
micro-organisms. Therefore special precautions were taken when working with RNA.
All reagents and equipments were specially treated to inactivate RNases prior to use.
• The devices were autoclaved at 121 oC for 60 min. Heat unstable devices were
wiped with sterile double distilled water and then with 70 % (v/v) ethanol. Metal
devices such as scalpel and forcebs were dipped in the 70% (v/v) ethanol. 
• Glass wares were baked at 250 oC for 5 h. 
• All the solutions were prepared in the double distilled Diethylpyrocarbonate
(DEPC) treated water. For this, the DEPC (0.05 %, v/v) added water was
incubated for overnight at 37 oC and then autoclaved to hydrolyze any unreacted
DEPC. Solutions containing Tris buffer were prepared in the double distilled
DEPC autoclaved water. 
• RNase free gel chambers were prepared by treating them with 3 % (v/v) H2O2 for
10 min and then rinsed with 70 % (v/v) ethanol.
• Fresh stock of plastic wares were used every time. 
• When working with RNA, all the samples were placed on ice and RNase inhibitors
were also added whenever needed.
• RNA dissolved in RNase-free buffer or water was stored at 70-80 oC.
 
2.6.2. P. aeruginosa PAO1 microarray 
The P. aeruginosa microarray (GeneChip) from Affymetrix was designed by the
initiative of the Cystic Fibrosis Foundation Therapeutics Inc. (CFFTI, USA) which has
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also financed for the P. aeruginosa genome sequencing project (Stover et al., 2000).
The P. aeruginosa GeneChip (Affymetrix) contains probes for 5549 open reading
frames, four rRNA operons (23S, 16S, 5S rRNA), 18 tRNA genes as well as 199
selected intergenic regions exceeding 600 base pairs from the completely sequenced
and annotated genome of P. aeruginosa PAO1 (Stover et al., 2000). In addition,
probes from 117 open reading frames of other P. aeruginosa strains are also present
on the GeneChip. Altogether 5986 different probe sets can be analyzed on the
GeneChip. This GeneChip also contains 14 genes from Bacillus subtilis,
Saccharomyces cerevisiae and Arabidopsis thaliana as controls. The sequences
which are present on the GeneChip are extracted from the sequence data base
GENE BANK available at (http://www.ncbi.nlm.nih.gov) and the further information for
the synthesis and order of the GeneChip is available on the data base NETAFFX
under http://www.affymetrix.com/analysis/index.affx. Sequence on the GeneChip
which can be analyzed is represented by a varying number of 25-mer
oligonucleotides according to its length (Lipshutz et al., 1999). Each oligonucleotide
is synthesized as probe cell with the help of a special photo-lithographic technology
in combination with solid phase combinatorial chemistry on a glass surface of 20 µm
x 20 µm in situ (Fodor et al., 1991). All pairs of probes, which represent a sequence
section on the GeneChip, are called probe set. The probe pairs of the probe set are
distributed on the 1.28 cm x 1.28 cm large gene chip. Thus the effect of local
irregularities (non-uniform hybridization and staining or mechanical damages, e.g.
scratches) is decreased during hybridization.
2.6.3. Bacterial growth conditions for RNA isolation  
In order to see the expression of the identified genes, bacterial cultures were grown
in following conditions in the 125 ml Capsenberg flasks. The growth in the
Capsenberg flasks allowed a RNA preparation with less experimental variation since
these flasks has caps leading to the same aeration rate for all the bacterial cultures.
The overnight grown preculture in the respective medium was inoculated in the flasks
for RNA isolation.   
2.6.3.1. Bacterial growth in LB medium
In this condition, all the bacterial cultures (P. aeruginosa TB and transposon mutants)
were grown separately in 15 ml of Luria broth at 37 oC and 300 rpm in 125 ml
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Capsenberg flasks to an optical density of 1.5 (early exponential phase) or up to 3.5
(late exponential phase) at 600 nm (OD600). Then the bacteria from the appropriate
growth phase were harvested by centrifugation (3800 x g, 2 min) and subjected for
RNA isolation as described below (see 2.6.4). 
2.6.3.2. Bacterial growth in presence of superoxide and oxidative
stress generating agents 
All the bacterial cultures were grown separately in 15 ml Luria broth at 37 oC and 300
rpm in 125 ml Capsenberg flasks to an optical density of 5.0 (early stationary phase)
at 600 nm. The stationary phase grown culture (3 X 1010 cells) was resuspended in 5
ml of Luria broth and kept in a dialysis tube (14 kDa cut-off, 25 mm width) with the
effective length of 6 cm for the exchange of fluids. Then the dialysis tube was
resuspended in a 1l Erlenmeyer flask containing 600 ml of Luria broth without or with
0.5 mM paraquat or 10 mM hydrogen peroxide. The flasks were incubated at 37 oC
and 200 rpm on a rotary shaker for 2 h. Flasks containing Luria broth without the
addition of paraquat or hydrogen peroxide were served as controls. After the
incubation period, bacteria were immediately recovered from the dialysis tube and
subjected to RNA isolation.
2.6.3.3. Bacterial growth in iron depleted LB medium
The LB medium was depleted for iron by using Chelex-100 beads. For this, 1 gm of
sodium azide sterilized Chelex-100 beads were added in the 1l Erlenmeyer flask
containing 200 ml of LB medium and incubated on shaker at 37 oC. After the
overnight incubation period, the beads were allowed to settle down at the bottom and
LB medium was transferred into a other 1l flask. This procedure was repeated thrice
by taking fresh beads every time. LB medium obtained after this procedure was
considered to be depleted from iron. Then all the bacterial cultures were grown
separately in 15 ml of iron depleted Luria broth at 37 oC and 300 rpm in 125 ml
Capsenberg flasks to an optical density of 1.5 (early exponential phase) at 600 nm.
The bacteria from this growth phase were harvested by centrifugation (3800 x g, 2
min) and subjected to RNA isolation.
Materials and methods
61
2.6.3.4. Bacterial growth in presence of PMNs
Bacteria were grown separately in 15 ml of Luria broth at 37 oC and 300 rpm in 125
ml Capsenberg flasks to an optical density of 5.0 (early stationary phase) at 600 nm.
The stationary phase grown culture (2 X 1010 cells) was resuspended in 2 ml of
RPMI1640 medium and kept in a dialysis tube (14 kDa cut-off, 25 mm width) with the
effective length of 3 cm for the exchange of fluids. The PMNs were isolated (see
2.3.2) from 30 ml blood provided by the healthy donor. These PMNs were divided
into two parts. One part of PMNs were lysed and then PMNs from both parts were
resuspended in 15 ml of RPMI1640 medium containing 10 % (v/v) serum. Then the
dialysis tube containing bacteria was resuspended in the 125 ml Erlenmeyer flasks
containing 15 ml of lysed and intact PMNs. The TB wild type was also added in the
flask (MOI 10:1) to stimulate the granulocytes and mimic this condition like the
phagocytosis assay. The flasks were incubated at 37 oC and 300 rpm on a rotary
shaker for 2 h. During this incubation period, the content outside the dialysis bag
travels and come in physical contact with the bacteria so that the bacteria can
respond to the host defense factors. After the incubation period, bacteria were
immediately recovered from the dialysis tube and subjected to RNA isolation.
2.6.3.5. Bacterial growth in minimal medium
For quorum sensing experiments, bacterial cultures were grown in the ABC-minimal
medium. So the same medium was used to grow bacteria for RNA isolation. The TB
wild type and D8A6 transposon mutant (defect in quorum sensing) were grown
separately in 15 ml of ABC-minimal medium at 30 oC and 250 rpm in 125 ml flask to
an optical density of 1.0 at 600 nm. Then the bacteria from this growth phase were
harvested by centrifugation (3800 x g, 2 min) and subjected for RNA isolation. 
2.6.4. RNA isolation
The bacterial cells grown under various conditions were harvested by centrifugation
at 3800 g for 2 min at 4 oC. Total RNA from approximately 3 x 1010 cells was
extracted with a modified hot phenol method (Tao et al., 1999). Bacteria were quickly
resuspended in 0.5 ml distilled water and lysed in 7.5 ml of preheated (65 oC)
phenol/lysis-buffer mix (pH 5.5) with vigorous shaking for 10 min. The cell lysate was
centrifuged (3800 x g, 20 min) and the supernatant was extracted with 3 ml of
phenol:chloroform:isoamyl alcohol (25:24:1, v/v) and then subsequently with 3 ml of
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chloroform:isoamyl alcohol (24:1, v/v). To pellet the nucleic acids, 0.1 volume of 3 M
sodium acetate (pH 5.2) and 2.5 volumes of ethanol were added, incubated at -20
oC overnight and centrifuged (3800 x g, 30 min). The pellet was washed with 5 ml
70% ethanol and resuspended in 175 µl of diethyl pyrocarbonate-treated (DEPC)
water. DNA was digested by the addition of 40 U DNase I and 20 U SUPERaseIn in
DNase I buffer (pH 6.5) for 30 min at 37 oC in a total volume of 200 µl. Then the RNA
was purified by using RNeasy columns (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions and the yield of total cellular RNA was quantified by
measuring the light absorption at 260 nm. RNA with a size below 200 bp (e.g. tRNAs,
5 S rRNA) is below the cut-off of the column and therefore could not be recovered.
All the steps were carried out at 4 oC or RNA was also incubated on ice intermittently
during the RNA isolation procedure. 
2.6.5. Separation of RNA by formaldehyde agarose gel
electrophoresis
Only completely denatured RNA can be separated as a function of its length by
electrophoresis (Ausubel et al., 1988). In order to check the RNA preparations,
formaldehyde agarose gel electrophoresis was performed in mini gel chambers (5 x 7
cm, gel volume 40 ml). If the RNA should be transferred afterwards to a nylon
membrane for hybridization, large blot gel chamber was used which accommodated
65 µl sample volume (8 x 11 cm with 15 slots, gel volume 220 ml). Every time the
chambers were cleaned with 3 % (v/v) H2O2 and 70% (v/v) ethanol separately.
RNase free agarose (SeaKemGTG, Biozym) at a concentration of 1.2 % (w/v) and 2
% (w/v) was used for mini gels and blot gels, respectively. The agarose was
 
                               Table 2.1. Sample preparation for formaldehyde gel electrophoresis.Mini-gel Blot-gel Components
2   µl 10   µg RNA
1   µl 5    µl MOPS-buffer (10 x)
2   µl 10    µl Formaldehyde (37 %, w/v)
5   µl 25    µl Formamide
2   µl 9.5 µl RNA-loading buffer
- x     µl Double distilled water
- 0.5 µl Ethidium bromide (10 mg/ml)
12   µl 60    µl62
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autoclaved (121 oC, 30 min) in 1x MOPS buffer and after cooling to approximately 50
oC, 2.4 ml or 13.3 ml formaldehyde (37 %, w/v) was added for mini gel or blot gel,
respectively to the other components mentioned in table 2.1. The RNA samples were
denatured afterwards at 65 oC for 10 min, cooled down on ice and centrifuged
(14.000 x g, 30 s, 4 oC). 5 µg of RNA molecular weight standard (0,16-1.77 Kb RNA
ladder) was loaded on the blot gel and 1x MOPS buffer was used as running buffer.
The samples were loaded on the gel after the pre-electrophoresis run (5 min, 60 V).
The constant applied field strength for mini gels and blot gels was 5 V/cm (running
time approx. 1 h) and 3 V/cm respectively (running time approx. 5 h). After the run,
the agarose mini gels were stained with ethidium bromide (10 µg/ml) for 15 min and
destained 2 X 15 min in distilled water and photographed under UV transilluminator.
The electrophoresis of the blot gels was stopped when the bromophenol blue dye
has migrated two-thirds of the gel length. The blot gel with a molecular weight
standard was photographed under UV transilluminator (figure 2.2) and the purity and
integrity of RNA preparation was checked using the 16S and 23S ribosomal bands as
reference.
Fig. 2.2. Formaldehyde agarose gel electrophoresis of isolated RNA under different growth conditions
[LE, Fe (-), H2O2 & PMNs]. The molecular weights of 16S and 23S rRNA are 2985 & 1536 bp
respectively (Stover et al., 2000). RNA molecular weight standard is shown on the left side of gel. This
RNA was subsequently transferred to a positively charged nylon membrane for hybridization with
different probes. (LE: late exponential phase; Fe(-): iron limiting; H2O2: in presence of 10 mM H2O2;
PMNs: in presence of PMNs).
RNA ladder
(Invitrogen)
1770  bp
1520  bp
1280  bp
Pseudomonas aeruginosa TB   
LE   H2O2  Fe (-) PMNs   
23S rRNA    
16S rRNA   
1 2 3 4 5 6 7 8
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2.6.5.1. Northern transfer
The completely denatured RNA was separated by formaldehyde agarose gel
electrophoresis and transferred (Ausubel et al., 1988) on a positively charged nylon
membrane (Hybond N+) by the following procedure.
1. The blot gel was kept in double distilled water for 20 min before making the
assembly of the blot equipment and then in 20x SSC buffer for 20 min. 
2. For the Blotting by a sandwich method, the previously mentioned arrangement
(see 2.2.9.1) was performed except that the 20x SSC buffer was used as a tank
buffer. The glass trays and metal stands which are necessary for this
arrangement were heat sterilized at 250 oC for 5 hours.
3. Transfer process was performed at room temperature for 20-24 h. 
4. Then the membrane was removed and washed with 2x SSC buffer for 1 min. 
5. Membrane was dried, cross linked and directly used or stored at -20 oC until use. 
2.6.5.2. RNA-DNA (Northern) hybridization
The Northern hybridization was performed by using following procedure. 
1. The required volume of prehybridization buffer was preheated to 42 oC and the
membrane/blot was kept in a large glass tubes (Biometra) or in 50 ml plastic
Falcon tubes. The membrane was kept in the tube with the RNA adhered side
inward in the tube. The prehybridization buffer (10 ml/100 cm2) was added in the
tube and prehybridized at 42 oC for at least 2-3 hours with constant shaking.
2. The Dig labeled probe was added in 10 ml total volume of prehybridization buffer
and denatured by boiling for 10 min then added in the tube containing blot. 
3. The blot was hybridized for 16-24 hours at 42 oC with gentle shaking in the
hybridization oven.
4. After hybridization, the hybridization buffer was poured in a sterile tube and the
probe was saved for future use at -20 oC. 
5. The blots were detected by a procedure described below. 
2.6.5.3. Detection of the Northern blot
Non-specifically bound probe to the membrane was removed by several washing
steps:
5 min with 6 x SSC + 3 % (w/v) SDS at room temperature
20 min with 2 x SSC + 3 % (w/v) SDS at 42 oC and then 
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20 min with 0.2 x SSC + 3 % (w/v) SDS at 42 oC. 
After these washes, the membrane was removed from the tube and further
procedure was carried out as described previously (see 2.2.9.4) except that all the
detection solutions used belong to RNA work. The developed membrane was
exposed to X-ray film at different time intervals.  
2.6.6. cDNA generation
cDNA synthesis, fragmentation and labeling were performed as described by
Affymetrix (Santa Clara, California) whereby the conditions for the fragmentation of
the synthesized cDNA by DNase I was optimized according to the recommendations
of the protocol. Briefly, 10 µg of total RNA were mixed with 750 ng random primers
and 8.67 pM (final concentration) control in-vitro transcripts from 10 non-
pseudomonal gene sequences (which was kindly provided by S. Lory and co-
workers, Harvard) in a total reaction mixture of 30 µl. The control in-vitro transcripts
were used as an internal quality control for the yield of labeling. This mixture was
incubated for 10 min at 70 oC followed by 10 min at 25 oC and then chilled to 4 oC. 30
µl of cDNA reaction mixture were added to the reaction mixture containing RNA.
cDNA synthesis was initiated by incubating the reaction mixture at 25 oC for 10 min,
at 37 oC for 60 min, at 42 oC for 60 min and then the enzyme was inactivated at 70
oC for 10 min. 
RNA was hydrolyzed by the addition of 20 µl 1N NaOH  and incubation at 65 oC for
30 min. The reaction mixture was neutralized by the addition of 20 µl 1 N HCl. The
cDNA was purified using the QIAquick column (Qiagen, Hilden, Germany) and
quantified by light absorbance at 260 nm (see 2.2.4.3). 
2.6.7. Fragmentation of cDNA
3 to 5 µg of cDNA were fragmented in One Phor-All Buffer with 0.5 U DNase I per µg
cDNA in a 50 µl reaction volume for 10 min at 37 °C. The DNase l enzyme was
subsequently inactivated at 98 oC for 10 min. To check if the majority of cDNA
fragments were in a 50-200 bp range, 5 µl fragmented product was loaded on a 2 %
(w/v) agarose gel and then stained for 40-60 min by keeping the gel in TBE buffer
bath containing 0.0001 % (v/v) SYBRGreen (figure 2.3).
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Following washing, the GeneChips were treated with a streptavidin solution mix for
10 min at 25 oC and washed 40 times with nonstringent buffer at 30 oC. Then each
GeneChip was subjected to a secondary stain at 25 oC for 10 min and then to a
tertiary stain at 25 oC for 10 min. Finally excess label was removed by 60 washings
with nonstringent buffer at 30 oC. 
The schematic representation of all the individual steps performed during GeneChip
experiments are shown in figure 2.4.
RNA Random primed167
Fig. 2.4. Schematic representation of the individual steps performed during a GeneChip experiment
(Courtesy by Goetz, 2003).
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2.6.10. GeneChip analyses
Data analysis was performed using the Affymetrix Microarray Suite Software 5.0 with
Affymetrix default parameters. A total of 2 GeneChips per strain and per growth
condition were scanned at 570 nm with 3 µm resolution in an Affymetrix GeneChip
scanner. The signals were calibrated by a scaling factor of 150. Two GeneChips for
the test were paired with the control of the same strain resulting in 4 total pairs. The
data was imported into a Microsoft Access databank to be capable to search for
genes which significantly changed their signal intensities by Wilcoxon rank test and
at least 2 fold change (MicroArray Suite 5.0 version) in all the 4 comparisons,
described as four-comparison survival method (Chen et al., 2000; Bakay et al.,
2002). The arithmetic average and the standard deviation (SD) of the 4 comparisons
were calculated. As an independent criterion for significantly changed signal
intensities, a Bonferroni correction of the signal ratios obtained from the MicroArray
Suite 5.0 Programme was applied to account for the number of tests, i.e. in this case
the total number of 5900 ORFs on the chip. First, the ratio of calibrated and corrected
hybridization signals per gene Si obtained of cultures grown under identical condition
was verified to follow a Gaussian distribution and the variance σ was calculated.
mRNA transcript levels of a gene i were considered to be significantly differentially
expressed, if the ratio S(i)test / S(i)control  or S(i)control / S(i)test exceeds the threshold (1 +
u σ), whereby the factor u defines that upper boundary of the normalized Gaussian
integral Φ(u) where Φ(u) = xn  matches the Bonferroni-corrected 95 % confidence
interval:
( 1-α ) = xn ( here: n = 5900, α = 0.025, 0.975 << x < 1.0 ).
The annotation of ORFs was extracted from the website of the P. aeruginosa PAO1
sequence project provided at http://www.pseudomonas.com. Differentially
transcribed genes were classified into different functional groups according to
metabolic categories except for orphan genes and conserved hypotheticals. 
The bendability/curvature propensity plot was calculated with the bend.it server
(http://www2.icgeb.trieste.it), using the DNase I based bendability parameters of
Brukner et al. (1995) and the consensus bendability scale (Gabrielian et al., 1996).
Materials and methods
69
2.7. Examination of P. aeruginosa pathogenicity in
murine infection model  
During this work, we found some mutants which have impaired survival in PMNs and
some mutants that even can survive better as compared to the P. aeruginosa TB wild
type. In order to asses the roles of these attenuated genes on virulence, we used
mouse infection model which was already established in Dr. Niels Hoiby’s laboratory
(Copenhagen). Dr. Hoiby is a member of European Graduate Program
“Pseudomonas: Pathogenicity and Biotechnology”. For this, the bacteria were
entrapped into seaweed alginate, a substance which is chemically similar to the
alginate produced in vivo by P. aeruginosa (Pedersen et al., 1990). This model has
been used in their laboratory for more than 10 years for different purposes (Johansen
et al., 1993; Johansen et al., 1995; Song et al., 1996; Song et al., 1997; Moser et al.,
1997). 
2.7.1. Mice
Female C3H/HeN mice were purchased from M & B Laboratory Animals (Ry,
Denmark) at 10 to 11 weeks of age. The mice were of equal size and were
maintained on standard mouse chow and water ad libitum for one week before
challenge. All experiments were conducted in accordance to the existing permissions
from appropriate ethical committees.
2.7.2. Bacterial inoculation and challenge procedure
2.7.2.1. Free bacteria
The infection inoculum was generated by growing P. aeruginosa TB in 250 ml flask
containing 100 ml of LB broth at 37 oC for 18 h on a shaker. The cells were
centrifuged (12,000 x g, 10 min, 4 oC ) and the pellet was resuspended in LB broth,
and adjusted to the appropriate challenge dosage in sterile, isotonic NaCl solution.
The 0.04 ml of bacterial suspension having different cfu/ml was used for intratracheal
challenge.
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2.7.2.2. Immobilization of bacteria in alginate beads
The bacteria that were chosen depending on the requirement of experiment, were
embedded into seaweed alginate beads as described previously (Johansen and
Hoiby, 1999; Pedersen et al., 1990). In brief, one bacterial colony was inoculated in
100 ml of LB broth and grown for 18 h at 37 oC (250 rpm). The culture was
centrifuged (12.000 x g,10 min, 4 oC) and the pellet was resuspended in 5 ml of LB
medium, then 1 ml suspension was serially diluted in the LB broth. This diluted 1 ml
culture (depending on requirement of cfu) was mixed with 9 ml of autoclave sterilized
seaweed alginate solution with 60 % guluronic acid content. The mixture was
transferred to a sterile plastic cylinder equipped with an 18 G needle at the bottom.
By applying a vertical pressure (0.3 hPa) to the top of the cylinder and
simultaneously with a horizontal pressure (1.0 hPa) through the needle, the solution
was forced to split into droplets of embedded bacteria in alginate beads. To stabilize
the alginate beads, the droplets were collected in 200 ml of sterile Tris-buffer (pH
7.0) containing calcium chloride while stirring. Beads were continuously stirred for 1 h
and then collected by centrifugation at 600 to 800 rpm for 10 min, washed twice in
sterile isotonic NaCl solution. The final bead pellet was resuspended in 10 ml of
sterile isotonic NaCl solution and the content of embedded bacteria in terms of
colony forming units was estimated by serial dilutions. The beads were stored at 4 oC
until further use. The challenge solution was composed by diluting the embedded
bacteria in sterile isotonic NaCl to the desired final concentration (104 to 109 cfu/ml)
according to the necessity of experiment. This concentration was verified by counting
colony forming units from the serially diluted challenge solution.
2.7.3. Infection of mice with P. aeruginosa TB
The detailed procedure for bacterial inoculation was described by Dr. Johansen and
Hoiby (1999). In brief, before surgical procedure, mice were anaesthetized by
subcutaneous injection of 0.2 ml of Hypnorm and Midazolam mixture in sterile water.
Anesthetized (sedated) mice were fixed. The trachea was exposed (figure 2.5 left)
and then alginate beads were intratracheally instilled with an 18 G bead-tipped
needle at a dose of 0.04 ml. The inoculum was installed in the left lung approximately
11 mm from the tracheal penetration site (figure 2.5 right). The incision was sutured
with silk and healed without any complications. 
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Fig. 2.5. Exposed trachea of an anaesthetized C3H/HeN mouse (left) and  Intratracheal installation of
the inoculum by a curved bead tipped needle in the left lung of same mouse (right).
2.7.4. Evaluation of different parameters
The mice were sacrified by intraperitoneal injection of 0.05 ml of 20 % pentobarbital
at different time-points according to the requirement of the experiment. Then the
thoracic cavity was exposed without damaging the lungs. These mice were used for
the evaluation of different parameters.
2.7.4.1. Collection of peripheral blood
Blood was collected from the heart by cardiac puncture (figure 2.6) in a 1 ml syringe
containing 20 µl heparin (5000 IE/ml)  and immediately put on ice until further use.71
Fig. 2.6. Collection of peripheral
blood from the heart
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2.7.4.2. Collection of sera
Blood was obtained by cardiac puncture and collected in a 1 ml syringe and stored
on ice for 1 h. Then the serum was separated by using centrifugation (14,000 x g, 10
min, 4 oC) and stored at -20 oC until further use.
2.7.5. Detection of lung bacteriology
The lungs removed from animals were immediately put into sterile containers and
stored at 4 oC (less than 2 hours) until homogenization. The lung samples in 3-5 ml
of cold autoclaved PBS buffer were homogenized with a blender (Heidolph, Struers,
Denmark) at 4 oC. The series of diluted samples plated on blue agar-plates (States
Serum Institute, Copenhagen, Denmark) containing selective culture medium for
Gram-negative bacilli and the colony forming units were determined after 20-24 h of
incubation at 37 oC. 
2.7.6. Collection of bronchoalveolar lavage 
The trachea was exposed and canulated with a size 22G catheter (OPTIVA* 2,
Johnson & Johnson Medical, Brussels, Belgium). Lavage was performed by repeated
flushing of lung with 1.5 ml of phosphate buffered saline (5 oC, without Ca2+ and
Mg2+) (PBS) for 6 times (figure 2.7). The bronchoalveolar lavage (BAL) fluid was
stored on ice until examination of leukocytes.
F
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ig. 2.7. Bronchoalveolar lavage (BAL) fluid collection. The collapsed lungs before flushing (left) and
e expanded lungs before retrieving BAL-fluid (right). 
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2.7.7. Measurement of leukocytes from blood and BAL-fluid
The concentration of leukocytes in the peripheral blood and BAL-fluids was
determined by estimating the relation between the number of leukocytes in a fixed
volume of sample and detectable beads in a known amount. For this, 50 µl of blood
or 200 µl of BAL-fluid was added to a TruCount Tube (Becton Dickinson). Cells were
fixed, erythrocytes were lysed, and the DNA of the leukocytes was stained for
discrimination by adding 450 µl of 10 % (v/v) FACS Lysing Solution (Becton
Dickinson) and 100 µg/ml propidium iodide in MiliQ water. The samples were kept on
ice in the dark for at least 10 minutes before analysis by flow cytometry. In the blood,
mouse PMNs were discriminated by the morphology dependent light scatter.
2.7.8. Estimation of leukocyte phenotypes 
Immunofluorescent staining of the phenotype was used for discrimination of the
leukocyte subpopulations and determination of the expression of activation markers
For this, 75 µl of peripheral blood or 100 µl BAL-fluid was added to 4 ml cold lysing-
buffer in Falcon tubes. The cell pellet obtained after centrifugation was washed in
PBS before adding the antibodies. The immuno-fluorescent staining was performed
by adding monoclonal antibodies (as shown in table 2.2). All antibodies used were
monoclonal rat antibodies. 
Table 2.2. Monoclonal rat anti-mouse antibodies.
Antibody Target Conjugated
Fluorochrome
Amount 
(µl)
Clone Isotype Company
Ly-6G PMNs PE 1 RB6-8C5 IgG2b, κ Pharmingen
F4/80 monocytes FITC 5 CI:A3-1 IgG2b, κ Serotec
CD11b Mac-1 APC 5 M1/70 IgG2b, κ Pharmingen
CD45 leukocytes PerCP 5 30-F11 IgG2b, κ Pharmingen
FITC: Fluorescein isothiocyanate; PerCP: Peridinin chlorophyll A protein; PE: Phycoerythrin; APC:
Allophycocyanin, Pharmingen, San Diego, CA, US; Serotec: Oslo, Norway.
The cells were incubated on ice in the dark for 30 min. Excess antibodies were
removed by adding 4 ml of cold PBS followed by centrifugation (10 min, 350 x g) and
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decanting. The stained cells were fixed by adding 150 µl 2 % (v/v) paraformaldehyde
in PBS and used for flow cytometry.
2.7.9. Measurement of respiratory burst
The respiratory burst was estimated using the BURSTEST kit (Orpegen Pharma).
This assay measures the leukocyte oxidative burst by the fluorescence obtained from
intracellular rhodamine 123 after the oxidization of dihydrorhodamine 123 by
intracellular H2O2. The kit was used in accordance to the modification of the
manufacturer’s prescription.
In brief, 50 µl of peripheral blood or 200 µl of BAL-fluid was added to a Falcon tube
and kept on ice for 10 min. To measure the induced burst, 10 µl of opsonized E. coli
and 10 µl dihydrorhodamine 123 solution were added to the blood samples and 40 µl
opsonized E. coli and 40 µl dihydrorhodamine 123 to the BAL-fluid samples. To
estimate the spontaneous burst, 10 µl dihydrorhodamine 123 solution were added to
the blood samples and 40 µl dihydrorhodamine 123 solution were added to the BAL-
fluid samples. A corresponding volume of PBS was added to samples for measuring
the baseline. The samples were incubated at 37 oC for 10 min in a water bath. The
incubation time was decided in a pilot experiment where the maximum intensity of
the specific signal was reached after 40 min in blood samples from 3 mice.
The reaction was terminated by placing the samples on ice and the samples were
fixed in 1 ml FACS Lysing Solution (Becton Dickinson) diluted 10 times in MilliQ
water for 20 min. The samples were centrifuged (7 min, 350 x g, 4 oC) and the
supernatant was discarded. 3 ml PBS were added and the samples were centrifuged
(7 min, 350 x g, 4 oC) and the supernatant was discarded. 200 µl of DNA staining
solution were added and the samples were incubated on ice for at least 10 min
before analysis by flow cytometry.
 
2.7.10. Measurement of cytokine production
The concentration of cytokines was measured in samples derived from lung. Lung
homogenizate was centrifuged (5,000 x g, 10 min, 4 oC) and the supernatant
obtained was filtered through 0.2 µM filters and stored at -20 oC until further use.
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The concentrations of cytokines in the lung supernatant were determined by
sandwich ELISA kits commercially available from two manufactures. Quantikine
(R&D Systems, Abingdon, UK) kits were used for detection of mouse MIP-2, KC, IL-
12, and GM-CSF. OptEIA (Pharmingen) kits were applied for measuring the mouse
interferon-γ (IFN-γ) and TNF-α. Cytokine measurements were performed according
to the manufacturer’s description.
a) Measurement of cytokines by Quantikine kit
50 µl of samples and standards in assay-diluent were added in duplicates to the
microtiter plates coated with capture antibody and incubated for 2 h. The microtiter
plates were washed 5 times in 200 µl washing solution [PBS with 0.05 % (v/v)
Tween 20]. 50 µl of detection antibody in conjugate-diluent were added for 2 h.
Excess detection antibody was removed by washing 5 times in 200 µl washing
solution and colour reagents were added. After 30 min incubation, coloring reaction
was terminated by adding stop-solution and the microtiter plates were analyzed on a
ELISA reader (Bio-Rad, Tokyo, Japan).
b) Measurement of cytokines by OptEIA kit
The microtiter plates were coated with capture antibody overnight. Excess capture
antibody was removed by washing 5 times in 200 µl washing solution. To reduce
unspecific binding, 200 µl of 10 % (v/v) FCS in PBS were added for 30 min and the
microtiter plates were washed 5 times. 50 µl of samples and standards in assay-
diluent were added in duplicates and incubated for 2 h. The microtiter plates were
washed 5 times with 200 µl washing solution. 100 µl of biotin conjugated detection
antibody and avidin conjugated horse radish peroxidase (HRP) were added and
incubated for 1 h. Excess detection antibody and HRP were removed by washing 5
times with 200 µl washing solution. 100 µl TMBPlus ready to use substrate
(Kementec, Copenhagen, Denmark) was added in the plate. When appropriate color
intensity was achieved, 50 µl of 2N H2SO4 were added and the microtiter plates
were analyzed on ELISA reader.  
The optical density (OD) of stained microtiter plates was immediately recorded at 492
nm by an ELISA reader (Bio-Rad, Tokyo, Japan). The mean OD of the duplicates
was calculated and the cytokine concentration was estimated by projection of the
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standard curve. The analytical variation was calculated from the standard curves
using the formula for the coefficient of variation (CV): CV = SD/m where SD is the
standard deviation and m is the mean. The analytical variation did not exceed more
than 20 %.
2.7.11. Flow cytometric measurements
The samples were analyzed using a FACSort (Becton Dickinson) equipped with a 15
mW argon-ion laser tuned at 488 nm for excitation and a red diode laser for
excitation at 635 nm. Light scatter and logarithmically amplified fluorescence
parameters from at least 10,000 events, when possible, were recorded in list mode
after gating on light scatter to avoid debris, cell aggregates, and bacteria. The
instrument was calibrated using Calibrite (Becton Dickinson). Leukocytes were
identified according to their morphology, by their expression of CD45, and their
content of DNA. The specific fluorescence from an immunochemically stained
sample was calculated by subtracting the fluorescence intensity from samples
stained with irrelevant isotypic control antibodies. In samples stained for respiratory
burst, the baseline was determined from samples not incubated with 123-
dihydrorhodamine.
2.7.12. Statistical analysis 
Data were analyzed by Mann-Whitney U test, Kruskal-Walis test, Chi-squared test, t-
test, Wilcoxon-signed pair-differences rank test, and Spearman Rank Correlation test
using Staview 4.51 (Abacus Concepts, Inc., Berkeley, CA, US) software for
Macintosh.
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3. RESULTS AND DISCUSSION
A highly virulent P. aeruginosa TB (TBCF10839) strain was isolated from the lung of
a cystic fibrosis patient (Miethke, 1985). This isolate belongs to a clone which was
responsible for nosocomial infections in the burn unit and the cystic fibrosis unit at
the Medizinische Hochschule Hannover (Tümmler, 1987). The severe problems in
eliminating P. aeruginosa TB infection after heavy antibiotic therapy indicated that the
bacterium either exhibits high resistance or an atypical pathogenicity mechanism.
After further investigation in the supervisor’s laboratory, it turned out that P.
aeruginosa TB (TBCF10839) survives and multiplies both in the phagolysosomal
compartment and the cytosol of polymorphonuclear granulocytes. When P.
aeruginosa isolates (PAO1 or SG17M or C) were incubated with the freshly isolated
granulocytes, all the cells were lysed within a 30 min incubation period (figure 1.4A).
However, this CF isolate survived in the granulocytes for the same incubation period
(figure 1.4B), and it showed the cell division intracellularly in granulocytes when
incubated for 1 h (figure 1.5).  
The dominant-negative selection by signature-tagged mutagenesis (STM) (Hensel et
al., 1995) has been applied to unravel the etiology of this uncommon virulence trait.
As the first step, the available STM protocol had to be adapted and optimized to the
needs of the GC-rich P. aeruginosa (Wiehlmann et al., 2002). STM allows for the
simultaneous examination of a large number of isogenic transposon mutants that are
differentiated by unique DNA marker sequences. Genes that are essential for
survival in the habitat of interest are identified by dominant-negative selection.
Persistence of bacteria in professional phagocytes is an optimal bioassay to perform
genomewide scans by signature tagged mutagenesis. P. aeruginosa TB transposon
mutants that do not survive the negative selection in PMNs are defective in the
expression of a gene or operon that is essential for the bacterium’s intracellular
survival and hence are interesting for further examination. As a first step, we have
screened the remaining pool of mutants for key genes that are essential for
intracellular growth of P. aeruginosa TB.
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3.1. Screening of STM library for intracellular
survival in PMN
We have screened the STM library in the phagocytosis (selection) assays for the
identification of genes that are necessary for intracellular survival in this CF isolate.
P. aeruginosa 892 was also added in each selection experiment to maintain the
constant selection pressure on the individual mutant and the granulocytes. Thus the
results obtained were comparable. The phagocytosis assays were performed
according to the previously described procedure (Wiehlmann, 2001). Each selection
assay comprised of 46 P. aeruginosa TB transposon mutants and P. aeruginosa 892
(A1) and P. aeruginosa PAO1 (A2) that contain the transposon episomally. Before
beginning the experiment, bacteria were grown separately in LB medium until
stationary phase by overnight incubation. This growth up to stationary phase was
highly important before incubating the P. aeruginosa TB transposon mutants with
granulocytes, because P. aeruginosa produces a high number of cytotoxic factors
particularly during the growth in logarithmic phase which damage the bacterial
phagocytosis by granulocytes. In contrast, production of these cytotoxic factors by P.
aeruginosa was strongly reduced during the growth in stationary phase (Dacheux et
al., 2000). The objectives of the present investigation were to find out the genes
which are necessary for intracellular survival in PMNs. So if the phagocytosis of P.
aeruginosa TB in granulocytes is damaged, the selection pressure on the bacteria
can decrease making the identification more difficult.  
A pool of separately grown 48 mutants was examined for intracellular survival in
PMNs in one experiment. The pooled mutants were mixed with the granulocytes and
incubated on a shaker. During the initial period, the mutants were phagocyted and
exposed to different environmental conditions in the PMNs. Two hours of incubation
period was kept for all the selection experiments. A longer incubation was not
possible since the whole experiment should finish within 6 hours after withdrawal of
blood. 
After the selection, the amplified signal sequences were hybridized on the dot blots
which were previously prepared by the PCR amplification of signal sequences from
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donor plasmids. The signal intensities from the output pool were compared with the
signal intensities from the input pool. 
3.1.1. Evaluation of selection
The evaluation of the selection results was performed by determining the optical
density of the radiographic (X-ray) film after hybridization. The membranes
developed by CDP star were exposed to X-ray films for a short time as to identify not
only loss-of-function mutants (arrow 2 in figure 3.1) but also gain-of-function mutants
(arrow 3 in figure 3.1). These X-ray films were scanned and densities of the
respective dots was determined with the PCBAS program, version 2.09f. The
example of the scanned blot for selection is shown in the figure 3.1. The signal
intensities from selection (input pool) and control (output pool) were normalized
separately with the intensities of respective control strains at the positions A1 and A2.
The ratio (quotient) from the normalized signal intensities of selection and control
was determined. Then the survival of each P. aeruginosa TB transposon mutant was
compared with the control strains (A1 and A2). The control strains P. aeruginosa 892
and P. aeruginosa PAO1 were used due to their different intracellular survival ability.    
P. aeruginosa 892 (position A1): This bacterium is a clonal variant of P. aeruginosa
TB and survived in the granulocytes nearly as good as TB. So this was considered
as the positive control. P. aeruginosa TB transposon mutant in which a gene
essential for intracellular survival is mutated, should exhibit a lower survival rate than
P. aeruginosa 892. 
P. aeruginosa PAO1 (position A2): This bacterium can not survive intracellularly in
PMNs. P. aeruginosa TB transposon mutant in which a gene essential for
intracellular survival is mutated, should exhibit a survival rate comparable to P.
aeruginosa PAO1. The positions of A1 and A2 are shown in the figure 3.1. 
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Fig. 3.1. Detection of the signature tags to determine the intracellular survival rate of P. aeruginosa
TBCF10839 transposon mutants. 48 transposon mutants were checked for their intracellular survival.
DIG-labeled, HindIII- digested signal sequences of the bacteria not subjected to selection (“unselected
P. aeruginosa transposon mutants”, upper panel) and of bacteria recovered from the PMN
phagocytosis assay (“after selection in PMN”, lower panel) were hybridized onto dot blots of the signal
sequences of the pTnModOGm SigTag. The membranes were developed with CDP- Star for a short
time as to identify not only loss- of- function (arrow 2) but also gain of function mutants (arrow 3).
Mutants indicated by significantly different signal strength on the two blots were subjected to further
analysis. A co- selected transposon mutant of P. aeruginosa PAO1 that is not able to survive
intracellularly in PMN served as negative control (A2 position indicated by arrow 1) and transposon
mutant of P. aeruginosa 892 that is able to survive intracellularly in PMN served as positive control (A1
position indicated by arrow 4).
After determining the signal intensity, those mutants were selected which showed the
signal intensity maximum of 20 % to the positive control or the average value for loss
of function mutant and double or more for gain of function mutant. From each pool,
5-10 mutants were identified as attenuated in the infection model. At some positions
in the input pool, signals were absent or very weak, indicating that the particular
mutant does not survive in the PMNs or the signals observed were very strong as
compared to the signals from the output pool indicating that the corresponding
mutant survives better than the wild type P. aeruginosa TB. About 200 transposon
4
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mutants with significant differences in signal strength compared to the average were
identified in the first round of selection. These mutants were re-tested in the
additional selection assays. In this way, we screened the remaining pool of non-
screened library consisting of 1344 transposon mutants for their intracellular survival
ability in human PMNs and 960 mutants were screened by the previous student
during his Ph. D. studies (Wiehlmann, 2001). 
Out of these 1344 mutants, we found 29 mutants with consistently high differences in
their survival rates in comparison to the P. aeruginosa TB wild type. Out of these 29
mutants, 22 mutants which has impaired survival in PMNs (loss of function mutants),
while 7 mutants which survived even better (gain of function mutants) as compare to
the P. aeruginosa TB wild type. The results of the STM library screening for
intracellular survival in PMNs are presented below in short. 
Loss-of-function mutants (with reduced survival): 
9B9 10B11 10B12 11D1 11D7 25A12
25D12 30B5 30B7 30B12 30D5 31B11
32B12 32C1 32D9 36C8 36D6 36D10
40B9 42D8 45A7 45A10
Gain-of-function mutants (with increased survival):
25C8 25D6 26C2 29D2 35D1 38A11 
40D12
The name of transposon mutant refers to their position in the library of P. aeruginosa
TB. One selection level consist of 48 mutants, which were arranged in four rows (A-
D) with 12 positions in each row (1-12). For example, a transposon mutant that was
arranged in the selection level 25 and in the row C at position 8 gets the name 25C8. 
The disrupted genes of these 29 mutants with consistently high differences in their
survival rates in comparison to the wild type were sequenced. After comparing the
gene sequences with the PAO1 genome, it was observed that most of the genes for
the intracellular survival in PMN are already known from PAO1 genome. 27 of these
genes exhibited about 99.5 % sequence identity to known P. aeruginosa PAO1
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genes. Two other sequences are strain specific, one with no homologies to any
known sequence, the other with some homology to an alcohol dehydrogenase. 
 3.2. Characterization of STM knockout mutants
STM technology was applied for the identification of genes which are essential for the
survival in a particular habitat. After screening the STM library, one can receive the
information which genes are essential for survival under the particular selection
conditions. However, the function of these genes with respect to intracellular survival
is not known. For this, each identified mutant should be characterized further to yield
more functional information.
3.2.1. In silico characterization of P. aeruginosa TB mutants
In silico analysis was performed for each mutant to get more information about the
influence on the neighbouring genes due to the transposon insertion. A survival rate
with respect to the positive control (P. aeruginosa 892) was also calculated for each
mutant. It indicates the degree of intracellular survival ability in PMNs. This
information is tabulated in the following table (Table 3.1). 
Table 3.1. P. aeruginosa TBCF10839 genes involved in virulence.
Mutant PAO No.1 Degree of intracellular
survival (%)2 
Possible polarity effect3
Loss-of-function mutants (with reduced survival):
9B9 PA4613, katB 31 No, transcription termination behind gene
10B11 PA1510 37 Yes, unknown ORFs PA1509-PA1508
10B12 PA2239 29 Yes, unknown ORFs PA2240-PA2242,
probable polysaccharide biosynthesis
11D1 PA1954 15 No, transcription termination behind gene
11D7 PA1104, fliI 25 Yes, fliJ
25A12 TB02 26 Yes, unknown ORFs (see 3.4.1 )
25D12 PA4489 42 Yes, unknown ORFs PA4487-PA4488
30B5 PA1174, napA 22 Yes, napB, napC
30B7 PA2822 19 No, terminal gene of operon
30B12 PA3933 15 No
30D5 PA1920 16 No
31B11 PA4065 32 Yes, unknown ORF PA4066
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Mutant PAO No.1 Degree of intracellular
survival (%)2 
Possible polarity effect3
32B12 PA0694, exbD2 21 Yes, unknown ORF PA0695
32C1 PA5177 35 No
32D9 PA0880 26 Yes, unknown ORFs PA0881-PA0883
36C8 PA5220 29 No, last gene of operon
36D6 PA4034, aqpZ 37 No
36D10 PA5248 22 Yes, unknown ORF PA5247
40B9 PA5373, betB 28 Yes, betI
42D8 PA2242 15 Yes, unknown ORFs PA2243-PA2245
45A7 TB01 26 Yes, unknown ORFs (see 3.4.1)
45A10 PA1452, flhA 18 Yes, flhF, flhN, fliA
Gain-of-function mutants (with increased survival):
25C8 PA4554, pilY1 540 Yes, pilY2, pilE
25D6 PA3270 625 No, transcription termination behind gene
26C2 PA4186 1170 No, transcription termination behind gene
29D2 PA4228, pchD 850 Yes, pchA, pchB, pchC
35D1 PA3704, wspE 720 Yes, wspA, wspB, wspC, wspD
38A11 PA0845 710 No
40D12 PA1677/
1678
1480 Yes, intergenic region of unknown ORFs
PA1677 or PA1678
1: Gene names are given in italics.
2: Degree of intracellular survival was calculated from five independent experiments, survival of P.
    aeruginosa 892 (positive control) was considered as 100%.
3: Polarity, the downstream genes are considered from P. aeruginosa PAO1 database
    (http://pseudomonas.com).
A previous student has also identified 15 mutants during the screening for
intracellular survival in PMNs (Wiehlmann 2001). Altogether, we have found 44
mutants, out of which 35 mutants have impaired survival ability (loss of function),
while the other 9 mutants survived even better than the TB wild type. The disrupted
genes of these 44 mutants with consistently high differences in their survival rates in
comparison to the wild type were sequenced. Forty of these genes exhibit about 99.5
% sequence identity to already known P. aeruginosa PAO1 genes. Three other
sequences are unknown, two with no homologies to any known sequence, the other
with some homology to an alcohol dehydrogenase. The identified genes were
categorized according to their known or estimated function (Table 3.2). From this
data, the identified genes with known functions are related to oxidative stress
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response, flagella and Type IV pili biosynthesis, membrane proteins and strain
specific or are involved in a  regulatory function.
Table 3.2. Screening of P. aeruginosa  TBCF10839 STM mutants in PMN phagocytosis assay:
localization of the Tn5 insertion in gain- of- function and loss- of-function mutants.
Mutanta PAO1
No.
Identity
(%)
Annotatione
Category I: loss of function (reduced survival in granulocytes )
Oxidative stress response
3D1a PA1288 99.6 outer membrane protein precursor fadL, putative
14C5a PA3344 99.4 ATP-dependent DNA helicase, recQ
9B9 PA4613 99.6 promoter region of catalase, katB 
2D5a PA4621 99.9 oxidoreductase, putative
41D3a PA5349 99.8 rubredoxin reductase, putative
40B9 PA5373 99.5 betaine aldehyde dehydrogenase, betB
Oxidative stress response, putative
32D9 PA0880 99.6 ring cleaving dioxygenase, putative
30B5 PA1174 100 periplasmic nitrate reductase, napA
Flagella biogenesis
11D7 PA1104 98.6 flagellum-specific ATP synthase, fliI
22D11a PA1441 99.6 hypothetical protein, 47% similar to fliK of Salmonella
typhimurium
45A10 PA1452 99.7 flagellar biosynthesis protein, flhA
Membrane protein and receptors
32B12 PA0694 99.6 transport protein, exbD
30B12 PA3933 99.3 choline transporter betT3, putative
36D6 PA4034 99.3 aquaporin Z, aqpZ
31B11 PA4065 99.9 hypothetical protein; membrane protein
36D10 PA5248 98.7 hypothetical protein; membrane protein
15A3a PA5252 99.8 ATP-binding component of ABC transporter, putative
Regulation
23B9a PA2468 99.8 sigma-70 factor, putative
24A12a PA3192 99.6 two-component response regulator, gltR
Unknown and hypothetical 
10B11 PA1510 99.5 hypothetical protein
19C2 a PA1572 99.7 conserved hypothetical protein
30D5 PA1920 99.6 conserved hypothetical protein 
11D1 PA1954 99.4 hypothetical protein
10B12 PA2239 99.5 transferase, putative
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Mutanta PAO1
No.
Identity
(%) 
Annotatione
18A12a PA2613 99.7 conserved hypothetical protein 
30B7 PA2822 99.5 conserved hypothetical protein
20A6a PA3953 99.9 conserved hypothetical protein
25D12 PA4489 99.6 hypothetical protein
32C1 PA5177 99.4 conserved hypothetical protein
42D8 PA2242 99.5 hypothetical protein
36C8 PA5220 99.7 hypothetical protein
24C5a PA5551 99.6 hypothetical protein
Not present in PAO1
45A7 TB01 b 71% dehydrogenase, putative
25A12 TB02 c 0% no homologies
47D7a TB03 d 0% no homologies
Category II: enhanced survival in granulocytes
Type IV pili biogenesis
35D1 PA3704 100 chemotaxis sensor/effector fusion protein, wspE
25C8 PA4554 99.3 type 4 fimbrial biogenesis protein, pilY1
15B10a PA5040 99.4 type 4 fimbrial biogenesis protein, pilQ
Other genes
14B12a PA1992 100 two-component sensor, putative
29D2 PA4228 99.4 pyochelin biosynthesis protein, pchD
Unknown and hypothetical
38A11 PA0845 99.8 conserved hypothetical protein
40D12
PA1677/PA
1678
99.8 intergenic region between hypothetical ORF and DNA
methylase
25D6 PA3270 100 hypothetical protein
26C2 PA4186 99.3 hypothetical protein
a: These genes were identified in the previous screening for intracellular survival in PMNs by a
    previous student (Wiehlmann Ph.D. thesis, 2001).
b: Strong homology with dehydrogenases 
   nucleotide level:
gi|887430|emb|X73835.1|ECFDH E.coli plasmid DNA for formaldehyde-dehydrogenase,
Expectation value = 1e-92
gi|15829254|ref|NC_002695.1| E. coli O157:H7, complete genome, 
Expectation value = 2e-69
   amino acid level:
gi|887431|emb|CAA52057.1| (X73835) formaldehyde dehydrogenase (glutathione) E. coli;
Expectation value = e-180
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gi|15800087|ref|NP_286099.1| (NC_002655) alcohol dehydrogenase class III; formaldehyde
dehydrogenase, glutathione-dependent E. coli O157:H7, Expectation value = e-173
c: No significant homologies (all expectation values > 0.3) at nucleotide and protein level to any gene
   deposited in the NCBI database, only present in clonal variants of P. aeruginosa TBCF10839.
d: Present in other clonal variants of P. aeruginosa TBCF10839 and clone C; no significant homologies
   (all expectation values > 0.1) at nucleotide level; low homology at amino acid level to
(gi|16505895|emb|CAD09774.1| (AL513383) hypothetical protein Salmonella enterica subsp.
   enterica serovar Typhi, Expectation value = 3e-08
e: Gene names are indicated in italics. 
A transposon insertion in 35 of the identified 44 ORFs resulted in a decreased
intracellular survival rate, while with an insertion in 9 genes, the bacterium was able
to survive even better in PMNs than the TB wild type. The function of the majority of
ORFs has yet to be elucidated. The search in the databases did not provide a clue
about the encoded function for 22 out of the 44 identified genes. Two of these 22
genes have no known homolog in the databases yet. A remarkable feature of 95 % of
the sequenced genes is that they are already known sequences from the PAO1
genome and exhibit an average of 99.7 % nucleotide homology (Table 3.2). 
Taking into account that the transposon mutants of the constructed library were
selected not to be auxotrophic mutants (Wiehlmann, Ph. D. thesis, 2001) and that the
redundancy of the library is less than 10 %, the 2300 asservated mutants should
represent mutations in a majority of all phenotypically relevant genes or operons. The
high amount of known PAO1 genes indicate that strain PAO1 is equipped with almost
all genes necessary for intracellular survival in PMNs. The change from an
opportunistic pathogen to a highly virulent pathogen apparently requires only a few
minor genetic changes. Amongst the 22 clearly annotated genes (Table 3.2), the two
largest subsets of genes are either associated with oxidative stress response or the
flagellar export and synthesis machinery. The respective mutants were subjected to
functional analysis.
3.2.2. Oxidative stress response in P. aeruginosa TB
Analysis of the resistance of the bacteria to hydrogen peroxide allowed for the
examination of the oxidative stress response of the mutants. As hydrogen peroxide is
an unstable compound, the bacteria are only initially subjected to this particular
stress factor. After only a few hours, the hydrogen peroxide concentration in the
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medium has decreased sufficiently to allow for the surviving P. aeruginosa to grow.
The conditions of this experiment correspond to those found in PMN, where the
bacteria are also initially subjected to considerable oxidative stress. Afterwards, the
severe damage to the PMN results in cell death. The outcome of the STM- screening
demonstrates that tolerance to initial oxidative stress is instrumental to persist in the
hostile environment of the PMN.
0 mM H O 8 mM H O 12 mM H O87
Fig. 3.2. Sensitivity of P. aeruginosa TBCF10839 transposon mutants with impaired survival in PMNs
towards hydrogen peroxide. TBCF10839 wild type and transposon mutants were incubated overnight
at 37°C on LB agar containing initially 8 or 12 mM hydrogen peroxide in order to assay the sensitivity
towards oxidative stress. LB agar without hydrogen peroxide was used as control (left plate) and
significant growth was observed for all strains. Only the TBCF10839 wild type strain exhibited
comparable growth on hydrogen peroxide-containing LB medium (right plate). The two transposon
mutants in the choline transporter betT3 and aquaporin Z were also impaired in growth. The other six
mutants whereby each carried the transposon in a gene assigned to the category ‘oxidative stress
response’ (Table 3.2) did not grow at all. (From left to right: upper row (mutants with defects in
osmoregulation): PA5373 (betB), PA4034 (aqpZ), PA3933 (betT3), middle row: PA5349 (rubR),
PA4621, PA4613 (katB), lower row: PA3344 (recQ), PA1288 (fadL), P. aeruginosa TBCF10839 (wt)
Eight out of the 44 mutants did not grow in the presence of 12 mM hydrogen
peroxide (figure 3.2). Besides obvious candidates such as catalase (PA4613) and
helicase (PA3344) which are involved in the inactivation of peroxide or in the repair of
oxidative DNA- damage, the relevance of other elements such as the rubredoxin
reductase (PA5349) for the resistance against oxidative stress is less obvious.
Rubredoxin reductases have been identified in many bacteria, can substitute for
superoxide dismutase (Lumppio et al., 2001; Pianzzola et al., 1996) and are involved
in the oxidation of aliphatic hydrocarbon compounds (Eggink et al., 1990). The
2 2 2 2 2 2
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homologs of PA1288 (FadL) transport long-chain aliphatic hydrocarbons in numerous
Gram-negative bacteria (DiRusso and Black, 1999) and it is reasonable to assume
that in P. aeruginosa FadL also provides the substrate for rubredoxin reductase.
Hence we would like to conclude that the capture of oxygen radicals by long-chain
hydrocarbons is an essential pseudomonal weapon against PMNs.
3.2.3. Flagellar export and synthesis machinery
Three mutants with decreased survival in PMNs carry the transposon in the fliI
(PA1104), fliK (PA1441) and flhA (PA1452) genes of the flagellar biogenesis
pathway. Motility was assessed in terms of swimming and swarming on agar plates.
Swarming which requires pili and flagellum (Köhler et al., 2000) was found not to be
impaired in the three mutants (data not shown). The flhA and fliK mutants were non-
motile, whereas motility of the fliI mutant was somewhat lower than that of the wild-
type TBCF10839 strain (figure 3.3).
The cellular morphotypes and the structure of the flagellum were characterized by
electron microsocopy in co-operation with G. Brandes (Medizinische Hochschule
Hannover). The flhA Tn5 mutant turned out to be non-flagellated (figure 3.3). The fliK
transposon mutant showed an elongated hook structure and misassembled filaments
(figure 3.3 & 3.4) as it has been observed in severely affected fliK mutants of
Salmonella enterica serovar Typhimurium (Williams et al., 1996; Minamino et al.,
1999). The flagellin FliC was demonstrated to be incorporated into these aberrant
hooks by both immunogold labeling (figure 3.4) and immunoblot with anti-FliC (type
b) antibody (data not shown). The hook-type mutant flagella of the mutant Tn5::fliK
strain are decorated with anti flagellin- gold particles along the whole surface which
shows up by the negatively stained oblique stripes. The density of the antibody -
protein A - complexes is higher on Tn5::fliK mutant flagella than on those of wild type
strain TBCF10839. Apparently the flagellin monomers of the Tn5::fliK mutant are
assembled to a flagellar structure with a hook- like relief that exposes more epitopes
on its surface than the wild- type flagella. The fliI Tn5 mutant exhibited a variable
number of one to six polar flagella (figure 3.3). The bacterial suspension contained
many isolated flagella with no basal body. Preparations of isolated flagella were a
mixture of about 10 % normal flagella and about 90 % of flagella without the MS and
C rings of the basal body suggesting that the physical interaction between the
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external rings and the flagellar protein export apparatus (Minamino and Macnab,
1999) is very labile. In other words, FliI seems to be necessary for the tight
association of the external ring with the export apparatus, rod and hook (figure 3.5).89
Fig. 3.3. Morphotype (upper panel) and swimming phenotype (lower panel) of the P. aeruginosa
TBCF10839 strain and its isogenic transposon mutants in fliI, fliK and flhA. The bar indicates the
length of 1 µm. (Courtesy by G. Brandes for EM of flagella mutants).
So far only few elements of the flagellar export and synthesis machinery have been
characterized in P. aeruginosa (Simpson et al., 1995; Arora et al., 1996; Fleiszig et
al., 2001). The primary sequence of the individual genes and the overall genetic
organization (Stover et al., 2000) is highly homologous to that in S. enterica serovar
Typhimurium. This homology provides the rationale to interpret findings on the P.
aeruginosa flagellum in analogy to the extensively studied Salmonella flagellum
(Macnab, 1996). In Salmonella FliI, FlhA and FliK are components of the flagellar
protein export apparatus (Minamino and Macnab, 1999). If we assume that the highly
homologous proteins in P. aeruginosa exert analogous functions and have a similar 
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Fig. 3.4. Electron microscopy of flagella preparations. (A) Negative stain of flagella of the P.
aeruginosa TBCF10839 strain and of its isogenic transposon mutants in fliI and fliK. A normal
flagellum is characterized by basal body, hook and extended filament. The preparations of the fliI
transposon mutants consisted of a minority of apparently normal flagella (left) and a majority of
filaments with a convex tip at one end probably representing parts of the flagellar export apparatus
(see figure 3.5). The fliK transposon mutant produced basal bodies and elongated hook-like
structures. (B) Immunogold labeling of the flagella of the wild-type strain and its fliK transposon mutant
with anti-flagellin FliC (type b) polyclonal goat antibody and secondary gold-labeled anti-goat antibody.
The bar indicates the length of 0.5 µm (Courtesy by G. Brandes).
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Fig. 3.5. Hypothetical model for the flagellar protein export apparatus (adapted from Minamino and
Macnab, 1999).
spatial organization, they are not exposed to the exterior. Consequently, the
interaction with the PMNs in our STM selection assays was not executed by neither
of the three proteins but rather by a yet unknown factor secreted by the flagellar
export apparatus. This conclusion is consistent with the uniform phenotype of the
three mutants in the phagocytosis assays, albeit their impact on flagella synthesis
and structure was different. The fliI mutant lacks sufficient stability of the basal body,
in the fliK mutant with its elongated hooks the hook cap protein FlgD is not properly
replaced by the hook-filament junction protein FlgK (Makishima et al., 2001), and the
flhA mutant does not produce any flagella. FliK (own unpublished data) and FhlA
(Fleiszig et al., 2001) the latter of which is homologous to the invasion protein InvA in
Salmonella have been shown in P. aeruginosa to be essential for motility and
internalization by epithelial cells underlining the double role of these proteins for
secretion and flagella biogenesis. In Yersinia enterocolitica, for example, the FhlA-
homologue is essential for the secretion of a virulence associated phospholipase
(Young et al., 1999).
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3.2.4. Cytotoxicity towards macrophage J774 cells
The flagella mutants and wild type were subjected to cytotoxicity test on murine
macrophage J774 cells. The results showed that fliK, flhA, CHAexsA mutants were
non-cytotoxic in addition to the P. aeruginosa 892 wild type (figure 3.6) and P.
aeruginosa TB was equally cytotoxic like another clinical isolate CHA. However, the
fliI mutant was also equally cytotoxic like the TB wild type which could be due to a
cell specific or unknown mechanism. P. aeruginosa CHA is a highly cytotoxic strain
and serves as a positive control for the assay, while the CHAexsA mutant exhibits no
cytotoxicity due to the defect in the type III secretion system regulator and serves as
a negative control for this assay. Recently, It has been reported that the CF clinical
isolate, P. aeruginosa CHA, is able to induce rapid oncosis of PMNs and
macrophages. The cytotoxicity is type III secretion system dependent but is
independent of the toxin ExoU (Dacheux et al., 1999; Dacheux et al., 2000). So these
results also support the hypothesis that the flagellar export apparatus may be
involved in the secretion of virulence factors. Further research is required to get
insights of flagella mediated virulence factor secretion in this CF isolate. 
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Fig. 3.6. Cytoxicity of P. aeruginosa strains toward J774 macrophage cells. The macrophages were
infected with P. aeruginosa and CHA strains (MOI, 20) and the cytotoxicity percentage was calculated
from the release of LDH activity. 
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 3.3. Screening of  STM library for mutants defective
in protease secretion
In P. aeruginosa, quorum sensing has been proposed as a global mechanism for
controlling virulence factor expression and the development of biofilms (Davies et al.,
1998). Several genes are regulated by quorum sensing, including toxA (exotoxin A;
Gambello et al., 1993), lasB (elastase; Brint & Ohman, 1995; Latifi et al., 1995;
Pearson et al., 1997) and lasA (LasA protease; Toder et al., 1991), aprA (alkaline
metalloproteinase; Gambello et al., 1993; Latifi et al., 1995), rhlAB, encoding proteins
involved in the synthesis of rhamnolipid (Ochsner et al., 1994; Pearson et al., 1997),
katA and sodA (catalase and superoxide dismutase; Hassett et al., 1999), lecA
(lectin; Winzer et al., 2000) and genes involved in pyocyanin synthesis (Brint &
Ohman, 1995; Latifi et al., 1995). The influence of the las and rhl quorum sensing
systems on the extracellular protein profile in P. aeruginosa was also examined by
Nouwens et al. (2003). All mutant strains showed a significant reduction in the total
concentration of secreted proteins, suggesting that the lack of any las or rhl gene
severely disrupts protein secretion, and/or expression of previously abundant
extracellular constituents (Nouwens et al., 2003). 
In order to screen the transposon library for mutants defective in quorum sensing, a
casein plate agar assay was developed. This is a fast assay where most of the lasI-
rhlI dependent proteases form a zone of hydrolysis on casein agar plates. The test
assay was developed by a previous student in our laboratory who detected 8
protease deficient mutants in a preliminary screen (Wiehlmann, 2001). We have
systematically screened the STM library for the defect in quorum sensing by this
protease secretion assay. Altogether, 2306 transposon mutants were screened on
casein agar where casein was supplied as sole carbon source. The transposon
mutant with a defect in quorum sensing did not grow or formed a weak zone of
clearance on the M9 medium containing casein. On the other hand, other mutants
formed a zone of clearance like the wild type due to the hydrolyzed proteins which
surrounded the colony. In this way, we have found about 200 mutants in the first
round of screening which did not grow or have a defect in protease secretion on
casein agar. These mutants were subsequently tested in the same assay for four
times and the comparative quantification of proteolytic activity/zone of clearance was
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monitored for 60 h. Induction of proteolytic activity was also monitored in further
experiments where the mutants were inoculated in a close proximity in the form of
the thick line perpendicular to the wild type TB (see figure 3.7). Since the homoserine
lactone molecules produced by wild type can diffuse to the mutant through the casein
agar, the quorum sensing in mutant can be induced resulting in the production of
proteases which form weak zone of clearance on the side of TB wild type. After these
assays, those mutants which had a defect either in the formation of zone of
clearance or formed a weak zone of clearance or formed a zone of clearance after
stimulation by the wild type or did not grow completely on casein agar were selected.
 
Fig. 3.7
casein 
mutants
incubat
product
showed94
. Examination of inducible proteolytic activity of P. aeruginosa TB transposon mutants on
agar. The P. aeruginosa TB wild type was inoculated in the center while the transposon
 were inoculated perpendicular to wild type in a close proximity on casein agar plates and
ed for 60 h.  44D5, 44D3, 41D3 and 39D8 showed proteolytic activity due to the diffusible
s secreted by wild type while 43A11 showed weak zone of hydrolysis from beginning and 38D7
 zone of hydrolysis after 48 h. 
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Table 3.3. Characteristics of the mutants that are defective in proteolytic activity on the casein plate
agar assay. 
Mutant No zone of
clearance 
(up to 48 h)
Weak zone of
clearance 
(from beginning)
Weak zone of
clearance 
(after 48 h)
Stimulation
by wild type
Defect in QS
assay1
1C4 + nt
2B6 + + nt
2D1 + + +
3B6 + + nt
4B6 + + nt
5B6 + + nt
6B6 + + nt
15D9 + nt
16C12 + + nt
18A8 + +
18D3 + nt
20D1 + + nt
23B11 + nt
37D7 + + +
38D7 + + nt
39D8 + + +
43A11 + nt
44D3 + + +
44D5 + + +
48A8 + nt
48D12 + + nt
+: Indicates that the mutant is positive for a mentioned characteristic.
1: These mutants were confirmed in the quorum sensing assays (see 2.4.1) and some mutants were
not tested (nt) in the same assays.
We have found 21 mutants, out of which 14 mutants were unable to produce a zone
of clearance, while the other 7 mutants which produced a weak zone of clearance as
compared to the TB wild type. For example, the mutant 38A11 showed a zone of
clearance after 48 h, the other mutant 43A11 showed a zone of clearance from the
beginning, while the other mutants 39D8, 41D3, 44D3 and 44D5 did not show a zone
of clearance but showed induction in protease secretion due to the wild type. The
characteristics of the individual mutants are given in the following table (Table 3.3).
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The subset of these attenuated mutants was confirmed by testing in a further assay
for quorum sensing in Prof. Dr. Leo Eberl’s lab. Then these mutants were subjected
to plasmid rescue to identify the disrupted genes. Out of the 21 mutants, we obtained
transformants from 14 mutants. Plasmid rescue failed for 7 mutants even after
successive efforts. The disrupted genes of these 14 mutants with consistently high
differences in their protease secretion characteristics in comparison to the TB wild
type were sequenced. Out of these 14 mutants, 5 mutants (2B6, 3B6, 4B6, 5B6 and
6B6) have turned out to have a transposon insertion in the same gene. All of the
genes from other 9 mutants exhibit about 99.5 % sequence identity to already known
P. aeruginosa PAO1 genes (Table 3.4). 
Table 3.4. Screening of P. aeruginosa  TB STM mutants for defect in protease secretion: localization
of the Tn5 insertion in the attenuated mutants.
Mutant PAO1
No.
Identity
(%)
Annotation1
1C4 PA4468 99.6 hypothetical protein
6B6 PA3095 99.1 general secretion pathway protein M, xcpZ
18A8 PA3477 99.2 transcriptional regulator, rhlR
18D3 PA0928 98.9 sensor/response regulator hybrid
20D1 PA3102 100 general secretion pathway protein F, xcpS
39D8 PA1436 99.3 probable RND efflux transporter
44D3 PA2751/
2752
99.6 intergenic region between hypothetical proteins on
either side
44D5 PA0447/
0448
99.8 intergenic region between glutaryl-CoA
dehydrogenase, gcdH and probable transcriptional
regulator
48D12 PA3105 100 general secretion pathway protein D, xcpQ
1: Gene names are indicated in italics.
The identified genes from the protease secretion assay belong to the general
secretion pathway such as xcpZ (PA3095), xcpS (PA3102) and xcpQ (PA3105),
unknown function (PA2751/PA2752, PA4468), RND efflux transporter (PA1436) and
some have regulatory functions (PA0928, PA3477) (Table 3.4). It has been reported
that loss of quorum sensing results in reduced expression of several secreted
proteins, including elastase (lasB) (Passador et al., 1993; Pearson et al., 1997). Out
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of the 9 mutants, we found a mutant that have transposon insertion in the already
known quorum sensing dependent gene (rhlR) and in three xcp genes (xcpZ, xcpS &
xcpQ). The xcp genes are not under the direct control of quorum sensing but are
positively regulated by vfr and gacA (Beatson et al., 2002). The rhlR is a positive
regulator involved in the second quorum sensing system rhlI-rhlR (Davis et al., 1998;
de Kievit and Iglewski, 2000). The other mutant 44D5 that has the insertion in the
intergenic region which can affect the transcription of both genes i.e. gcdH and a
probable transcriptional regulator because they are transcribed in the opposite
direction. The gcdH gene was also found to be quorum sensing promoted during the
microarray experiment performed by Wagner et al. (2003). So we can conclude that
this is the fast and easy method to screen genomic libraries and identify genes
involved in quorum sensing.
3.4. Transcriptional analysis of P. aeruginosa
3.4.1. Global transcriptional analysis of P. aeruginosa
strains against superoxide and oxidative stress 
Background
The polymorphonuclear leukocyte (PMN) is the principle effector cell responsible for
clearance of P. aeruginosa (Tümmler and Kiewitz, 1999). At the initial stage of
infection by P. aeruginosa, the pathogen must colonize and proliferate in an hostile
environment where it is exposed to several stresses, such as limitation of certain
nutrients, thermal stress, osmotic stress and oxidative stress. The latter stress is
induced during phagocytosis when a phagosomal NADPH oxidase complex
undergoes a burst of oxygen consumption (Babior et al., 1973; Chanock et al., 1994).
The electrons are transferred from cytoplasmic NADPH to oxygen on the
phagosomal side of the membrane, generating superoxide as a reactive oxygen
species. It can form the hydroxyl radicals via the iron-catalysed Haber-Weiss reaction
(Cohen et al., 1988) or by reacting with hypochlorous acid (Candeias et al., 1993),
and it can also react with nitric oxide to produce peroxynitrite (Zhu et al., 1992). This
oxidative burst is essential for killing of number of micro-organisms. Superoxide is a
moderately reactive compound capable of acting as an oxidant and reductant in
biological systems (Fridovich, 1997). The superoxide produced by PMNs also acts as
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a precursor of hydrogen peroxide. A common model compound that continuously
produces superoxide is the chemically inert xenobiotic paraquat (Ma et al., 1998).
Bacteria have developed a sequential series of defense strategies to evade the
detrimental action of superoxide and the hydroxyl radicals (Kettle and Winterbourn,
1990). Some organisms inhibit the NADPH oxidase dependent oxidative burst and
thus reactive oxidant production within the phagosome (Miller and Britigan, 1997).
They have also developed highly specific and reactive enzymatic pathways of
oxidant inactivation, including those catalyzed by superoxide dismutase (SOD),
catalase/peroxidase, and glutathione in combination with glutathione peroxidase and
glutathione reductase (Hassett and Cohen, 1989). SOD detoxifies the O2- anion by a
dismutation reaction that generates H2O2 and O2 , while catalase converts toxic H2O2
into H2O and O2 (Fridovich, 1978). The production of SOD enzymes is a key defense
strategy aimed at the elimination of superoxide.  
Prior to the complete sequencing of the P. aeruginosa PAO1 genome (Stover et al.,
2000), a candidate gene approach has been pursued to uncover the oxidative stress
defense in P. aeruginosa (Hassett et al., 1992; Brown et al., 1995; Hassett et al.,
1995; Hassett et al., 1996; Ochsner et al., 2000b; Ochsner et al., 2001). P.
aeruginosa possesses numerous enzymes for defense against reactive oxygen
intermediates, including two superoxide dismutases (SodB, SodM) (Hassett et al.,
1995), three catalases (KatA, KatB, KatC) (Brown et al., 1995) and four
alkylhydroperoxide reductases (AhpA, AhpB, AhpCF, Ohr) (Ochsner et al., 2000b;
Ochsner et al., 2001). Some of the genes involved in oxidative stress response,
including the major catalase katA and the ferredoxin-dependent alkyl hydroperoxide
reductase ahpC are constitutively expressed at high levels during normal aerobic
growth and hence even significant oxidative stress causes only a maximal twofold
increase in expression (Ochsner et al., 2000b). Key regulators modulating the
oxidative stress response in bacteria are soxR and oxyR, both of which are activated
at the post-translational level. The soxR- and oxyR-regulons have been studied in
detail in E. coli, but recently an oxyR homolog has been identified in P. aeruginosa
PAO1 (Ochsner et al., 2000b). The oxyR gene is encoded in an operon together with
recG, the latter being involved in DNA repair. 
Results and discussion
99
Phagocytosis and killing by PMNs is the major human defense mechanism against P.
aeruginosa. We were interested to know whether and, if yes, how P. aeruginosa can
evade the detrimental superoxide and the oxidative stress. The recent sequencing of
the P. aeruginosa PAO1 genome (Stover et al., 2000) and the subsequent
development of genome arrays provide the opportunity to study the global response
of P. aeruginosa to superoxide oxidative stress without making any a priori
hypotheses on candidate genes. In order to minimize the biological variation and to
compare the array data with those by the candidate gene approach (Hassett et al.,
1992; Brown et al., 1995; Hassett et al., 1995; Hassett et al., 1996; Ochsner et al.,
2001; Ochsner et al., 2000b), the model compounds paraquat and hydrogen
peroxide were chosen to unravel the response of P. aeruginosa to superoxide and
oxidative stress respectively. The expression profile of the sequenced reference
strain PAO1, a burn wound isolate from the 1950s, was compared with that of the
two clonal variants TB and 892 isolated from cystic fibrosis lungs that differ
substantially in their resistance to PMNs (Tümmler, 1987). 
3.4.1.1. GeneChip analysis
P. aeruginosa GeneChips (microarrays) were used to study the global expression
profile of P. aeruginosa in response to paraquat and hydrogen peroxide. Cultures
grown in LB broth to stationary phase were exposed to 0.5 mM paraquat or to 10 mM
of hydrogen peroxide in a dialysis bag for 2 h. 0.5 mM paraquat was measured to be
the highest concentration in a two-fold concentration dilution series that did not affect
cell growth. The hydrogen peroxide is degraded by the bacteria and it is a volatile
compound, which decreases gradually from the medium. So 10 mM of hydrogen
peroxide in excess was added to the medium. Dialysis bags were employed so that
the diffusion of paraquat and hydrogen peroxide into the dialysis bag was the rate-
limiting step for the equilibration between the two compartments. Hence the bacteria
were allowed to adapt to asymptotically increasing concentrations of the stressor. We
chose these conditions, because first, we wanted to minimize the activation of global
stress pathways, and second, we wanted to investigate the steady state response
rather than the early adaptation phase. After 2 hours of incubation, about 6 mM of
hydrogen peroxide was still present in the medium (data not shown). 
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Fig 3.8. Logarithmic scatter plot of normalized signal intensities of all ORFs of the P. aeruginosa
PAO1 genome represented by 5900 individual array spots. 
A: Global expression profiles of two PAO1 cultures grown in LB medium until stationary phase. The
normalized signal intensities of one replicate are plotted against the signal intensities of the second
replicate.
B: Normalized signal intensities from paraquat-treated PAO1 cells are plotted against the signal
intensities of untreated cells. The circle indicates that the expression of the three genes PA0939 -
PA0941 was increased by more than one order of magnitude during superoxide stress generated by
paraquat.
Total RNA was extracted from treated and untreated cultures and was used to
synthesize cDNA which was hybridized on gene arrays. The oligonucleotide-array
represents the whole sequenced genome of P. aeruginosa PAO1 (5549 CDS, 18
tRNA genes and one rRNA operon, 199 probe sets corresponding to all intergenic
regions exceeding 600 base pairs as well as 117 additional genes which are present
in other P. aeruginosa strains). The signal from each spot in the arrays served as a
measure of the expression level of each gene and was used to calculate the
expression ratio between the paraquat- treated or hydrogen peroxide- treated and
untreated cultures for all the strains in duplicate experiments. Two stringency criteria
were applied to each experimental data set. Only those genes were further analyzed
that first, exhibited a significant change according to the Wilcoxon rank test, and
showed an at least twofold change in expression in all 4 independent comparisons
from the same experiment. Third, a Bonferroni correction for multiple comparisons
revealed the subset of significantly differentially regulated genes. The genes having
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signal intensities below 100 were discarded because of the large experimental
variation (figure 3.8).
3.4.1.2. Paraquat mediated superoxide stress response 
Figure 3.8 shows the correlation between the treated and untreated culture samples
of the averaged expression levels for the 5900 genes and the in vitro control
transcripts represented in the arrays for one experiment. The Pearson coefficient of
independent experiments was 0.96 and 0.98 for the paraquat- treated and untreated
cells respectively. Only 0.5 % of ORFs were significantly modulated in its expression
level by paraquat. 
Common response to paraquat in P. aeruginosa 
Table 3.5 and figure 3.9 list the six genes that are up-regulated in all three analyzed
P. aeruginosa strains. No gene was found to be commonly repressed. Expression
was moderately up-regulated for the conserved hypothetical PA2229 and the
ferredoxin NADP reductase Fpr.
Table 3.5. Genes up-regulated in all analyzed P. aeruginosa strains exposed to paraquat. 
Average fold change1  PAO
  No. TB 892 PAO1
Protein name2
PA0939 201.65 (58.11) 44.18 (26.27) 51.39 (13.16) hypothetical protein 
PA0940 58.79 (3.42) 26.75 (10.33) 20.01 (5.20) hypothetical protein 
PA0941 106.22 (9.63) 64.49 (26.75) 48.78 (16.30) hypothetical protein 
PA0942 6.85 (0.20) 2.11 (0.39) 3.85 (0.62) probable transcriptional regulator
PA2229 7.23 (0.56) 2.14 (0.36) 4.32 (0.95) conserved hypothetical protein
PA3397 2.05 (0.21) 2.08 (0.18) 2.47 (0.30) ferredoxin NADP+ reductase, fpr 
1: Values are means (SD) of four independent RNA preparations.
2: Gene name indicated in italics.
When paraquat is taken up by the bacterial cell, it is reduced by oxidoreductases
(Liochev et al., 1994) in a NADPH-dependent reaction and then re- oxidized by O2 to
form superoxide. Thus paraquat exerts its harmful action by superoxide itself and the
consumption of NADPH. The up-regulated ferredoxin NADP reductase Fpr rescues
some NADPH and could restore the activity of fumarases, aconitases and the other
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(4Fe-4S)- containing dehydratases that are inactivated by superoxide molecules
(Fridovich, 1997).
Fig. 3.9. PAO1 genes with significantly changed expression levels in paraquat-treated P. aeruginosa
TB, 892 and PAO1. Black letters indicate the up-regulated genes while white letters indicate repressed
genes. Intersections indicate the genes with changed mRNA transcript levels in two or three strains.
One complete operon (PA0939-PA0942) of yet undescribed function was highly up-
regulated in all three strains, whereby the expression levels of putative transcriptional
regulator (PA0942) were increased by 2 to 7 fold and those of the structural genes by
20 to 200 fold. The highly virulent strain TB showed the most dramatic increase of
gene expression. No homologs are known for the structural genes, but
the putative transcriptional regulator exhibits amino acid sequence homology with the
regulators EmrR (30 %) (Brooun et al., 1999) and PecS (31 %) (Nasser et al., 1999)
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from Escherichia coli and Erwinia chrysanthemi, respectively. According to the
curvature-propensity plot the 94 bp large intergenic region between PA0941 and
PA0942 could adopt a curved conformation (figure 3.10). A stretch of bended DNA is
a typical target for a transcriptional regulator, and hence we assume that paraquat-
derived signals are channeled to the PA0939-PA0941 genes in trans by a DNA
binding protein that modulates the bending of the non-transcribed region. This
conformational change could first activate the expression of the PecS-homolog
PA0942 which then induces the transcription of the structural genes. PA0942 is
probably not under the control of OxyR because its consensus binding sequence
(Ochsner et al., 2000b) is missing in the promoter region upstream of PA0942. The
up-regulation of the operon PA0939-PA0942 is the only prominent and consistent
response of all tested P. aeruginosa strains to paraquat at the mRNA expression
level. Hence we conclude that the operon has the function to confer resistance to
paraquat in addition to the constitutively expressed genes (see following sections).103
Fig 3.10. Curvature propensity plot of PAO1 gene PA0941 (position 20-235) and its upstream
sequence (position 236-330) until the start of PA0942 that is transcribed in the opposite direction. The
profile exhibits two peaks of stronger bending with maxima of 13.8 and 10.2 at nucleotide positions
280 and 320.
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Strain-specific responses to paraquat
Table 3.6. Differential transcription profile of P. aeruginosa TBCF10838 exposed to paraquat.
PAO1 No. Fold change1 Protein name2,3
A. Paraquat induced genes
          Oxidative stress response
PA0140 2.11 (0.12) alkyl hydroperoxide reductase subunit F, ahpF 
PA0848 2.04 (0.16) probable alkyl hydroperoxide reductase 
          Iron responsive genes
PA0672 3.62 (1.03) heme oxygenase, hemO
PA1300 4.42 (1.87) probable sigma70 factor (28 %, fecI, E. coli)
PA2033 2.89 (0.79) hypothetical protein (27 %, vibriobactin utilization
protein viuB, Vibrio cholerae)
PA2426 7.08 (2.88) sigma factor, pvdS
PA3899 2.73 (1.09) probable sigma70 factor (75 %, PupI, P. putida)
PA4227 2.52 (0.21) transcriptional regulator, pchR
PA4467 7.99 (4.34) hypothetical protein
PA4468 4.14 (1.08) superoxide dismutase, sodM
PA4469 5.43 (1.32) hypothetical protein
PA4470 6.69 (1.61) fumarate hydratase, fumC1
PA4471 16.89 (4.49) hypothetical protein
          Other genes
PA2230 2.68 (0.47) hypothetical protein 
PA4570 5.46 (1.42) hypothetical protein
B. Paraquat repressed genes
           Other genes
PA2662 4.08 (0.32) conserved hypothetical protein
PA2663 4.56 (0.59) conserved hypothetical protein
PA2664 6.87 (0.61) flavohemoprotein, fhp 
1: Values are means (SD) of four independent RNA preparations.
2: Brackets indicate % homology with genes from other bacterial species.
3: Gene names are indicated in italics.
Tables 3.6, 3.7, 3.8 and figure 3.9 list the genes whose expression was significantly
induced or repressed by paraquat in either one or two of the three tested P.
aeruginosa strains TB, 892 and PAO1. Paraquat stimulates the production of
superoxide and hydrogen peroxide (Greenberg and Demple, 1989; Hassan and
Fridovich, 1979) which can be degraded by alkyl hydroperoxide reductases (AhpF
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and PA0848) and superoxide dismutase (Hassett et al., 1992; Brown et al., 1995).
AhpF and PA0848 were up-regulated in strains 892 and TB whereas the superoxide
dismutase operon (PA4467-PA4471) was only up-regulated in strain TB. The
paraquat-induced stress reduced the expression of the cytochrome c oxidase cox
operon in strains PAO1 and 892 and that of the flavohemoprotein fhp operon in
strains TB and 892. Some steps of aerobic (cox) and anaerobic electron transport
(fhp) were apparently down-regulated by the bacteria to escape the deleterious
interference by superoxide.
Table 3.7. Differential transcription profile of P. aeruginosa 892 exposed to paraquat.
PAO1 No. Fold change1 Protein name2
A. Paraquat induced genes
          Oxidative stress response
PA0140 2.54 (0.62) alkyl hydroperoxide reductase subunit F, ahpF
PA0848 2.00 (0.11) probable alkyl hydroperoxide reductase 
B. Paraquat repressed genes
          Energy metabolism
PA0106 3.21 (1.10) cytochrome c oxidase, subunit I, coxA
PA0108 3.62 (1.82) cytochrome c oxidase, subunit III, coIII
PA1172 3.03 (1.08) cytochrome c type protein, napC 
PA3415 5.01  (2.96) probable dihydrolipoamide acetyltransferase 
PA3416 4.77 (2.45) probable pyruvate dehydrogenase E1 component, beta
chain 
PA3417 4.17 (2.08) probable pyruvate dehydrogenase E1 component,
alpha subunit 
          Other genes
PA2662 2.24 (0.51) conserved hypothetical protein 
PA2663 2.24 (0.32) hypothetical protein 
PA2664 2.50 (0.65) flavohemoprotein, fhp
PA4296 3.40 (1.46) probable two component response regulator 
PA4573 3.51 (1.65) hypothetical protein 
PA4648 4.34 (2.26) hypothetical protein 
PA4702 3.60 (1.79) hypothetical protein 
1: Values are means (SD) of four independent RNA preparations.
2: Gene names are indicated in italics.
Results and discussion
106
Table 3.8. Differential transcription profile of P. aeruginosa PAO1 exposed to paraquat.
PAO1 No. Fold change1 Protein name2,3
A. Paraquat induced genes
          TCA cycle and acetoin metabolism 
PA0887 3.51 (1.30) acetyl-coenzyme A synthetase, acsA
PA3568 2.50 (0.61) probable acetyl-CoA synthetase 
PA4148 2.55 (0.48) probable short-chain dehydrogenase 
PA4149 3.13 (1.15) conserved hypothetical protein (41 %, acetoin
catabolism protein X, Ralstonia eutropha)
PA4150 3.11 (0.73) probable dehydrogenase (57 %, acetoin: DCIP
oxidoreductase alpha subunit, Ralstonia eutropha)
PA4151 4.32 (1.68) acetoin catabolism protein, acoB
PA4152 2.28 (0.34) probable hydrolase (67 %, acetoin dehydrogenase
component E2, P. putida)
PA4153 2.59 (0.45) 2,3-butanediol dehydrogenase 
          Transport
PA3234 3.69 (1.56) probable sodium:solute symporter 
PA4502 2.01 (0.22) probable binding protein component of ABC
transporter 
PA4504 2.04 (0.12) probable permease of ABC transporter 
PA4505 2.01 (0.22) probable ATP-binding component of ABC transporter 
PA4506 2.92 (0.73) probable RND efflux membrane protein precursor 
          Other genes
PA3038 4.16 (1.34) probable porin 
PA3235 3.31 (0.90) conserved hypothetical protein 
PA3790 2.92 (0.67) putative copper transport outer membrane porin, oprC
B. Paraquat repressed genes
          Energy metabolism
PA0105 2.85 (0.28) cytochrome c oxidase subunit II, coxB
PA0106 3.15 (0.86) cytochrome c oxidase subunit I, coxA
PA0107 3.78 (1.33) conserved hypothetical protein (55 %, cytochrome c
assembly protein, Paracoccus denitrificans)
PA0108 3.20 (1.33) cytochrome c oxidase subunit III, coIII
          Other genes
PA1888 2.53 (0.72) hypothetical protein 
PA2190 2.47 (0.67) conserved hypothetical protein 
1: Values are means (SD) of four independent RNA preparations.
2: Brackets indicate % homology with genes from other bacterial species.
3: Gene names are indicated in italics.
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P. aeruginosa superoxide dismutase Mn-SOD is only expressed under iron limitation
conditions (Hassett et al., 1995; Hassett et al., 1996). Exposure of strain TB to
paraquat presumably affected iron homeostasis because besides Mn-SOD, the heme
oxygenase HemO (PA0672), siderophore-associated sigma factors (PA1300,
PA2426, PA3899, PA4227) and a homolog of the vibriobactin utilization protein
(PA2033) were up-regulated (Table 3.6). This data most likely reflects the
perturbation of the intracellular redox status by  hydrogen peroxide and superoxide.
More ionized iron is oxidized and correspondingly the demand of P. aeruginosa TB
for iron increases.
Strain PAO1 changed its central carbon metabolism in response to paraquat. The
synthesis of acetyl-CoA (PA0887, PA3568) and the NAD(H)-dependent conversion of
acetoin (operon PA4148-PA4153) was stimulated. The relative yield of diacetyl and
butane-2,3-diol from acetoin depends on the intracellular redox potential. P.
aeruginosa PAO1 can exploit acetoin and acetyl-CoA for the use as a carbon source
and for the production of ATP by substrate phosphorylation independent of the
electrochemical potential. In other words, the PAO1 cells probably activated
alternative pathways for carbon and energy metabolism in order to escape the
influence of superoxide on the cellular redox status and aerobic ATP production. The
data that the expression of the cytochrome oxidase c operon was repressed (see
above) is consistent with this interpretation.
Oxidative stress defense genes sensu strictu
Paraquat reduction within E. coli is catalyzed by three paraquat:NADPH
oxidoreductases (Liochev and fridovich, 1994). P. aeruginosa possesses both
NADPH and NADH-dependent paraquat oxidoreductases; there are two of the latter
and at least five of the former (Ma et al., 1998). With the exception of Fpr (Tables 3.5,
3.6, 3.7 and 3.8) none of these enzymes was up-regulated at the transcriptional level
in response to paraquat in our experiments. Unexpectedly the expression of the zwf
gene was also not induced, although its gene product glucose-6-phosphate
dehydrogenase is known to confer some resistance to paraquat in P. aeruginosa (Ma
et al., 1998). 
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Table 3.9. Expression of mRNA transcripts involved in oxidative stress response: GeneChip
normalized signal intensities in the absence ( - ) and presence ( + ) of 0.5 mM paraquat.
Gene PAO1 No. strain TB strain 892 strain PAO1
- + - + - +
ahpB PA0847 10 4 22    5 106 69
ahpC PA0139 2274 2738 2017 2278 2158 2802
ahpF PA 0140 62 166 54   120 81 182
ohr PA 2850 45 66 55 51 31 26
katA PA 4236 1659 1657 1650 1176 3770 3623
katB PA 4613 22 37 13 30 21 22
katE PA 2147 6 2 5 8 22 5
katN PA 2185 11 12 12 10 2 22
sodB PA 4366 1517 1619 1426 1427 1218 1106
sodM PA 4468 34 192 26 26 62 36
pqrC PA 0939 6 1634 1 120 3 371
pqrB PA 0940 62 3949 38 756 77 2398
pqrA PA 0941 37 5375 32 1239 26 2559
pqrR PA 0942 114 682 97 144 101 435
Sensitivity to paraquat is discussed in the literature (Ma et al., 1998) to be dependent
on the presence or absence of multiple cellular factors, some of which include alkyl
hydroperoxide reductase AhpF, SodM, catalase, methionine sulfoxide reductase,
DNA repair systems, glutathione reductase and various regulatory proteins (e.g.,
OxyR, SoxRS). It is interesting to note that only the expression of ahpF and sodM,
but none of the other genes was induced under our carefully controlled experimental
conditions. The up-regulation of katB, ahpB and ahpC mRNA transcript levels upon
exposure of paraquat to strain PAO1 reported by others (Ochsner et al., 2000b) was
not observed in our GeneChip analyses (Table 3.9). We would like to attribute these
discrepant findings to the different exposure kinetics. In Ochsner‘s (2000b)
experimental design, the paraquat concentration changed within the few seconds
mixing time from zero to final concentration whereas our set-up to exchange the
outer medium allowed for a diffusion-controlled equilibration across the dialysis
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membrane between the outer and the bacteria-containing inner compartments. In our
opinion the two-compartment model is more appropriate to mimic the situation in vivo
than the one-step addition of paraquat.
Under our experimental conditions the superoxide dismutase sodB, the catalase A
katA and the alkyl hydroperoxide reductase ahpC were constitutively expressed at
high levels in the absence and presence of paraquat. Table 3.9 displays the
normalized signal intensities of operon PA0939-PA0942 and of the major genes
known from the literature to be involved in the handling of reactive oxygen
intermediates. sodB is expressed above average. katA and ahpC belong to the 100
most strongly expressed genes of the transcriptome. In other words, the two latter
genes are already expressed at such a high level that any further up-regulation upon
exposure to oxidative stress would not be biologically meaningful for the cell.
Conclusion
Paraquat-mediated stress affected only few mRNAs of the P. aeruginosa
transcriptome. Besides some fine tuning to degrade superoxide and hydrogen
peroxide and to neutralize the effect of these toxic oxygen species on iron
homeostasis and aerobic respiration, the major response was exerted by one yet
uncharacterized operon. Although the detoxifying activity of its gene products awaits
experimental proof, the unique strong up-regulation of mRNA transcript levels is
sufficient evidence to designate the PA0939-PA0942 genes as the pqrCBAR operon
(paraquat response). This previously unrecognized operon PA0939-PA0942 and the
constitutively highly expressed SodB, KatA and AhpC seem to be the key players to
combat the paraquat-induced oxidative stress.
3.4.1.4. Hydrogen peroxide mediated oxidative stress response
We performed the global gene expression analysis against hydrogen peroxide
induced oxidative stress response in three strains of P. aeruginosa (TB, 892 and
PAO1) by using DNA microarrays. Cultures grown in LB broth to stationary phase
were exposed to 10 mM hydrogen peroxide in a dialysis bag for 2 h. Total RNA was
extracted from H2O2 treated and untreated cultures and was used to synthesize
cDNA which was hybridized onto gene arrays. Thus the expression ratio for each
gene was measured in duplicate for treated and untreated cultures. Upon exposure
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to hydrogen peroxide, 23.5, 17.5, 15 % of ORFs were significantly differentially
regulated in P. aeruginosa TB, 892 and PAO1 respectively. The total number of
genes expressed in the chosen condition were about 75 % from all the three strains.
This indicates that most of the genes were essential for the cell metabolism in
response to hydrogen peroxide. It was observed that a greater number of genes
were significantly modulated against the H2O2 response in TB as compared to 892
and PAO1 (Table 3.16). The modulated genes were sorted and divided into 20
different categories depending upon the known function. The table 3.10 shows a
summary of functional categories which were observed  in all the three strains
against H2O2 response.
Table 3.10. Number of up- or down-regulated genes in different functional categories from the three
strains of P. aeruginosa TB, 892 and PAO1. 
Functional categories Up-regulation Down-regulation
TB 892 PAO1 TB 892 PAO1
Energy metabolism 64 39 27 67 65 42
Amino acid biosynthesis & metabolism 54 37 27 15 12 18
Biosynthesis of cofactors, prosthetic groups &
carriers
23 18 3 1 1 3
Quorum sensing 0 0 0 26 18 10
Flagella biogenesis & chemotaxis 0 0 0 49 58 30
Sulfur metabolism 11 9 4 0 0 0
Iron metabolism 16 15 18 0 0 0
Cell rescue/defense 23 20 17 7 5 6
Cell processes (including adaptation,
protection)
16 7 6 2 2 0
Carbon compound catabolism 10 4 1 9 7 2
Nucleotide biosynthesis and metabolism 32 13 12 7 5 5
DNA replication & recombination 11 5 6 0 0 0
Transcription, RNA processing & degradation 10 1 1 0 0 0
Translation, post-translational modification 52 15 38 7 5 7
Protein secretion/export 7 4 9 6 5 1
Cellular organization 28 12 8 11 9 9
Putative regulatory proteins 15 9 5 24 21 18
Putative transport & binding proteins 36 20 7 17 15 26
Other known 33 21 22 76 69 76
Unknown/unclassified 272 179 116 343 295 293
Total 713 428 327 667 592 546
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From the abovementioned data (Table 3.10), it was observed that a significantly
greater number of genes were up-regulated in TB from the functional groups such as
energy metabolism; amino acid biosynthesis and metabolism; carbon compound
catabolism; DNA replication and recombination; transcription, RNA processing &
degradation; translation & post-translational modification and cellular organization as
compared to 892 and PAO1 when the cells were treated with hydrogen peroxide. In
the functional groups, such as biosynthesis of cofactors, prosthetic groups & carriers;
sulfate metabolism; iron metabolism; cell rescue; cell processes; nucleotide
biosynthesis & metabolism; DNA replication & recombination; translation, post-
translational modification, the number of up-regulated genes surpassed those of
down-regulated genes significantly, suggesting that these groups of genes were
generally induced by hydrogen peroxide. The genes from other categories such as
quorum sensing and flagella biogenesis and chemotaxis were down-regulated upon
exposure to hydrogen peroxide. The number of up-regulated genes was much higher
than down-regulated genes in many functional categories.
The genes from major functional categories are listed in the following table 3.11. The
data from other categories are given in a appendix III. 
Table 3.11. Differential transcription profile of P. aeruginosa TB, 892 and PAO1 exposed to hydrogen
peroxide. 
PAO No. Average fold changea Protein nameb
TB 892 PAO1
I) Hydrogen peroxide induced genes
A) Cell rescue/defense
Oxidative stress response
PA0139 3.81 (0.34) alkyl hydroperoxide reductase subunit C, ahpC
PA0140 23.87 (1.61) 36.19 (7.89) 36.89 (3.74) alkyl hydroperoxide reductase subunit F, ahpF
PA0848 15.96 (3.09) 25.10 (7.56) 32.26 (8.27) probable alkyl hydroperoxide reductase, 
PA2532 2.85 (0.73) thiol peroxidase, tpx
PA2850 3.45 (0.88) 4.67 (1.97) 8.22 (2.70) organic hydroperoxide resistance protein, ohr
PA3397 2.23 (0.20) ferredoxin-NADP+ reductase, fpr
PA3450 6.70 (1.25) 5.89 (0.70) probable antioxidant protein
PA4613 56.98 (6.59) 118.41 (17.81) 185.57 (71.85) catalase, katB
General stress response
PA0961 3.94 (0.26) 3.48 (1.02) 3.32 (0.30) probable cold-shock protein
PA1596 2.89 (0.30) heat shock protein, htpG
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PAO No. Average fold changea Protein nameb
TB 892 PAO1
I) Hydrogen peroxide induced genes
A) Cell rescue/defense
General stress response
PA3126 3.49 (0.28) heat-shock protein, ibpA
PA3266 3.56 (0.41) 2.73 (0.57) cold acclimation protein B, capB
PA3625 2.69 (0.24) survival protein, surE
PA3810 3.16 (0.46) 2.36 (0.37) heat shock protein, hscA
PA3811 2.67 (0.46) 2.52 (0.26) heat shock protein, hscB
PA4428 2.42 (0.16) stringent starvation protein A, sspA
PA4557 3.49 (0.28) 2.89 (0.33) 2.94 (0.35) LytB protein, lytB
PA5193 4.12 (0.75) 3.34 (0.94) 2.47 (0.20) heat shock protein HSP33, yrfI
DNA repair
PA0382 3.74 (0.30) 3.12 (0.88) DNA mismatch repair protein, micA
PA0750 2.57 (0.37) 2.75 (0.40) uracil-DNA glycosylase, ung
PA1534 4.52 (1.68) 3.46 (0.62) 5.45 (2.22) recombination protein, recR
PA2545 2.98 (0.10) 3.06 (0.20) exodeoxyribonuclease III, xthA
PA3007 4.07 (0.14) 5.47 (0.39) 5.37 (0.19) repressor protein, lexA
PA3617 3.25 (0.00) 4.09 (0.43) 4.52 (0.13) RecA protein, recA
PA3620 2.56 (0.23) 2.44 (0.37) DNA mismatch repair protein, mutS
PA3725 2.26 (0.19) single-stranded-DNA-specific exonuclease, recJ
PA4042 2.63 (0.47) exodeoxyribonuclease VII small subunit, xseB
PA4234 2.23 (0.27) excinuclease ABC subunit A, uvrA
PA4763 4.94 (0.39) 7.23 (0.65) 5.20 (0.35) DNA repair protein, recN
PA5443 2.30 (0.18) DNA helicase II, uvrD
II) Hydrogen peroxide repressed genes
B) Microaerophilic and anaerobic growth
Denitrification
PA0024 3.61 (0.24) 3.28 (0.84) coproporphyrinogen III oxidase, hemF
PA0509 61.86 (2.47) 41.99 (11.54) 2.26 (0.15) probable c-type cytochrome, nirN
PA0510 357.51 (86) 217.37 (182) 2.93 (0.) probable uroporphyrin-III c-methyltransferase
PA0511 68.67 (15.1) 37.84 (12.95) 2.99 (0.25) heme d1 biosynthesis protein, nirJ
PA0512 123.29 (45) 62.58 (40.42) 2.56 (0.23) conserved hypothetical protein
PA0513 164.49 (42) 85.02 (66.07) 2.60 (0.22) probable transcriptional regulator
PA0514 148.96 (54) 73.18 (48.90) 2.88 (0.90) heme d1 biosynthesis protein, nirL
PA0515 528.02 (98) 170.58 (167) 2.75 (0.40) probable transcriptional regulator
PA0516 95.72 (9.84) 60.13 (40.17) 3.10 (0.32) heme d1 biosynthesis protein, nirF
PA0517 223.37 (94) 161.33 (169) 2.74 (0.24) probable c-type cytochrome precursor, nirC
PA0518 97.24 (7.7) 84.45 (85.36) 2.31 (0.29) cytochrome c-551 precursor, nirM
PA0519 32.08 (2.5) 45.58 (45.37) nitrite reductase precursor, nirS
PA0520 19.01 (4.0) 11.28 (5.59) regulatory protein, nirQ
PA0521 16.98 (4.3) 14.31 (4.87) probable cytochrome c oxidase subunit
PA0522 2.85 (0.36) hypothetical protein
PA0523 104.12 (38) 54.95 (53.83) 4.49 (2.37) nitric-oxide reductase subunit C, norC
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PAO No. Average fold changea Protein nameb
TB 892 PAO1
II) Hydrogen peroxide repressed genes
B) Microaerophilic and anaerobic growth
Denitrification
PA0524 243.58 (103) 124.73 (114) 4.56 (2.52) nitric-oxide reductase subunit B, norB
PA0525 65.31 (15.1) 86.19 (52.29) 4.37 (2.21) probable dinitrification protein
PA1172 34.83 (7.04) 22.04 (5.70) 18.71 (0.66) cytochrome c-type protein, napC
PA1173 40.03 (8.53) 27.64 (7.36) 15.31 (2.16) cytochrome c-type protein, napB
PA1174 35.94 (6.31) 22.93 (6.68) 17.19 (1.37) periplasmic nitrate reductase protein, napA
PA1175 16.85 (3.61) 19.05 (4.16) 14.51 (1.87) NapD protein of periplasmic nitrate reductase,
napD
PA1176 26.53 (6.16) 28.70 (8.10) 16.59 (6.13) ferredoxin protein, napF
PA1177 38.93 (4.70) 26.74 (7.49) 16.90 (3.81) periplasmic nitrate reductase protein, napE
PA1546 2.71 (0.42) 4.81 (2.54) oxygen-independent coproporphyrinogen III
oxidase, hemN
PA1555 12.75 (4.51) probable cytochrome c
PA1556 7.13 (1.79) probable cytochrome c oxidase subunit
PA1557 2.27 (0.27) probable cytochrome oxidase subunit 
PA1861 3.28 (0.47) 2.43 (0.21) molybdenum transport protein, modC
PA1862 2.27 (0.27) 4.86 (0.50) molybdenum transport protein, modB
PA1863 3.13 (0.66) 2.49 (0.41) 2.90 (0.40) molybdate-binding periplasmic protein, modA
PA2664 11.52 (0.4) flavohemoprotein, fhp
PA3032 2.74 (0.68) 2.59 (0.52) cytochrome c Snr1, snr1 
PA3391 61.78 (39) 85.11 (91.69) 3.95 (0.41) regulatory protein, nosR
PA3392 86.70 (13) 94.18 (79.88) 2.23 (0.20) nitrous-oxide reductase precursor, nosZ
PA3393 19.72 (1.1) 23.87 (1.61) 2.52 (0.29) NosD protein, nosD
PA3394 26.49 (1.7) 25.84 (9.07) 2.35 (0.27) NosF protein, nosF
PA3395 36.27 (3.7) 17.10 (4.90) NosY protein, nosY
PA3396 37.38 (21) 29.93 (7.01) NosL protein, nosL
PA3870 24.29 (8.9) 26.67 (3.82) 17.50 (5.56) molybdopterin biosynthetic protein A1, moaA1
PA3871 34.99 (17) 28.22 (18.74) 22.99 (6.89) probable peptidyl-prolyl cis-trans isomerase
PA3872 36.91 (12) 50.36 (4.50) 17.98 (6.35) respiratory nitrate reductase gamma chain, narI
PA3873 55.17 (22) 76.70 (11.05) 22.10 (10.80) respiratory nitrate reductase delta chain, narJ
PA3874 79.11 (25) 305.34 (2.51) 24.83 (12.93) respiratory nitrate reductase beta chain, narH
PA3875 272.60 (110) 415.01 (421) 20.79 (13.82) respiratory nitrate reductase alpha chain, narG
PA3876 62.39 (16.2) 70.76 (44.30) 12.23 (8.15) nitrite extrusion protein 2, narK2
PA3877 20.10 (6.36) 64.18 (55.25) 10.58 (6.38) nitrite extrusion protein 1, narK1
PA3879 2.70 (0.28) 4.60 (2.47) two-component response regulator, narL
PA3914 45.03 (8.10) 130.25 (79.2) molybdenum cofactor biosynthetic protein A1,
moeA1
PA3915 13.86 (2.49) 44.62 (31.54) 5.07 (3.58) molybdopterin biosynthetic protein B1, moaB1
PA3916 4.87 (0.59) molybdopterin converting factor, moaE
PA3917 2.34 (0.15) 6.09 (0.69) molybdopterin converting factor, moaD
PA3918 3.90 (0.64) molybdopterin biosynthetic protein C, moaC
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PAO No. Average fold changea Protein nameb
TB 892 PAO1
II) Hydrogen peroxide repressed genes
B) Microaerophilic and anaerobic growth
Denitrification
PA4196 2.31 (0.29) probable two-component response regulator
PA4810 3.83 (0.60) nitrate-inducible formate dehydrogenase, fdnI
PA4811 3.94 (0.26) 3.42 (1.56) nitrate-inducible formate dehydrogenase, fdnH
PA4812 2.73 (0.11) formate dehydrogenase-O, fdnG
Arginine fermentation
PA5051 2.42 (0.16) arginyl-tRNA synthetase, argS
PA5170 2.60 (0.17) 21.76 (20.59) arginine/ornithine antiporter, arcD
PA5171 15.85 (2.27) 34.78 (28.79) 2.30 (0.18) arginine deiminase, arcA
PA5172 52.48 (8.35) 41.11 (32.16) 2.39 (0.21) ornithine carbamoyltransferase, arcB
PA5173 63.24 (7.64) 48.99 (25.57) 2.56 (0.23) carbamate kinase, arcC
Cytochrome biogenesis
PA0105 13.65 (5.74) 13.12 (3.50) 15.63 (9.18) cytochrome c oxidase, subunit II, coxB
PA0106 12.05 (2.14) 12.03 (3.20) 50.20 (16.05) cytochrome c oxidase, subunit I, coxA
PA0108 12.08 (2.33) 6.51 (2.39) 11.54 (3.50) cytochrome c oxidase, subunit III, coIII
PA0113 3.11 (0.43) 3.92 (1.13) probable cytochrome c oxidase assembly factor
PA0918 7.39 (1.06) 5.27 (1.87) 3.57 (0.67) cytochrome b561
PA2475 3.70 (0.61) 3.43 (0.23) probable cytochrome P450
PA3331 3.69 (1.22) cytochrome P450
PA4571 3.44 (0.42) 5.96 (3.39) probable cytochrome c
PA5328 6.94 (1.99) probable cytochrome c(mono-heme type)
a: Values are means (SD) of four independent RNA preparations.
b: Gene names are indicated in Italics.
Up-regulated genes in P. aeruginosa strains
The following categories of genes (figure 3.11) were up-regulated in the P.
aeruginosa strains after exposure to hydrogen peroxide. Most of the genes show a
common expression pattern in all the three strains of P. aeruginosa after exposure to
hydrogen peroxide except that few of the genes were not up-regulated in 892 and
PAO1. The most obvious category of genes i.e. cell rescue/defense is discussed
further in detail.
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Fig. 3.11 . Various categories of differentially regulated genes in P. aeruginosa TB, 892 and PAO1
after exposure to hydrogen peroxide. 
Cell rescue/defense
A hallmark of the P. aeruginosa response to hydrogen peroxide is the rapid and
strong induction of a set of OxyR-regulated genes, including ahpC, ahpF, PA0848,
ohr and katB. We observed  >10-fold induction of all the genes except ahpC in all the
strains, provided an internal validation of the microarray experiment (Table 3.11). It
was observed that all the above mentioned genes (except ahpC) showed 2-3 times
higher up-regulation in PAO1 as compared to TB. Each of these genes is important
in combating hydrogen peroxide mediated stress. Aerobic respiration in P.
aeruginosa leads to the production of toxic metabolic products including the
superoxide anion, H2O2, hydroxyl radicals and organic hydroperoxides. Sublethal
level of superoxide and H2O2 are detoxified by two superoxide dismutases and two
catalases respectively. In our experiments, bacterial cells were always encountered
with the exogeneously added hydrogen peroxide which generated oxidative stress. In
this stress response, both superoxide dismutases (sodB & sodM) and catalases
(katA & ahpB) were not up-regulated in any of the strains used. Some of the genes
involved in oxidative stress defense, including katA, sodB are expressed at high
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levels during aerobic and microaerophilic growth (Table 3.12). These results suggest
that the further up-regulation of superoxide dismutase (sodB) and catalase (katA)
would not be meaningful to the cell. The differential regulation of Oxy-R dependent
genes: katE, katN, ahpB and sodM was not observed in all the three P. aeruginosa
strains upon exposure to hydrogen peroxide during our carefully monitored growth
conditions (Table 3.12). 
Table 3.12. Expression of mRNA transcripts involved in oxidative stress response: GeneChip
normalized signal intensities in the absence ( - ) and presence ( + ) of 10 mM hydrogen peroxide.
Gene PAO No. strain TB strain 892 strain PAO1
- + - + - +
ahpB PA0847 13 4 17 5 112 19
katA PA 4236 1770 2374 1510 2363 3712 5742
katE PA 2147 4 4 3 3 18 5
katN PA 2185 11 12 11 5 12 7
sodB PA 4366 1490 2053 1434 2188 1121 2014
sodM PA 4468 30 75 24 45 52 112
It appears that redundancy of oxidative stress defense system allows P. aeruginosa
to optimally cope with reactive oxidative intermediates (ROIs) generated by its own
aerobic metabolism and respond rapidly to exogenous hydrogen peroxide mediated
ROIs. Here, we have found that some of the Oxy-R independent genes were also up-
regulated in either one or two or all the three of P. aeruginosa strains. These genes
encodes cold and heat shock proteins (HSPs). Recently it has been reported that
HSPs stabilize and protect intracellular proteins and prevent damage caused by heat
and oxidative stress (Kitagawa et al., 2002). All organisms living in aerobic
environments are exposed to reactive oxygen by-products that can damage most
cellular components, including lipids, proteins and DNA. Active oxygen species are
generated during normal aerobic metabolism, as well as by exogeneously added
chemicals. Although all organisms have evolved mechanisms of defense against
oxidative damage, those have been best characterized in the bacterium E.coli. When
E. coli encounters oxidative stress during aerobic growth, it induces the expression of
a set of genes encoding enzymes that degrade the reactive oxygen species and
repair the damaged macromolecules, such as DNA repair systems (Farr and
Kogoma, 1991). These genes are organized in two independent stimulons that are
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turned on by different oxidative stresses, the superoxide stress response (induced by
the superoxide radical and regulated by soxR and soxS) and the peroxide stress
response (induced by hydrogen peroxide and organic peroxides and regulated by
oxyR). These inducible responses are critical for survival of E.coli against oxidative
stress, as well as for decreased mutagenesis. During our studies, the set of genes
involved in DNA repair were up-regulated in either one or two or in all the three P.
aeruginosa strains. The recR, lexA, recA and recN were up-regulated nearly at the
same level in all the three P. aeruginosa strains after exposure to hydrogen peroxide
(Table 3.11). The RecA protein plays a central role in homologous recombination
and, in conjunction with the LexA protein, induces the SOS regulon in response to
DNA damage (Lusetti and Cox, 2002). It was also observed that other DNA repair
proteins encoded by micA, ung, xthA, mutS, recj, and xseB were up-regulated only in
TB and 892. DNA glycosylase (encoded by ung) excise damaged or unconventional
bases in DNA and initiate the base excision repair (BER) pathway to maintain
genomic integrity. XthA play an important role in the repair of abasic sites in DNA
(Doetsch and Cunningham, 1990). Unless lesions are repaired prior to DNA
replication, the non-coding lesions promote misincorporation of nucleotides and
mutagenesis. Our findings suggest that the more number of genes involved in DNA
repair in TB could give advantage for the efficient DNA repair and more resistant
against the hydroxyl radicals.
The other categories of up-regulated genes belongs to energy metabolism, amino
acid biosynthesis and metabolism, biosynthesis of cofactors, prosthetic groups &
carriers, iron acquisition, sulfur metabolism, transcription RNA processing &
degradation, translation & post-translational modification and cellular organization
and biogenesis (figure 3.11 and appendix III). 
The expression profile of genes involved in cellular processes including glycolysis,
TCA cycle, anpleurotic reactions, aerobic electron transport chain components, fatty
acid and phospholipid metabolism, NADH dehydrogenase and ATPase was up-
regulated in all the three strains after exposure to hydrogen peroxide (appendix III).
This suggest that the oxygen was produced in presence of hydrogen peroxide and
the bacterium utilizes aerobic respiratory metabolism for energy conservation. Most
of the genes involved in the biosynthesis and catabolism of acidic, basic, aromatic
Results and discussion
118
and sulfur amino acids were up-regulated. This global change in amino acid pattern
suggests that the amino acids could be utilized for the synthesis of various building
blocks and thus aiding adaptation in presence of hydrogen peroxide. We could
speculate that the up-regulation of genes those are involved in cobalamin and
vitamin biosynthesis, can adapt the physiological and metabolic status of the
organism to respond rapidly and sometimes dramatically to the environmental
changes. Some of the genes involved in iron acquisition and sulfur metabolism were
up-regulated in all the three strains after exposure to hydrogen peroxide. It observed
that more number of genes which are involved in iron acquisition were up-regulated
in PAO1 and most of the genes showed higher up-regulation in PAO1 as compared
to TB. These genes are presumed to be involved in iron homeostasis. Iron and sulfur
is also necessary for the reductive reconstitution of oxidatively inactivated (4Fe-4S)
containing dehydratases. The up-regulation of genes involved in iron and sulfur
metabolism are important for the cycle of oxidative inactivation by hydroxyl radicals,
followed by reductive reactivation of iron-sulfur clusters, could act as a sink for
hydroxyl radicals. The global response of the cells when grown in presence of
hydrogen peroxide in the experiments analyzed here was up-regulation of reasonably
high number of transcription and translation apparatus genes. We considered the
expression profiles of all the genes that are involved in transcription and translation,
including the major subunits of RNA polymerase, ribosomal proteins, and
transcription and translation factors. The GeneChip experiment revealed that there is
the global expression and co-ordination of the ribosome number and components of
the transcription and translation apparatus for faster growing cells. We could observe
the up-regulation of genes involved in cellular organization and biogenesis
suggesting that there was rapid cell wall turnover and/or repair, presumably in
response to hydrogen peroxide-mediated cell wall damage.
Down-regulated genes
The three major categories of genes involved in microaerophilic and anaerobic
growth, quorum sensing and flagella biogenesis and chemotaxis were down-
regulated in P. aeruginosa strains after exposure to hydrogen peroxide (figure 3.11).
Out of these, only one category of genes is discussed in detail.
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Microaerophilic and anaerobic growth
After exposure to hydrogen peroxide, it was observed that 55, 49 and 33 genes those
are involved in denitrification were down-regulated in TB, 892 and PAO1 respectively
(Table 3.11). The interesting finding was that most of the genes from operon
PA0509-PA0525 were 10-200 times more strongly down-regulated in TB and 892
as compared to the PAO1 strain, while the other operon PA3870-PA3879 was just
2-10 times more strongly down-regulated in TB and 892 as compared to the PAO1.
Then we checked the absolute signal intensities of genes from above mentioned
operons (Table 3.13). We found that most of the genes has almost same signal
intensity in absence of hydrogen peroxide in all the three P. aeruginosa strains.
However, the signal intensities for PAO1 strain are significantly higher as compared
to the intensities of TB and 892 strains in presence of hydrogen peroxide. The
observed difference in the expression of these genes for PAO1 is due to the different
expression pattern in the presence of hydrogen peroxide. The P. aeruginosa TB and
892 strains belongs to the same clone. This similar down-regulation pattern of
denitrification genes could be due to the clonal similarity. This data suggests that TB
and 892 do not prefer denitrification for the energy generation in presence of
hydrogen peroxide. The other genes involved in heme biosynthesis, cytochrome
biogenesis and molybdopterin biosynthesis showed random pattern of down-
regulation. Many species of Gram-negative as well as Gram-positive bacteria can
use inorganic N oxides as alternative electron acceptors for respiratory growth under
oxygen-limiting conditions by a process referred to as denitrification. We incubated
the bacteria in dialysis bags in presence of hydrogen peroxide (test sample) and in
absence of hydrogen peroxide (control sample), for 2 h before RNA isolation. This
can lead to fully aerobic conditions in presence of hydrogen peroxide and oxygen-
limiting conditions in absence of hydrogen peroxide. Oxygen-limiting conditions are
usually necessary for denitrification. The expression of nir and nor gene clusters are
regulated by two FNR-like regulators, anr and dnr, in P. aeruginosa (Arai et al., 1995;
Arai et al., 1997). FNR regulate the expression of many genes that are required for
anaerobic growth when oxygen is depleted. But in our experiment, we could not see
the differential regulation of both regulators anr & dnr required for denitrification. One
possibility is that, they may be expressed below the cut-off value. This down-
regulation of whole number of denitrification genes indicates that fully aerobic
condition was created in presence of hydrogen peroxide.
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Table 3.13. Expression of mRNA transcripts involved in microaerophilic and anaerobic growth:
GeneChip normalized signal intensities in the absence ( - ) and presence ( + ) of 10 mM hydrogen
peroxide.
Gene PAO No. strain TB strain 892 strain PAO1
- + - + - +
nirN PA0509 1537 28 1627 46 1578 637
PA0510 1545 5 1369 14 1202 410
nirJ PA0511 1813 32 1680 52 2459 830
PA0512 1656 12 1373 25 962 371
PA0513 1503 8 1403 27 1023 361
nirL PA0514 1504 6 1393 27 2144 726
PA0515 2297 3 2198 49 2702 960
nirF PA0516 2319 18 2070 48 2014 676
nirC PA0517 3080 16 3045 100 3878 1391
norC PA0523 3366 32 3045 130 1983 363
norB PA0524 2666 8 2348 35 959 218
PA0525 1143 13 981 14 1348 315
nosR PA3391 586 6 554 27 639 170
nosZ PA3392 2332 22 2555 47 3145 1520
nosD PA3393 674 31 853 36 562 233
nosF PA3394 338 10 386 10 412 168
moaA1 PA3870 278 11 482 8 558 31
PA3871 524 10 697 10 1589 59
narI PA3872 994 29 1754 23 3306 204
narJ PA3873 1016 14 1774 25 1880 81
narH PA3874 1135 20 1984 15 1908 75
narG PA3875 1008 2 1697 12 1208 50
narK2 PA3876 686 11 1202 25 4925 42
narK1 PA3877 785 63 1309 47 1106 96
arcA PA5171 4057 200 3885 185 9525 4190
arcB PA5172 4842 79 4652 178 11199 4754
arcC PA5173 3465 37 3651 81 5571 2216
    
We found that the whole operon (PA5170-PA5173) for arginine deiminase pathway
was also down-regulated in  all the three strains in presence of hydrogen peroxide. It
has been reported that anr acts on a sequence related to fnr box to regulate the
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expression of the arginine deiminase pathway under oxygen limiting conditions in P.
aeruginosa. It was observed that this operon was 10-20 times down-regulated in TB
and 892 as compare to PAO1. This could be also due to the clonal similarity of TB
and 892. The absolute signal intensities of arcABC operon were higher in PAO1
strain as compared to the TB and 892 in presence of hydrogen peroxide (Table
3.13). The arcABC operon is strongly up-regulated in PAO1 in presence and
absence of hydrogen peroxide. This suggests that P. aeruginosa PAO1 prefers
arginine deiminase pathway for the energy generation in presence of hydrogen
peroxide. In other words, the arcABC operon is a paradigmatic example for the clone
specific regulation of metabolic features. In summary, the genes involved for growth
in oxygen limiting conditions were severely down-regulated in P. aeruginosa TB and
892 as compared to PAO1 strain after exposure to hydrogen peroxide. 
Summary
The growth and survival of bacteria in diverse environments is achieved through
homeostatic mechanisms that have evolved to maintain relatively constant
cytoplasmic conditions. In parallel, gene expression is modulated so that the overall
activity of metabolic pathways remains adequate for growth and survival. Despite
these mechanisms, the cell has to cope with significant variations in the cytoplasmic
constitution, e.g. solute composition and concentration, and pH, as well as oxidative
stress generated during aerobic growth. Hydrogen peroxide-mediated stress
response modulated a higher number of genes in TB as compared to 892 and PAO1.
Being clonal variants, TB and 892 shared the common differential expression pattern
on transcriptome. The global gene response against hydrogen peroxide showed the
up-regulation of genes necessary for the energy generation during the aerobic
growth by creating the oxygen-rich environment and up-regulation of amino acid
metabolism genes, as the preferred nitrogen source. The transcriptome data
indicated that bacterial cell needs adequate amount of iron and sulfur for the
synthesis of oxidatively damaged iron-sulfur clusters. It was observed that most of
the key players to combat hydrogen peroxide mediated oxidative stress response
and DNA repair genes were up-regulated in all the three strains. Consistent with a
need for increased energy and biosynthetic activity for production of P. aeruginosa
cell wall components and oxidative damage protection proteins, most of the genes
necessary for nucleotide metabolism, transcription and translation were up-regulated
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in TB as compared to the PAO1. This result can be explained that the turnover
number of TB could be much higher as compared to the PAO1 in response to
hydrogen peroxide. These findings indicated that enough oxygen was generated
during our growth conditions to down-regulate the genes necessary for arginine
fermentation and anaerobic respiration. Down-regulation of quorum sensing system,
chemotaxis genes show that it is not necessary for the cell against the hydrogen
peroxide mediated oxidative stress response. Several lines of evidence indicate that
global changes in P. aeruginosa gene expression are essential for survival in
presence of hydrogen peroxide. We discovered that in addition to genes involved in
oxidative damage and DNA repair, several genes for pathways in energy generation
and cell biogenesis likely contribute to the ability of P. aeruginosa TB to evade the
hydrogen peroxide mediated oxidative stress.
3.4.2. Transcriptional analysis of non-PAO1 ORFs 
During our screening for intracellular survival in PMNs, we have found putative
transcriptional regulators and strain specific genes called non PAO1 genes which are
attenuated for intracellular survival in PMNs. The function of these genes is not
characterized so far. So we have used a microarray (GeneChip) approach to obtain
functional details about these genes.
3.4.2.1. Gene organization of non-PAO1 sequences
Altogether, we have found three mutants that have insertions in genes which do not
show any homology with the sequenced PAO1 strain. Out of these, two mutants
were further characterized in this dissertation. The plasmids from these mutants were
sequenced further on either side to obtain more sequence information. The G+C
content from these sequence was about 60 % which is low as compared to the
average G+C content (67 %) of P. aeruginosa. This suggests that these sequences
could have extrachromosomal origin and integrated through horizontal gene transfer.
In order to determine the abundance of these sequences in other P. aeruginosa
strains, we hybridized these non-PAO1 sequences on Southern blots prepared from
the genomic DNA of P. aeruginosa clinical isolates CSGB8 and 892 and
environmental isolate SG17M in addition to the reference PAO1 strain. The P. putida
KT2440 was used as a negative control during the Southern hybridization. We could
see signals on the genomic DNA of P. aeruginosa TB and 892 but there were no
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signals obtained on the genomic DNA from other isolates (figure 3.12 and 3.13). The
P. aeruginosa TB and 892 belongs to the same clone. The results from Southern
hybridization suggests that this non-PAO1 sequence is present only in the TB clone.
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PAO1 TB CSGB8 SG17M 892 KT2440.12. Genomic abundance of the non-PAO1 sequence from 25A12 mutant. The genomic probe
5A12 mutant was hybridized on the Southern blot prepared from genomic DNA of different P.
inosa isolates.
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.13 . Genomic abundance of the non-PAO1 sequence from 45A7 mutant. The genomic probe
45A7 mutant was hybridized on the Southern blot prepared from genomic DNA of different P.
inosa isolates.
 the sequences from 25A12 and 45A7 mutants were subjected to the gene
r program to predict the open reading frames (ORFs) and gene organization
figure 3.14 and 3.15).
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Fig. 3.14. Gene organization of non-PAO1 sequence (2454 bp) from 25A12 mutant.
                                                Tn5 insertion
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Fig. 3.15. Gene organization of non-PAO1 sequence (3986 bp) from 45A7 mutant.
We predicted three ORFs, one truncated on the right side and two complete on the
left side from 25A12 non-PAO1 sequence (Table 3.13). Five ORFs, two truncated on
either side and three complete in the middle were predicted from 45A7 non-PA01
sequence. The truncated ORFs on either side in both the mutants were due to the
small size of the inserted DNA. We could not detected the anti-termination loops in
both non-PAO1 sequences by in silico analysis. These ORFs were blasted for protein
homology searches on NCBI database (http://www.ncbi.nlm.nih.gov/BLAST/),
including finished and unfinished genome projects. The homologies obtained are
listed below (Table 3.14).
It was observed that the ORFs from 25A12 non-PAO1 sequence did not show
significant homology with any other gene from the available databases. The ORFs
from 45A7 non-PAO1 sequence showed homology on protein level from 55-84 %
with nitrilase or α-helix motif or hypothetical proteins. This in silico analysis did not
give any functional clue for these ORFs with respect to the intracellular survival in
PMNs. Hence we used P. aeruginosa PAO1 microarrays to obtain the functional
information and how these genes react with the core P. aeruginosa genome.
....
E
...
G HD F
1 8 693
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 Table 3.14. Predicted ORFs and homology on protein level from non-PAO1 sequence. 
ORF Start End Size
(bp)
Homology on protein level Identity
(%)
A 113 1606 1494 no         -
B 1628 2215 588 no         -
C 2371 >2454 >84 no         -
D >1 693 >693 nitrilase (Xanthomonas campestris pv. campestris) 68
E 943 1251 309 α-helix chain (E. coli) 58
F 1311 2420 1110 alcohol dehydrogenase (E. coli) 83
G 2464 2862 399 hypothetical protein (Proteus vulgaris) 84
H 2976 >3986 >1011 hypothetical protein (Mesorhizobium loti) 55
3.4.2.2. Expression of 25A12 non-PAO1 ORF
Before going to GeneChip analysis, the critical and essential requirement was to see
the expression of these unknown ORFs. For this, we used standard conditions like
growth in LB medium to early and late exponential phase, exposure to stress
conditions like growth in iron limiting LB medium, growth in presence of chemicals
generating oxidative stress (paraquat and hydrogen peroxide) and growth in
presence of PMNs. For the last two conditions, the bacterial cells were grown in LB
medium up to early stationary phase, harvested and were exposed to chemicals
generating oxidative stress or to PMNs in a dialysis bag for about 2 h. There was
virtually no direct contact of cells with PMNs. Because of difficulties in the separation
of eukaryotic and prokaryotic RNA, this system was developed. After the incubation
period, the cells were directly recovered from the dialysis bag and RNA was isolated
as mentioned previously (see 2.6.4). Then the expression pattern of these non-PAO1
ORFs was compared on Northern blots (figure 3.16 and 3.17).
We could not see the signal of 25A12 non-PAO1 ORF on the Northern blot when the
TB wild type was grown under above mentioned conditions. However, a strong signal
was obtained when the mutant 25A12 was grown under the same conditions (figure
3.16). These results suggested that this may be a very lowly expressed and essential
gene and could modulate the gene expression very precisely at low levels. The
signal intensity of the mutant was weak when grown in iron depleted medium as
compared to the other growth conditions. The strong signal on the Northern blot for
mutant could be due to the feedback mechanism because the mutant tries to express
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a truncated and non-functional ORF at high levels. However, the pattern of truncated
ORFs vary when the mutant was grown under standard and stress conditions. We
could see the high molecular weight truncated ORFs when the mutant was grown in
presence of oxidative stress generating agents and PMNs. We did not find the anti-
termination loops in the sequence from 25A12 mutant indicating that all the genes
from this sequence are expressed simultaneously. These results suggests that it
could be polycistronic mRNA and form an operon structure. However, there were not
clear cut bands obtained on the Northern blot indicating the faster degradation of
mRNA. 
Fig. 3.16. Expression profile of non-PAO1 ORF from 25A12 mutant on Northern blot under various
growth conditions. RNA from various growth conditions was hybridized with the probe prepared from
25A12 non-PAO1 sequence.
3.4.2.3. Expression of 45A7 non-PAO1 sequence
This non-PAO1 gene showed three strong signals on the Northern blot when the wild
type was grown in the above mentioned conditions, whereas we could see only the
low molecular weight signal at the bottom on the mutant which is weak as compared
to the TB wild type (figure 3.17). This indicates that this is a highly expressed gene in
all the tested conditions. The approximate molecular weight sizes of these signals
corresponds to 3.1 Kb, 2.5 Kb and 4.5 Kb. The intergenic region of almost 249 and
113 nucleotides is present between E and F ORFs and G and H ORFs, respectively
W W W W W WM M M MM M
Early
exponential
Late
exponential
Fe (-) H2O2
(10 mM)
Paraquat
(0.5 mM)
PMNs
(W : P. aeruginosa TB wild type; M : transposon mutant)
23 S rRNA
(2890 bp)
16 S rRNA
(1536 bp)
Results and discussion
(figure 3.15). We could not find the anti-termination loop in the intergenic region and
in the whole sequence from 45A7 mutant by in silico analysis. The expression pattern
of 45A7 non-PAO1 sequence suggests that it could be a polycistronic mRNA and
form an operon structure.
Early Late Fe (-) H O Paraquat PMNs127
Fig. 3.17. Expression profile of non-PAO1 ORF from 45A7 mutant on Northern blot under various
growth conditions. RNA from various growth conditions was hybridized with the probe prepared from
45A7 non-PAO1 sequence.
3.4.2.4. GeneChip analysis of 25A12 and 45A7 non-PAO1 sequences
GeneChip expression analysis was performed for these two mutants that have
insertion in the non-PAO1 genes. For this, three expression conditions were chosen:
growth of wild type and mutants in LB medium up to late exponential phase, growth
in presence of hydrogen peroxide and PMNs. The idea of choosing the standard
condition was that it would show the impact of the transposon insertion on the
expression of the PAO1 defined core genome and on the metabolism of P.
aeruginosa TB. The latter two conditions can mimic the situation close to the PMNs
because oxidative stress response is the major host defense mechanism exerted by
PMNs for microbial killing. RNA from these conditions was isolated and processed
further for GeneChip hybridization as previously described (see 2.6.4-2.6.10).
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3.4.2.4.1. Down-regulation in the non-PAO1 mutants 
Differentially regulated genes from both mutants having known function were
classified. The differential expression pattern of both the mutants were compared
from all the three conditions. The most striking observation is that both mutants
showed similar pattern on the transcriptome in the two conditions i.e. when grown in
the presence of hydrogen peroxide and PMNs. For the third condition i.e. growth in
LB medium up to late exponential phase, we could see the slight down-regulation of
genes involved in arginine metabolism in the 25A12 mutant (see table 7.2 in
appendix III). It was observed that 14 genes involved in arginine metabolism were
modestly down-regulated in the 25A12 mutant when grown in LB medium up to late
exponential phase. The arginine metabolism genes from arginine transport (PA0888-
PA0893), arginine succinyltransferase (AST) pathway (PA0895-0899) and arginine
deiminase (ADI) pathway (PA5171-PA5173) and the transcriptional regulator anr
were down-regulated in the mutant 25A12. P. aeruginosa can utilize arginine under
aerobic conditions as a sole source of carbon, energy, and nitrogen via the arginine
succinyltransferase pathway (Haas et al., 1990). Despite the preference for an
aerobic environment, P. aeruginosa can utilize arginine under anaerobic conditions
via the arginine deiminase pathway (Luthi et al., 1990). The ADI pathway in
association with anr was modestly down-regulated in the 25A12 mutant. This
pathway catabolizes L-arginine to L-ornithine, with concomitant formation of ATP
from ADP. So these results suggests that this unknown sequence has modest impact
on the arginine utilization as a energy source. We could not see the significant down-
regulation of arginine utilization genes in 45A7 mutant when grown under the same
condition.
There were virtually no differentially regulated genes in the mutant 45A7 when grown
in LB medium up to late exponential phase. This GeneChip data uncovered that
there is no interference with the core genome of P. aeruginosa under standard
growth conditions and these two genes could be regulated their own.
Differential regulation of genes involved in denitrification
Table 3.15 shows the genes whose expression was significantly down-regulated by
hydrogen peroxide or PMNs in either one or both tested P. aeruginosa transposon
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Table 3.15. Genes down-regulated in 25A12 and 45A7 mutants compared to the wild type strain when
grown in presence of hydrogen peroxide or PMNs1. 
PAO No. Average fold change Protein name2 
H2O2 PMNs
25A12 45A7 25A12 45A7
Denitrification
PA0024 2.12 2.15 coproporphyrinogen III oxidase, hemF
PA0291 2.19 1.89 1.62 1.76 outer membrane porin, oprE
PA0518 1.93 cytochrome c-551 precursor, nirM
PA0519 6.71 15.85 nitrite reductase precursor, nirS
PA0527 22.00 29.92 1.83 3.14 transcriptional regulator, dnr
PA0538 2.95 3.26 disulfide bond formation protein, dsbB
PA1544 3.05 2.34 1.52 1.62 transcriptional regulator, anr
PA1546 10.19 14.12 1.62 1.57 oxygen-independent coproporphyrinogen III
oxidase, hemN
PA1556 6.44 13.77 1.74 1.61 probable cytochrome c oxidase subunit
PA1557 11.11 15.05 2.96 2.51 cytochrome oxidase subunit (cbb3-type)
PA2664 30.20 22.08 flavohemoprotein, fhp
PA3873 1.81 1.58 respiratory nitrate reductase delta chain, narJ
PA3874 2.05 1.60 respiratory nitrate reductase beta chain, narH
PA3875 2.69 2.29 respiratory nitrate reductase alpha chain,
narG
PA3876 2.47 2.27 nitrite extrusion protein 2, narK2
PA3877 9.43 6.80 2.14 2.17 nitrite extrusion protein 1, narK1
PA3878 2.53 2.35 two-component sensor, narX
PA3879 2.69 3.52 2.73 2.50 two-component response regulator, narL
PA4133 1.60 1.71 1.52 2.81 cytochrome c oxidase subunit (cbb3-type)
PA4464 2.04 2.30 nitrogen regulatory IIA protein, ptsN
PA4812 1.72 1.46 formate dehydrogenase-O, fdnG
1: No down-regulated genes from above mentioned categories were observed when both the mutants
   were grown in LB medium up to late exponential phase.
2: Gene names are indicated in italics.
mutants 25A12 and 45A7. It was observed that the down-regulation gene pattern in
both mutants was similar in the presence of hydrogen peroxide and PMNs. But the
number of down-regulated denitrification genes in presence of hydrogen peroxide
were higher and the absolute values were high on the negative side in both the
mutants as compared to the PMNs. This pattern reflects that the signal provided by
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direct contact of hydrogen peroxide for gene modulation could be stronger than the
indirect contact with PMNs. It was observed that the cells in presence of hydrogen
peroxide were more active metabolically. That could be the reason why they need
strong gene modulation.
The expression of the nir and nor genes involved in denitrification is regulated by two
FNR-like regulators, ANR and DNR, in P. aeruginosa (Arai et al., 1995; Arai et al.,
1997). We could see the down-regulation of these regulators in both the mutants
when exposed to hydrogen peroxide and PMNs. These FNR-like regulators regulates
the expression of many genes that are required for anaerobic growth when oxygen is
depleted. During our experiments, we observed the down-regulation of some of the
genes from nir (nirM, nirS) and nar (narJ, narH, narG, narK2, narK1, narX, narL)
gene cluster, heme biosynthesis (hemF, hemN) and anaerobically induced genes
(oprE, dsbB,  ptsN, fdnG) in both the mutants 25A12 and 45A7. Fhp was also
strongly down-regulated in both the mutants after exposure to hydrogen peroxide. It
is able to scavenge oxygen molecules, improve microaerobic cell growth and
enhance oxygen-dependent product formation in several organisms (Frey et al.,
2000). These results suggest that most of the genes necessary for growth in oxygen
limiting condition or in anaerobic respiration were down-regulated in both mutants. 
3.4.2.4.2. Up-regulation in the non-PAO1 mutants
Differential regulation of genes involved in type III secretion system
The type III secretion system (TTSS) is widespread in Gram-negative pathogens,
including Yersinia, Salmonella and Shigella, and in plant pathogens such as
Pseudomonas syringae and Erwinia chrysanthemi (Galan and Collmer, 1999). This
unusual system requires close contact between infecting bacteria and the host cell to
secrete and deliver toxic bacterial proteins directly to the cytosol of the host cell.
TTSS and its secreted effector proteins are considered the most prominent virulence
factor of P. aeruginosa.
Table 3.16 lists the genes that were up-regulated in both mutants 25A12 and 45A7
which are involved in building the type III secretion machinery. Out of the 36 TTSS
genes, 6 were up-regulated when grown in LB medium up to exponential phase and
12 were up-regulated after exposure to PMNs. Both mutants showed a similar
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expression pattern under these two conditions. P. aeruginosa secretes at least four
effector proteins through its type III secretion system, namely ExoS, ExoT, ExoY and
ExoU (Frank, 1997). But we could not see the up-regulation of these effector proteins
in both examined P. aeruginosa TB mutants. Results from several laboratories
strongly suggest that P. aeruginosa strains collected from diverse infection
environments express different type III system-secreted effectors (or effector
combinations), and this therefore results in different phenotypes (Dacheux et al.,
2001). In our case, the signal from PMNs may not be enough to stimulate the
secretion of the effector proteins since there was not direct contact with the PMNs. 
Table 3.16. Genes up-regulated from type III secretion system in 25A12 and 45A7 mutants when
grown in LB medium up to late exponential phase and in presence of PMNs1.
PAO No. Average fold change Protein name2 
LE PMNs
25A12 25A12 45A7
PA1692 2.30 2.27 2.94 translocation protein in type III secretion  
PA1697 5.50 5.68 ATP synthase in type III secretion system
PA1698 3.26 3.81 type III secretion outer membrane protein, popN
PA1703 3.48 4.52 4.61 type III secretary apparatus protein, pcrD
PA1705 2.42 3.00 4.33 regulator in type III secretion, pcrG
PA1707 2.07 2.14 regulatory protein, pcrH
PA1713 1.87 1.87 transcriptional regulator, exsA
PA1715 4.21 5.87 type III export apparatus protein, pscB
PA1716 2.46 2.73 type III secretion outer membrane protein, pscC
PA1721 3.51 3.62 type III export protein, pscH 
PA1723 2.78 3.26 3.93 type III export protein, pscJ
PA1724 2.64 type III export protein, pscK
PA1725 2.88 4.51 3.39 type III export protein, pscL 
1: No up-regulated genes from type III secretion system were observed when both the mutants grown
   in presence of hydrogen peroxide. 
2: Gene names are indicated in italics.
Differential regulation of genes involved in quorum sensing and iron uptake 
Table 3.17 shows the genes involved in quorum sensing and iron uptake which were
up-regulated in both mutants after exposure to hydrogen peroxide. P. aeruginosa
produces a wide spectrum of secreted virulence factors, including LasB elastase,
Results and discussion
132
Table 3.17. Genes up-regulated from quorum sensing system and iron uptake in 25A12 and 45A7
mutants when exposed to hydrogen peroxdie1.
PAO No. Average fold change Protein name2
25A12 45A7
PA1247 3.73 3.10 alkaline protease secretion protein, aprE
PA1249 3.48 3.61 alkaline metalloproteinase precursor, aprA
PA1871 3.55 4.33 LasA protease precursor, lasA
PA4210 4.00 11.85 probable phenazine biosynthesis protein, phzA1
PA4211 4.76 3.52 phenazine biosynthesis protein, phzB1
PA1901 59.90 42.96 phenazine biosynthesis protein, phzC2
PA1902 27.00 12.21 phenazine biosynthesis protein, phzD2
PA1903 5.02 3.49 phenazine biosynthesis protein, phzE2
PA1904 47.04 33.24 phenazine biosynthesis protein, phzF2
PA1905 8.02 4.19 pyridoxamine 5'-phosphate oxidase, phzG2
PA2194 3.37 4.57 hydrogen cyanide synthase, hcnB
PA2195 2.85 4.51 hydrogen cyanide synthase, hcnC
PA3478 4.86 4.46 rhamnosyltransferase chain B, rhlB
PA3479 4.21 3.41 rhamnosyltransferase chain A, rhlA
PA3724 12.31 7.06 elastase LasB, lasB
PA4224 2.36 2.15 pyochelin biosynthetic protein, pchG 
PA4225 2.61 2.38 pyochelin synthetase, pchF
PA4226 2.04 2.14 dihydroaeruginoic acid synthetase, pchE
PA4228 2.35 2.14 pyochelin biosynthesis protein, pchD
PA4229 2.22 pyochelin biosynthetic protein, pchC 
PA4230 2.83 salicylate biosynthesis protein, pchB 
PA4231 2.78 3.03 salicylate biosynthesis isochorismate synthase, pchA
1: No up-regulation of genes from the abovementioned categories were observed when both mutants
    were grown in LB medium and when grown in presence of PMNs.
2: Gene names are indicated in italics.
rhamnolipids, pyocyanin, lipase, and hydrogen cyanide (Van Delden and Iglewski,
1998). The las and rhl quorum-sensing systems regulate the production of these
factors in a cell density dependent manner. This regulation relies on the accumulation
of two autoinducer (AI) molecules in the medium, 3-oxo-C12-homoserine lactone (3-
oxo-C12-HSL) and C4-HSL, which induce the las and rhl quorum-sensing systems
when the bacterial cell density reaches a certain threshold (quorum), leading to the
transcription of specific genes and the production of the virulence factors cited above.
Results and discussion
133
Both systems involve a transcriptional regulator (rhlR and lasR, respectively) and an
AI synthase (RhlI and LasI, respectively). A hierarchy was proposed in which the las
system activates the rhl system by inducing the transcription of the activator gene
rhlR (Pesci et al., 1997). 
During this study, the quorum sensing repressor rsaL was repressed in both mutants
when exposed to hydrogen peroxide (data not shown). So we could expect the up-
regulation of quorum sensing dependent genes. Here, alkaline proteases (aprA,
aprE), LasA protease precursor (lasA), elastase (lasB), phenazine biosynthesis
genes (phzA1, phzB1, phzC2, phzD2, phzE2, phzF2, phzG2), hydrogen cyanide
biosynthesis genes (hcnB, hcnC), rhamnolipid biosynthesis genes (rhlA, rhlB) and
pyochelin biosynthesis genes (pchA, pchB, pchC, pchD, pchE, pchF, pchG) were
significantly up-regulated in both the mutants after exposure to hydrogen peroxide.
All these gene products belong to both quorum sensing (rhlR-rhlI and lasR-lasI)
systems. These results suggest that the transposon mutant could be handicapped in
certain known or unknown virulence factors and then up-regulate the quorum sensing
dependent virulence factors in presence of hydrogen peroxide as a rescue
mechanism.
Iron is one of the essential elements for almost all bacteria, and the ability of
pathogenic bacteria to acquire iron in hosts is essential for their growth and infection
(Bullen, 1981; Neilands, 1981). In animal hosts, iron is usually bound to proteins such
as transferrin, lactoferrin, and ferritin and bound as heme to hemoglobin (Hb) and
various enzymes (Otto et al., 1992; Wooldridge and Williams, 1993). To utilize such
complexes as iron sources, bacteria possess some sophisticated mechanisms,
including an iron uptake system mediated by high-affinity iron chelators called
siderophores such as pyoverdin and pyochelin and a heme uptake system, which
involve specific receptors (Marinez et al., 1990; Otto et al., 1992). Most of the
pyochelin biosynthesis genes (pchA, pchB, pchC, pchD, pchE, pchF and pchG) were
up-regulated in both the mutants when exposed to hydrogen peroxide. It is known
that iron and iron-containing proteins play important roles in the growth and
pathogenesis of P. aeruginosa, especially in its defense against oxidative stress
(Vasil and Ochsner, 1999). Many proteins involved in respiration (e.g. ferredoxins and
other iron–sulphur proteins) and degradation of H2O2 and (e.g. haem catalase, iron
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superoxide dismutase and peroxidase) require iron for functionality. Therefore, this
up-regulation in pyochelin biosynthesis genes in both the non-PAO1 mutants would
help to combat the oxidative stress response generated by hydrogen peroxide.
The microarray (GeneChip) results from these two mutants can be summarized in the
following way. Inspite of constitutive expression of these non-PAO1 ORFs in all the
tested conditions, the microarray data showed that there were only subtle changes in
the expression of the PAO1 defined core genome in both the mutants under the
standard growth conditions. Only one mutant, 25A12, exhibited a modest down-
regulation of arginine utilization. This shows that there is virtually no interference with
the core P. aeruginosa genome. The down-regulation of large number of
denitrification genes in both the mutants when exposed to hydrogen peroxide and
PMNs suggests that P. aeruginosa TB could switch off the aerobic respiration during
the intracellular survival and growth in PMNs. The type III secretion system and
quorum sensing systems were up-regulated in both the mutants suggesting that this
derepression of virulence factor expression may be critical for minimizing the stress
exerted by hydrogen peroxide and PMNs by over-expressing the virulence factors.
The GeneChip experiments showed that these two non-PAO1 ORFs are regulated
by their own without severely affecting the core metabolism of P. aeruginosa. These
two sequences have a low G+C content (60 %) as compared to the average G+C
content of P. aeruginosa which is 67 %. This suggests that they could be a part of
extrachromosomal genetic elements and acquired through horizontal gene transfer.
Out of these two ORFs, the ORF from 25A15 is expressed at very low levels in wild
type while the other ORF from 45A7 is highly expressed in the wild type P.
aeruginosa TB. The GeneChip data revealed that transposon insertion into the non-
PAO1 ORFs leads to the up-regulation of the type III secretion and quorum sensing
systems. The up-regulation of virulence factors suggests that these transposon
mutants are more virulent than the P. aeruginosa TB wild type but impaired for
intracellular survival and growth in PMNs. This suggests that these ORFs stabilizes
the expression of virulence genes in P. aeruginosa TB wild type but are necessary
for the intracellular survival and growth in PMNs. The similar pattern of differential
expression on microarray in both the mutants indicate that they have a common
phenotypic and genotypic effect on the normal metabolism and virulence factor
synthesis in P. aeruginosa TB. 
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3.4.3. Transcriptional analysis of sigma-70 factor
The mutant 23B9 that carries a mutation in the gene PA2468 (probable sigma-70
factor, ECF subfamily) was identified as being impaired for intracellular survival in the
granulocytes. It has 70 % homology with the fecI from E. coli but the function of this
sigma factor is not well characterized so far. The upstream (PA2469) and
downstream (PA2467) genes are a transcriptional regulator and a probable
transmembrane sensor (53 % pupR, P. putida) respectively. We used P. aeruginosa
microarrays to uncover the regulatory mechanism of this gene. 
3.4.2.1. Expression of sigma-70 factor under various growth
conditions
Several standard as well as stress growth conditions (see 2.6.3) were used to see
the expression of this gene on Northern blot. The RNA from several growth
conditions was isolated from P. aeruginosa TB wild type and 23B9 mutant and
Northern blot was prepared. Then the probe spanning the whole gene of 23B9 was
generated and hybridized on the Northern blot for overnight. The hybridized blot was
 
Fig. 3.18. Expression profile of sigma-70 factor on Northern blot under various growth conditions. RNA
from various growth conditions was hybridized with the probe prepared from the PA2468 gene. (A:
functional ORF; B: truncated and non-functional ORF).
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detected as described previously (see 2.6.5.3). We could see the expression of this
gene under iron limiting conditions, in presence of hydrogen peroxide and PMNs
(figure 3.18), while the expression of this gene under other growth conditions was not
observed. Northern blot analysis showed that the signal is weak for P. aeruginosa TB
wild type, while it is stronger for the mutant. This could be the lowly expressed gene
and the mutant tries to produce more and more since it is a truncated and non-
functional ORF. 
3.4.2.2. GeneChip analysis of sigma-70 factor
GeneChip expression analysis was performed for the mutant 23B9 having a mutation
in the probable sigma-70 factor gene. We observed on the Northern blot that this
sigma factor was expressed under three growth conditions i.e. when P. aeruginosa
TB wild type and mutant strains were grown in iron limiting LB medium or when
exposed to hydrogen peroxide or PMNs. The RNA from these three growth
conditions was isolated and processed further for GeneChip hybridization as
previously described.  
The differential expression pattern of the wild type was compared with the mutant
from all the three growth conditions. Then the differentially regulated genes were
classified based on the known or predicted function (Table 3.18). The other genes
with unknown function were not included in this table. 
Table 3.18. Differentially regulated genes in the sigma-70 factor (PA2468) grown under stress
conditions (iron limitation, in presence of hydrogen peroxide and PMNs).
PAO No.ab Average fold change Protein namec
Fe (-) H2O2 PMNs
Down-regulated genes in mutant
Aerobic/anaerobic growth
PA0024 2.47 coproporphyrinogen III oxidase, hemF
PA0517 2.26 probable c-type cytochrome precursor, nirC
PA0519 21.32 nitrite reductase precursor, nirS
PA0527 61.15 transcriptional regulator, dnr
PA1173b 2.43 cytochrome c-type protein NapB precursor , napB
PA1174 2.01 periplasmic nitrate reductase protein, napA
PA1175 b 2.04 napD protein of periplasmic nitrate reductase, napD
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PAO No.ab Average fold change Protein namec
Fe (-) H2O2 PMNs
Down-regulated genes in mutant
Aerobic/anaerobic growth
PA1505 1.90 molybdopterin biosynthetic protein A2, moaA2
PA1544 1.50 2.02 transcriptional regulator, anr
PA1546 14.85 oxygen-independent coproporphyrinogen III oxidase,
hemN
PA1556 10.01 probable cytochrome c oxidase subunit 
PA1557 43.79 probable cytochrome oxidase subunit (cbb3-type)
PA2664 35.81 flavohemoprotein, fhp
PA3877 14.69 nitrite extrusion protein 1, narK1
PA3878 3.12 two-component sensor, narX
PA3879 3.40 two-component response regulator, narL
PA4130 b 1.98 2.30 probable sulfite or nitrite reductase
PA4133 b 2.24 3.28 cytochrome c oxidase subunit (cbb3-type)
PA4464 2.51 nitrogen regulatory IIA protein, ptsN
PA4587 2.68 cytochrome c551 peroxidase precursor, ccpR
PA5170 1.96 36.80 arginine/ornithine antiporter, arcD
PA5171 1.88 2.69 arginine deiminase, arcA
PA5172 2.12 ornithine carbamoyltransferase, arcB
PA5173 1.91 carbamate kinase, arcC
Quorum sensing
PA0026 1.84 hypothetical protein
PA0109 a 1.87 hypothetical protein
PA0122 2.20 conserved hypothetical protein
PA0176 1.52 probable chemotaxis transducer
PA0179 1.43 probable two-component response regulator
PA0263 4.03 2.69 secreted protein Hcp, hcpC
PA0567 1.91 conserved hypothetical protein
PA0586 1.66 conserved hypothetical protein
PA0588 1.60 conserved hypothetical protein
PA0652 a 1.41 transcriptional regulator, vfr
PA1003 a 2.19 transcriptional regulator, mvfR
PA1004 1.59 quinolinate synthetase A, nadA
PA1323 1.50 hypothetical protein
PA1430 a 1.41 transcriptional regulator, lasR 
PA1431 a 1.68 4.06 1.26 regulatory protein, rsaL
PA1432 a 3.03 autoinducer synthesis protein, lasI
PA1659 1.78 hypothetical protein
PA1664 15.95 hypothetical protein
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PAO No.ab Average fold change Protein namec
Fe (-) H2O2 PMNs
Down-regulated genes in mutant
Quorum sensing
PA1667 2.71 hypothetical protein
PA1869 a 1.96 hypothetical protein
PA1871 a 1.40 lasA protease precursor, lasA
PA1901 a 3.02 phenazine biosynthesis protein, phzC2
PA1902 2.85 phenazine biosynthesis protein, phzD2
PA1903 2.58 phenazine biosynthesis protein, phzE2
PA1904 3.12 probable phenazine biosynthesis protein, phzF2
PA1905 2.94 probable pyridoxamine 5'-phosphate oxidase, phzG2
PA2031 1.52 hypothetical protein
PA2066 1.60 hypothetical protein
PA2067 1.52 probable hydrolase
PA2068 1.53 probable MFS transporter
PA2069 1.50 probable carbamoyl transferase
PA2300 a 2.76 chitinase, chiC
PA2331 2.43 hypothetical protein
PA2366 2.18 conserved hypothetical protein
PA2426 a 1.70 sigma factor, pvdS
PA2570 a 1.99 2.81 PA-I galactophilic lectin, pa1L
PA2586 a 1.40 response regulator, gacA
PA2588 1.40 probable transcriptional regulator
PA2747 2.28 2.20 hypothetical protein
PA2939 2.36 3.44 probable aminopeptidase
PA3006 2.88 2.57 transcriptional regulator, psrA
PA3326 a 1.85 probable Clp-family ATP-dependent protease
PA3329 a 3.23 hypothetical protein
PA3331 a 2.48 cytochrome P450
PA3332 1.68 conserved hypothetical protein
PA3334 6.48 probable acyl carrier protein
PA3418 1.77 leucine dehydrogenase, ldh
PA3478 a 1.50 1.71 rhamnosyltransferase chain, rhlB
PA3479 a 1.79 rhamnosyltransferase chain, rhlA
PA3520 1.81 hypothetical protein
PA3691 1.60 hypothetical protein
PA3692 1.40 probable outer membrane protein precursor
PA3724 1.40 elastase, lasB
PA3904 3.00 hypothetical protein
PA4129 2.31 hypothetical protein
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PAO No.ab Average fold change Protein namec
Fe (-) H2O2 PMNs
Down-regulated genes in mutant
Quorum sensing
PA4134 11.96 hypothetical protein
PA4139 1.64 hypothetical protein
PA4141 2.62 hypothetical protein
PA4210 a 7.62 probable phenazine biosynthesis protein, phzA1
PA4211 6.49 probable phenazine biosynthesis protein, phzB1
PA4217 a 5.70 flavin-containing monooxygenase, phzS
PA4296 1.84 2.06 3.11 probable two-component response regulator
PA4311 1.50 conserved hypothetical protein
PA4587 2.68 cytochrome c551 peroxidase precursor, ccpR
PA4739 2.17 conserved hypothetical protein
PA4770 5.08 L-lactate permease, lldP
PA4778 1.50 probable transcriptional regulator
PA4880 2.14 probable bacterioferritin
PA5220 a 1.52 hypothetical protein
PA5356 a 1.75 transcriptional regulator, glcC
PA5482 2.25 6.80 hypothetical protein
Regulation
PA2469 2.43 probable transcriptional regulator
Type III secretion system
PA0044 1.76 exoenzyme T, exoT
PA1694 1.69 translocation protein in type III secretion, pscQ
PA1701 1.87 conserved hypothetical protein in type III secretion
PA1706 3.90 type III secretion protein, pcrV
PA1707 2.93 regulatory protein, pcrH
PA1708 1.83 translocator protein, popB
PA1714 1.49 hypothetical protein
PA1718 5.55 type III export protein, pscE
PA1719 4.02 type III export protein, pscF
PA3841 3.82 exoenzyme S, exoS
Iron homeostasis
PA4221 11.49 fe(III)-pyochelin receptor precursor, fptA
PA4224 3.15 pyochelin biosynthetic protein, pchG
PA4225 44.18 pyochelin synthetase, pchF
PA4226 31.43 dihydroaeruginoic acid synthetase, pchE
PA4228 3.62 pyochelin biosynthesis protein, pchD
PA4229 4.98 pyochelin biosynthetic protein, pchC
PA4230 8.90 salicylate biosynthesis protein, pchB
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PAO No.ab Average fold change Protein namec
Fe (-) H2O2 PMNs
Down-regulated genes in mutant
Iron homeostasis
PA4231 4.27 salicylate biosynthesis isochorismate synthase, pchA
PA4880 2.14 probable bacterioferritin
Antimicrobial peptide resistance
PA1178 13.48 PhoP/Q and low Mg2+ inducible outer membrane
protein H1 precursor, oprH
PA1179 8.48 two-component response regulator, phoP
Up-regulated genes in mutant
Regulation
PA2467 4.81 4.01 probable transmembrane sensor
Quorum sensing
PA0852 a 4.54 chitin-binding protein CbpD precursor, cbpD
PA0996 2.12 probable coenzyme A ligase, pqsA
PA0997 1.78 homologous to beta-keto-acyl-acyl-carrier protein
synthase, pqsB
PA0998 1.78 beta-keto-acyl-acyl-carrier protein synthase, pqsC
PA0999 1.60 3-oxoacyl-(acyl-carrier-protein) synthase III, pqsD
PA1000 1.70 quinolone signal response protein, pqsE
PA1001 a 1.72 anthranilate synthase component I, phnA
PA1317 2.26 cytochrome o ubiquinol oxidase subunit II, cyoA
PA1318 2.19 cytochrome o ubiquinol oxidase subunit I, cyoB
PA1901 a 26.12 phenazine biosynthesis protein, phzC2
PA1903 3.18 phenazine biosynthesis protein, phzE2
PA1904 18.96 probable phenazine biosynthesis protein, phzF2
PA1905 4.05 pyridoxamine 5'-phosphate oxidase, phzG2
PA3478 a 3.31 rhamnosyltransferase chain, rhlB
PA3724 a 6.96 elastase, lasB
Iron homeostasis
PA3407 1.98 heme acquisition protein, hasAp
PA3408 1.70 haem uptake outer membrane receptor, hasR
PA4224 3.27 pyochelin biosynthetic protein, pchG 
PA4225 2.67 pyochelin synthetase, pchF
PA4229 3.05 pyochelin biosynthetic protein, pchC
PA4231 3.66 salicylate biosynthesis isochorismate synthase, pchA
a: Genes previously identified as being QS regulated (de Kievit et al., 1999;  Gambello et al., 1993;
   Pearson et al., 1997; Pesci et al., 1997; Pessi and Haas, 2000; Toder et al., 1991; Toder et al.,
  1994; Whitely et al., 1999).
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b: Genes identified as being QS regulated by microarray analysis (Wagner et al., 2003; Schuster et
   al., 2003).
c: Gene names are indicated in italics.
We could see that the genes involved in aerobic and anaerobic growth, quorum
sensing, type III secretion system, iron homeostasis, antimicrobial peptide resistance
were down-regulated in the mutant in either one or two growth conditions. The genes
involved in oxidative phosphorylation (PA1556 and PA1557) were severely down-
regulated in the mutant after exposure to hydrogen peroxide. Most of the genes
(hemF, nirC, nirS, dnr, moaA2, anr, hemN, fhp, narK1, narX, narL, ptsN, ccpR)
involved in denitrification were down-regulated in the mutant when exposed to
hydrogen peroxide, while the other genes napA, napB, napD, anr, PA4130 and
PA4133 were down-regulated during the growth in iron limiting condition or when
exposed to PMNs. The nirS and dnr regulators in denitrification were severely down-
regulated in the mutant after exposure to hydrogen peroxide. The other genes (arcA,
arcB, arcC and arcD) for arginine fermentation were repressed during the growth in
iron limiting condition and when exposed to hydrogen peroxide. We could not see the
repression of arcB and arcC when exposed to hydrogen peroxide. In some instances,
for genes that formed an operon, such as arcABCD, the changes for the first gene
(arcD) in the operon were much greater than the changes for the downstream genes.
This phenomenon has also been noted by the other scientists and has been
attributed to RNA degradation from the 3‘ end of the transcript (Whiteley et al., 2000).
During microaerophilic or anaerobic growth, it is known that P. aeruginosa generates
energy through the arginine fermentation or nitrate respiration respectively. The
GeneChip data revealed that the mutant is unable to generate energy via oxidative
phosphorylation under aerobic growth condition, via arginine fermentation under
microaerophilic condition and through denitrification under anaerobic condition. This
suggests that the mutant is handicapped for the metabolic energy generation in all
the growth conditions. We also found that lot of genes involved in quorum sensing
were down-regulated in the mutant in either one or multiple growth conditions (Table
3.18). Some of these genes are already confirmed as being quorum sensing
regulated by experimental evidence, while the other genes from the quorum sensing
category were identified by using the microarray approach used by us and others
(see table 3.19) (Wagner et al., 2003; Schuster et al., 2003). So such genes are also
included in this table 3.18. Twenty seven, thirteen and forty three known or predicted
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genes involved in quorum sensing were repressed in the mutant when grown in iron
limitation, in presence of hydrogen peroxide and in presence of PMNs respectively.
Only two genes (rsaL and PA4296) identified as being QS regulated were down-
regulated in the mutant under all the growth conditions. Interestingly, most of the
known genes (mvfR, rsaL, phzCDEFG2, pa1L, gacA, rhlAB, lasB, phzAB1, phzS)
identified as being quorum sensing regulated are repressed when the mutant was
exposed to PMNs. Some of these genes act as virulence factors. Some investigators
have presented evidence showing that additional genes are controlled by quorum
sensing in P. aeruginosa (Wagner et al., 2003; Schuster et al., 2003). Furthermore,
several reports have shown that a variety of regulatory proteins can influence the
expression of quorum sensing controlled genes (Schuster et al., 2003). The other
transcriptional regulator PA2469 with unknown function was also down-regulated in
the mutant. This gene is upstream of the sigma factor (PA2468) and could form an
operon structure. So the sigma factor could be involved in the stimulation of this
transcriptional regulator by transferring the signals. We also identified that the genes
involved in building the type three secretion apparatus and the effector proteins
(exoT, exoS) were down-regulated in the mutant when exposed to hydrogen
peroxide. The type III secretion system in P. aeruginosa is very well characterized
and contributes to the pathogenesis. The opportunistic human pathogen P.
aeruginosa responds to iron-limiting growth conditions by the production of two major
siderophores, pyoverdin (Meyer et al., 1996) and pyochelin (Cox et al., 1981). These
compounds are released to the extracellular environment, where they form a complex
with iron and deliver it to the bacterial cell via their specific membrane receptors,
FpvA (Poole et al., 1993) and FptA (Ankenbauer and Quan, 1994), respectively. Both
siderophores contribute to the virulence of P. aeruginosa (Meyer et al., 1996; Takase
et al., 2000). During our studies, the fptA, pchABCDEFG genes involved in iron
acquisition were significantly down-regulated in the mutant when exposed to PMNs.
Under the same growth condition, the genes (oprH, phoP) which are expressed
under low magnesium ion concentration and involved in antimicrobial peptide
resistance were down-regulated in the mutant. PMNs are known to produce
antimicrobial peptides as a defense mechanism for microbial killing. 
Several genes were up-regulated in the mutant, which could be the rescue
mechanism. We found that the downstream gene (PA2467) which is a
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transmembrane sensor with unknown function was significantly up-regulated in the
mutant in presence of hydrogen peroxide and PMNs. This could be up-regulated due
to the feedback mechanism in the mutant due to a non-functional PA2468 (sigma-70
factor). Six and nine genes involved in quorum sensing were also up-regulated in the
mutant when grown in iron limiting LB medium and in presence of hydrogen
peroxide, while we could not see a derepression of quorum sensing regulated genes
in the mutant when exposed to PMNs. However, significant number of QS regulated
genes were down-regulated in the mutant when exposed to PMNs. The bacterium
could encounter extremely low concentrations of free iron during growth in iron
limiting LB medium. Iron restriction plays a central role in the stress response in P.
aeruginosa, which has thus evolved numerous iron-acquisition systems. These
include the release of siderophores, production of extracellular proteases, secretion
of cytotoxic exotoxin A, and, the capacity to utilize haem and haemoglobin from
exogenous sources (Ochsner et al., 2000a). The up-regulation of hasAp, hasR and
some pyochelin biosynthesis genes (pchA, pchC, pchF, pchG) could rescue the
mutant during growth under iron limitation. Interestingly, the pyochelin biosynthesis
cluster was down-regulated when the mutant was grown in the presence of PMNs,
while it is up-regulated during the growth in presence of hydrogen peroxide. These
results suggests that this sigma factor respond to the environmental conditions and
influences the gene regulation in various growth conditions. 
Summary
The ECF family of sigma factors constitutes a group of environmentally responsive
transcription factors of the RpoD (σ70) family (Lonetto et al., 1994; Missiakas and
Raina, 1998). These proteins are found in a diverse spectrum of bacteria and control
a very wide range of functions such as response to heat, osmotic and oxidative
stresses, virulence, motility, transport of metal ions and synthesis of alginate or
carotenoids (Missiakas and Raina, 1998). Multiple members of the ECF family can be
present in the same species. The ECF sigma factors PvdS from P. aeruginosa, PbrA
from P. fluorescens, PfrI and PupI from P. putida and FecI from E. coli K-12 are
involved in iron uptake and their production is negatively regulated by Fur (Visca et
al., 2002). Here, we investigated the putative sigma-70 factor which also responds to
the iron limiting growth condition. The GeneChip data revealed that the mutant is
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necessary for iron acquisition and quorum sensing in the mutant indicate that the
sigma-70 factor can modulate gene expression depending on the environmental
stimuli during the diverse growth conditions. The differentially regulated genes from
different metabolic categories are summarized in the following model (figure 3.19).
3.4.4. Transcriptional analysis of C47 gene involved in
quorum sensing 
During the screening of the transposon library for mutants defective in protease
secretion, a previous Ph. D. student (Wiehlmann, 2001) found the mutant D8A6
which is completely defective in protease secretion on casein agar plate (D8 is the
number of micro titer plate and A6 stands for the position of the mutant in this plate).
Latter, this mutant has been confirmed as attenuated in the quorum sensing assays
by luminescence production on TLC plate in Dr. Leo Eberl‘s lab.  
1 52 3 4 6145
Fig. 3.20. TLC analyses of N-butanoyl homoserine lactone (BHL) and N-hexanoyl-L-homoserine
lactones (HHL) produced by P. aeruginosa TB. Samples were chromatographed on C18 reversed-
phase thin-layer plates, developed with methanol/water (60:40, v/v) and spots were visualized by
overlaying the TLC plates with C. violaceum CV026. AHL profiles of P. aeruginosa TB wild type (Wt)
and selected mutants are shown (lanes 1-6). The positions of identified AHLs (BHL & HHL) are
marked.
Wt 19C2 D8A6 D8B6 D8B7 D9C10
HHL
BHL
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It has been observed that the D8A6 mutant was completely attenuated for the
production of both N-butanoyl homoserine lactone (BHL) and N-hexanoyl-L-
homoserine lactone (HHL) quorum sensing molecules (figure 3.20). While the other
mutants 19C2 and D8B6 showed production of HHL only and BHL was slightly
produced in both mutants. D9C10 mutant was also attenuated for the production of
BHL, while it produced very less amounts of HHL. These results indicated that these
mutants were attenuated in the quorum sensing at various regulatory levels. 
 
Then the genomic insertion in D8A6 mutant was identified by plasmid rescue. It
observed that the 800 bp sequence did not show homology with the other DNA
sequences on the available database. The other graduate student from our
laboratory is analyzing the hyper variable regions in different clinical and
environmental P. aeruginosa isolates. It observed that this sequence showed signals
on the Southern blot prepared from the P. aeruginosa strain C (CF isolate) and
SG17M (river isolate). He identified that the homologous sequence is present in the
mobile gene island inserted in C and SG17M strains. Then this gene was named as
C47 (C for strain C and 47 number ORF from the 105 Kb gene island).   
Since this C47 mutant was unable to produce both BHL and HHL quorum sensing
molecules, we were interested to uncover the regulatory function of this gene in the
quorum sensing cascade. For this, the P. aeruginosa PAO1 GeneChip approach has
been persued. 
3.4.4.1. Expression of C47 gene on Northern blot
ABC minimal medium was used for the detection of homoserine lactone molecules in
the quorum sensing assays. So we used the same medium to see the expression of
this unknown gene (C47) on the Northern blot. It was observed that we could not see
the visible signals for the wild type mRNA, while the signal for the mutant was
comparatively stronger on the Northern blot (figure 3.21). It suggests that the gene is
lowly expressed but essential since the mutant tries to produce more and more.
However, the mRNA produced is non-functional since it is truncated.   
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3.4.4.2. GeneChip analysis for C47 mutant
In order to determine the function of C47 gene in quorum sensing cascade, samples
of total RNA were extracted from two independent cultures (wild type and D8A6
mutant) grown aerobically in ABC minimal medium. RNA samples were processed
and hybridized to P. aeruginosa PAO1 GeneChips. Altogether, 4 GeneChips were
used, 2 per strain (wild type and mutant respectively). Then the data obtained was
sorted as described previously. The gene expression pattern of P. aeruginosa TB
wild type and C47 mutant was compared. By using this approach, 400 genes were
identified as being QS regulated. Table 3.19 shows genes that were differentially
regulated in the mutant C47 (D8A6) and were identified as being QS regulated. 
Of the 400 genes whose expression was identified as being QS regulated, 285 genes
were down-regulated, while 115 genes were up-regulated in the mutant strain (Table
3.19). The expression of 53 genes was decreased more than 15-fold, and 11 genes
exhibited decrease of more than 100-fold in the C47 mutant. In comparison, only 4
genes showed a increase in expression of more than 15-fold, and the expression of 9
genes was increased in between 5 to 15 fold in the mutant. In the meantime, Wagner
et al. (2003) and Schuster et al. (2003) have also performed experiments using P.
aeruginosa PAO1 microarrays for the identification of quorum sensing regulated
genes. So our data obtained from this mutant was compared with the data from
Wagner et al. (2003) and Schuster et al. (2003) even though different experimental
23 S rRNA
(2890 bp)
16 S rRNA
(1536 bp)
P. aeruginosa TB
Wild type C47 (D8A6)
Fig 3.21. Northern blot expression for C47 mutant grown
aerobically in the ABC minimal medium.
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conditions were used in all the three investigations. Both groups of investigators
(Wagner et al., 2003; Schuster et al., 2003) employed mutants deficient in AHL
production (defective in luxI and rhlI) and compared the transcriptional responses in
the mutant to those in the parental strain in the presence and absence of AHL.
Schuster et al. (2003) also compared the transcript levels in a strain lacking the AHL
receptors (deficient in lasR and rhlR), while Wagner et al. (2003) explored the
responses in the presence of a range of growth media and other environmental
conditions. Both groups reported that a striking number of genes were induced and
repressed by AHL-mediated signaling. Schuster et al. (2003) found 315 and 38 such
genes, respectively, and Wagner et al. (2003) found 394 and 222 such genes,
respectively. The quorum-sensing regulon thus comprises about 6 % of the P.
aeruginosa genome. Many of the genes that were previously identified as being
quorum sensing regulated were verified in the data obtained from these three
independent investigations (Table 3.19). Wagner et al. (2003) and Schuster et al.
(2003) were frequently agreed in the assignment of many genes or operons with
known or unknown functions which had not previously been identified as responsive
to AHL quorum sensing. We have included such genes in the following table (Table
3.19) and the other unknown genes were omitted due to the space limitations.
Table 3.19. Genes which are differentially regulated in C47 mutant and whose expression was
identified as being QS regulated by using microarrays. 
PAO No.a Protein nameb Fold
change
Wagner
et al.
Schuster
et al. 
Down-regulated (QS-promoted) genes in C47 
PA0026 hypothetical protein 2,79 +
PA0050 hypothetical protein 4,72 +
PA0059 osmotically inducible protein, osmC 5,57 +
PA0106 cytochrome c oxidase, subunit I, coxA 9,86 + +
PA0108 cytochrome c oxidase, subunit III, coIII 2,61 + +
PA0109a hypothetical protein 2,60 + +
PA0122 conserved hypothetical protein 17,90 + +
PA0143 nonspecific ribonucleoside hydrolase, nuh 4,88 +
PA0176 probable chemotaxis transducer 2,11 +
PA0179 probable two-component response regulator 2,94 + +
PA0263 secreted protein Hcp, hcpC 37,47 +
PA0355 protease PfpI, pfpI 4,96 +
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PAO No.a Protein nameb Fold
change
Wagner
et al.
Schuster
et al. 
PA0365 hypothetical protein 1,74 +
PA0399 cystathionine beta-synthase 3,81 +
PA0567 conserved hypothetical protein 10,54 +
PA0586 conserved hypothetical protein 3,54 +
PA0588 conserved hypothetical protein 6,24 +
PA0652 a transcriptional regulator, vfr 1,60
PA0852 a chitin-binding protein CbpD precursor, cbpD 10,62 + +
PA0855 a hypothetical protein 5,60 + +
PA0996 probable coenzyme A ligase, pqsA 158,15 +
PA0997 homologous to beta-keto-acyl-acyl-carrier protein
synthase, pqsB
76,12 + +
PA0998 homologous to beta-keto-acyl-acyl-carrier protein
synthase, pqsC
955,80 + +
PA0999 3-oxoacyl-(acyl-carrier-protein) synthase III, pqsD 99,20 + +
PA1000 quinolone signal response protein, pqsE 157,07 +
PA1001 a anthranilate synthase component I, phnA 73,04 +
PA1002 a anthranilate synthase component II, phnB 62,02 +
PA1003 a transcriptional regulator, mvfR 7,28 + +
PA1173 cytochrome c-type protein NapB precursor, napB 4,41 +
PA1174 periplasmic nitrate reductase protein, napA 2,98
PA1175 NapD protein of periplasmic nitrate reductase, napD 3,03 +
PA1176 ferredoxin protein, napF 9,14 +
PA1177 periplasmic nitrate reductase protein, napE 5,74 +
PA1216 hypothetical protein 4,54 +
PA1245 hypothetical protein 12,08 + +
PA1250 alkaline proteinase inhibitor, aprI 13,56 + +
PA1289 hypothetical protein 2,12 +
PA1317 cytochrome o ubiquinol oxidase subunit II, cyoA 2,07 +
PA1318 cytochrome o ubiquinol oxidase subunit I, cyoB 2,35 + +
PA1320 cytochrome o ubiquinol oxidase subunit IV, cyoD 3,00 +
PA1323 hypothetical protein 7,94 +
PA1324 hypothetical protein 8,71 +
PA1431 a regulatory protein, rsaL 622,83 + +
PA1432 a autoinducer synthesis protein, lasI 14,48 +
PA1656 hypothetical protein 15,42 +
PA1657 conserved hypothetical protein 53,69 + +
PA1658 conserved hypothetical protein 24,75 +
PA1659 hypothetical protein 11,51 +
PA1660 hypothetical protein 6,25 +
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PAO No.a Protein nameb Fold
change
Wagner
et al.
Schuster
et al. 
PA1662 probable ClpA/B-type protease 15,30 +
PA1663 probable transcriptional regulator 21,44 +
PA1664 hypothetical protein 27,51 +
PA1665 hypothetical protein 98,14 +
PA1666 hypothetical protein 10,11 +
PA1667 hypothetical protein 66,77 +
PA1668 hypothetical protein 5,32 +
PA1669 hypothetical protein 8,84 +
PA1670 serine/threonine phosphoprotein phosphatase, stp1 10,19 +
PA1745 hypothetical protein 4,13 +
PA1869 a probable acyl carrier protein 76,24 + +
PA1881 probable oxidoreductase 4,51 +
PA1894 a hypothetical protein 15,06 + +
PA1895 hypothetical protein 4,13 + +
PA1896 a hypothetical protein 9,75 + +
PA1897 a hypothetical protein 13,07 + +
PA4210 probable phenazine biosynthesis protein, phzA1 11,95 + +
PA4211 probable phenazine biosynthesis protein, phzB1 53,66 + +
PA1901 a phenazine biosynthesis protein, phzC2 46,30 + +
PA1903 phenazine biosynthesis protein, phzE2 7,46 + +
PA1904 probable phenazine biosynthesis protein, phzF2 18,93 + +
PA1905 probable pyridoxamine 5'-phosphate oxidase, phzG2 5,91 + +
PA1987 pyrroloquinoline quinone biosynthesis protein, pqq C 2,97
PA2030 hypothetical protein 3,05 + +
PA2031 hypothetical protein 3,63 +
PA2067 probable hydrolase 3,81 +
PA2068 probable MFS transporter 13,58 + +
PA2069 probable carbamoyl transferase 12,67 + +
PA2080 hypothetical protein 7,69 +
PA2193 a hydrogen cyanide synthase, hcnA 30,22 + +
PA2194 a hydrogen cyanide synthase, hcnB 14,98 + +
PA2195 a hydrogen cyanide synthase, hcnC 12,24 + +
PA2300 a chitinase, chiC 5,21 + +
PA2305 probable non-ribosomal peptide synthetase 10,09 + +
PA2306 conserved hypothetical protein 21,62 +
PA2331 hypothetical protein 3,37 + +
PA2365 conserved hypothetical protein 4,45 +
PA2366 conserved hypothetical protein 6,99 + +
PA2367 hypothetical protein 20,33 + +
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PAO No.a Protein nameb Fold
change
Wagner
et al.
Schuster
et al. 
PA2375 hypothetical protein 12,95
PA2423 hypothetical protein 7,02 + +
PA2587 a probable FAD-dependent monooxygenase, pqsH 20,83 + +
PA2588 probable transcriptional regulator 3,57 + +
PA2591 a probable transcriptional regulator 6,34 + +
PA2592 a probable periplasmic spermidine/putrescine-binding
protein
20,18 + +
PA2593 hypothetical protein 44,06 +
PA2747 hypothetical protein 7,08 +
PA2939 probable aminopeptidase 16,64 +
PA3022 hypothetical protein 1,84 +
PA3100 general secretion pathway protein H, xcpU 1,75 +
PA3101 general secretion pathway protein G, xcpT 1,60 +
PA3102 general secretion pathway protein F, xcpS 1,69 +
PA3103 general secretion pathway protein E, xcpR 2,93 +
PA3104 a secretion protein, xcpP 4,48 + +
PA3105 general secretion pathway protein D, xcpQ 3,80 +
PA3326 a probable Clp-family ATP-dependent protease 24,25 + +
PA3327 a probable non-ribosomal peptide synthetase 10,99 +
PA3328 a probable FAD-dependent monooxygenase 50,81 + +
PA3329 a hypothetical protein 131,53 + +
PA3330 a probable short chain dehydrogenase 67,69 + +
PA3331 a cytochrome P450 52,31 + +
PA3332 conserved hypothetical protein 45,54 + +
PA3333 a 3-oxoacyl-(acyl-carrier-protein) synthase III, fabH2 24,53 + +
PA3334 probable acyl carrier protein 91,28 + +
PA3335 hypothetical protein 33,27 + +
PA3336 a probable MFS transporter 11,63 +
PA3346 probable two-component response regulator 4,32 +
PA3347 hypothetical protein 2,97 +
PA3369 hypothetical protein 3,91 +
PA3370 hypothetical protein 2,86 +
PA3418 leucine dehydrogenase, ldh 5,40 + +
PA3476 a autoinducer synthesis protein, rhlI 10,76 +
PA3477 a transcriptional regulator, rhlR 13,17 + +
PA3478 a rhamnosyltransferase chain, rhlB 6,61 + +
PA3479 a rhamnosyltransferase chain, rhlA 18,14 + +
PA3520 hypothetical protein 4,56 + +
PA3535 probable serine protease 9,97 +
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PAO No.a Protein nameb Fold
change
Wagner
et al.
Schuster
et al. 
PA3622 sigma factor, rpoS 3,20 +
PA3691 hypothetical protein 9,88 +
PA3692 probable outer membrane protein precursor 7,32 +
PA3724 a elastase, lasB 22,67 + +
PA3904 hypothetical protein 48,53 + +
PA3906 hypothetical protein 107,11 + +
PA3907 a hypothetical protein 26,56 +
PA3908 hypothetical protein 142,63 + +
PA3904 hypothetical protein 48,53 +
PA3923 hypothetical protein 3,10 +
PA4117 probable bacteriophytochrome 2,19 +
PA4129 hypothetical protein 17,58 + +
PA4130 probable sulfite or nitrite reductase 22,93 + +
PA4131 probable iron-sulfur protein 141,31 + +
PA4132 conserved hypothetical protein 9,02 + +
PA4133 cytochrome c oxidase subunit (cbb3-type) 39,24 + +
PA4134 hypothetical protein 22,42 + +
PA4139 hypothetical protein 126,01 +
PA4141 hypothetical protein 66,46 + +
PA4142 probable secretion protein 16,59 + +
PA4143 probable toxin transporter 6,31 +
PA4144 probable outer membrane protein precursor 8,24 +
PA4175 Pvds-regulated endoprotease, lysyl class, prpL 4,87 + +
PA4209 probable phenazine-specific methyltransferase, phzM 35,90 + +
PA4217 a flavin-containing monooxygenase, phzS 9,61 + +
PA4296 probable two-component response regulator 3,37 + +
PA4311 conserved hypothetical protein 2,24 +
PA4496 probable binding protein component of ABC transporter 5,37 +
PA4590 protein activator, pra 4,27 +
PA4677 hypothetical protein 15,52 + +
PA4738 conserved hypothetical protein 13,70 +
PA4739 conserved hypothetical protein 19,45 +
PA4778 probable transcriptional regulator 5,48 +
PA4869 a hypothetical protein 4,52 +
PA4876 osmotically inducible lipoprotein, osmE 5,09 +
PA4880 probable bacterioferritin 6,69 +
PA5058 poly(3-hydroxyalkanoic acid) synthase 2, phaC2 2,45 +
PA5220 a hypothetical protein 11,36 + +
PA5356 a transcriptional regulator, glcC 2,12 + +
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PAO No.a Protein nameb Fold
change
Wagner
et al.
Schuster
et al. 
PA5481 hypothetical protein 25,58 +
PA5482 hypothetical protein 17,19 +
Up-regulated (QS-repressed) genes in C47 mutant 
PA0165 hypothetical protein 3,01 +
PA0413a still frameshift probable component of chemotactic signal
transduction system
2,01 +
PA0510a probable uroporphyrin-III c-methyltransferase 9,68 +
PA0511a heme d1 biosynthesis protein, nirJ 3,95 +
PA0512a conserved hypothetical protein 14,68 +
PA0513a probable transcriptional regulator 4,18 +
PA0515a probable transcriptional regulator 17,06 +
PA0516a heme d1 biosynthesis protein, nirF 15,00 +
PA0517a probable c-type cytochrome precursor, nirC 7,07 +
PA0518a cytochrome c-551 precursor, nirM 4,92 +
PA0519 nitrite reductase precursor, nirS 2,66
PA0527 transcriptional regulator, dnr 2,74
PA1458a probable two-component sensor 1,41 +
PA2540 conserved hypothetical protein 1,75 +
PA4587 cytochrome c551 peroxidase precursor, ccpR 5,48 +
PA4770 L-lactate permease, lldP 3,84 +
a: Genes previously identified as being QS regulated (de Kievit et al., 1999; Gambello et al., 1993;
Pearson et al., 1997; Pesci et al., 1997; Pessi and Haas, 2000; Toder et al., 1991; Toder et al., 1994;
Whitely et al., 1999). 
b: Gene names are indicated in italics.
3.4.4.3. Correlation of GeneChip data to previously QS-regulated
genes
P. aeruginosa is a highly adaptable bacterium that can colonize various
environmental niches, including soil and marine habitats, plants, animals, and
humans (de Kievit and Iglewski, 2000). P. aeruginosa possesses one of the best-
studied models of QS, and two complete lux-like QS systems, las and rhl, have been
identified (Pesci et al., 1997). The las system consists of the transcriptional regulatory
protein LasR and its cognate signaling molecule, N-(3-oxododecanoyl) homoserine
lactone (3O-C12-HSL), whose production is directed by the autoinducer synthase
encoded by lasI. The rhl system consists of the RhlR protein and an autoinducer
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synthase (RhlI), which is involved in production of the cognate autoinducer N-butyryl
homoserine lactone (C4-HSL). These systems are intertwined in a hierarchical
manner, and the las system controls the rhl system at both the transcriptional and
post-translational levels. QS has been shown to regulate the production of P.
aeruginosa virulence factors (such as proteases, exotoxin A, rhamnolipids, and
pyocyanin) and to be involved in biofilm formation and development, and it has been
implicated in antibiotic resistance (Davies et al., 1998).
Of 52 previously reported QS-regulated genes, 49 were confirmed by using
microarrays (Table 3.19). These 49 genes are PA0109, PA0413, PA0511 (nirJ),
PA0512, PA0513, PA0515, PA0516 (nirF), PA0517 (nirC), PA0518 (nirM), PA0652
(vfr), PA0855 (cbpD), PA0855, PA1001 (phnA), PA1002 (phnB), PA1003 (mvfR),
PA1431 (rsaL), PA1432 (lasI), PA1458, PA1869, PA1894, PA1896, PA1897, PA1901
(phzC2), PA2193 (hcnA), PA2194 (hcnB), PA2195 (hcnC), PA2300 (chiC), PA2587
(pqsH), PA2591, PA2592, PA3104 (xcpP), PA3326, PA3327, PA3328, PA3329,
PA3330, PA3331, PA3333 (fabH2), PA3336, PA3476 (rhlI), PA3477 (rhlK), PA3478
(rhlB), PA3479 (rhlA), PA3724 (lasB), PA3907, PA4217 (phzS), PA4869, PA5220,
PA5356 (glcC) (Wagner et al., 2003; de Kievit et al., 1999; Gambello et al., 1993;
Pearson et al., 1997; Pesci et al., 1997; Pessi and Haas, 2000; Toder et al., 1991;
Toder et al., 1994; Whitely et al., 1999). However, 37 and 43 known genes were
confirmed by Wagner et al. and Schuster et al. respectively in the experiments
performed for AHL-mediated quorum sensing (Wagner et al., 2003; Schuster et al.,
2003). We found that PA3622 (rpoS) is QS promoted (3.20-fold change) which
agreed with several previous reports (Latifi et al., 1996; van Delden et al., 2001) but
differed from one study in which it was concluded that rpoS was not QS-regulated
(Whiteley et al., 2000). Wagner et al. (2003) also detected that rpoS was QS-
promoted (2.7 fold change) during the AHL-mediated quorum sensing experiments.
They have also recently identified that PA0179 and PA3904 are being QS-promoted
by using a fluorescence-activated cell sorting approach (Wagner et al., 2003). We
also confirmed the up-regulation of these two genes. We also confirmed the QS-
repression of 10 known genes (Table 3.19) but Wagner et al. (2003) and Schuster et
al. (2003) could detect only 3 genes (PA308, PA3234, PA3235) as being QS-
repressed. However, we could not see these genes as being QS-repressed during
our experiments. We also included the genes those are identified by Wagner et al.
Results and discussion
155
(2003) and Schuster et al. (2003) in the above table (Table 3.19). Our data showed
that there is 43 % and 69 % agreement regarding the QS inducible genes, while there
is 10 % and 2 % concordance regarding the genes listed as being QS repressible
that are identified by Wagner et al. (2003) and Schuster et al. (2003) respectively.
This microarray experiment showed that the quorum-sensing regulon comprises
about 6 % of the genome. In the present study with P. aeruginosa TB, the largest
percentage of QS-regulated transcripts (50 %) encoded proteins having hypothetical,
unclassified and unknown function. Microbial pathogenesis has been intimately
linked to QS regulatory circuits, and several P. aeruginosa virulence factors are
known to be quorum sensing regulated (de kievit and Iglewski, 2000). More than 50
probable or known virulence genes such as those that may be involved in tissue
destruction (PA4142-PA4144), were identified as being QS regulated. Expression of
the transcripts of several well characterized genes involved in the denitrification
system (PA510-PA0519 and PA0527) were repressed by quorum sensing. It
suggests that QS has impact on the anaerobic growth of P. aeruginosa.    
It is already known that the two QS systems (lasI-lasR and rhlI-rhlR) are regulated in
a hierarchical manner in P. aeruginosa responsible for regulating the expression of
many virulence determinants, secondary metabolites, stationary phase genes and
genes involved in biofilm formation (Withers et al., 2001). In P. aeruginosa, there is
an interesting co-ordination of the two QS systems (figure 3.22), the LasR protein
regulating expression of the rhlR and the rhlI genes (Latifi et al., 1995). The lasR
gene itself is positively controlled by the gacA two-component response regulator, a
common regulator of virulence in P. aeruginosa (Reimmann et al., 1997) and also by
a CRP homologue called vfr (Albus et al., 1997). The environmental conditions to
which these regulators respond and their influence are not yet fully understood. The
lasI, lasR, rhlI, rhlR, rsaL, gacA and vfr are the major hierarchical regulators in
Pseudomonas aeruginosa quorum sensing system. The GeneChip experiment
revealed that all these major regulators except lasR and gacA were significantly
down-regulated in the C47 mutant. Then we checked the absolute signal intensities
for lasR and gacA and found that they were not changed in mutant as compared to
the wild type P. aeruginosa TB (data not shown). From this microarray data, it
observed that nearly all the known genes including major regulators, involved in
quorum sensing were differentially regulated by the C47 mutant. However, lasR and
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gacA were not up- or down-regulated in the mutant strain. If we believe that the
quorum sensing system in P. aeruginosa TB is regulated by the same hierarchical
manner like PAO1 strain. Then we should not find differentially regulated genes in
the mutant since lasR, the major regulator for both quorum sensing systems is not
affected. So the plausible hypothesis is that the gene regulation for quorum sensing
hierarchy is different in P. aeruginosa TB unlike to the well studied quorum sensing
system in PAO1 strain. We would like to say that the gene product from C47 makes
lasR boxes accessible due to the DNA-protein interactions for the expression of
quorum sensing dependent regulated genes in P. aeruginosa TB. So we would
conclude that this gene product is necessary for the functioning of quorum sensing
hierarchy and the whole quorum sensing dependent gene expression cascade. The
large number of quorum sensing regulated genes that encode known or probable
virulence genes identified in the present investigation further emphasizes the role of
QS in P. aeruginosa pathogenesis.  
Fig. 3.22. Schematic diagram showing the proposed hierarchical position of C47 gene in the las-rhl
quorum sensing system in P. aeruginosa TB. 
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3.5. Examination of P. aeruginosa pathogenicity in
murine infection model
We used a murine lung infection model for the examination of STM knockout mutants
which were obtained during the screening for intracellular survival in PMNs and
quorum sensing. The subset of mutants was examined in the murine infection lung
model which is already established in Dr. Hoiby’s Laboratory at the Copenhegan
University. This model has been used in their laboratory for more than 10 years for
different purposes (Johansen et al., 1993; Johansen et al., 1995; Song et al., 1997).
Since Dr. Hoiby is a member of European Graduate Program ‘Pseudomonas:
Pathogenicity and Biotechnology‘, we had the opportunity to exploit this model during
our studies. 
Since each P. aeruginosa strain differs in its degree of virulence, we optimized the
following different parameters to test the pathogenicity of P. aeruginosa TB mutants. 
3.5.1. Optimization of challenge procedure  
P. aeruginosa must be entrapped into immobilizing agents such as agar, agarose or
seaweed alginate to limit bacterial clearance in order to achieve a chronic infection.
However, other challenge procedure has been established in Dr. Hoiby’s Laboratory
where they have used free bacteria without entrapment in alginate. For this, the free
bacterial cells of P. aeruginosa clinical isolate which is alginate hyper-producer, were
used to infect the mice (Dr. Hoiby, unpublished data). Therefore we used both
methods to establish the chronic infection with our CF isolate P. aeruginosa TB.
In order to optimize the challenge procedure and inoculum size, the 11-12 week old
C3H/HeN mice were intratracheally challenged with various doses of free as well as
alginate embedded P. aeruginosa TB cells directly in the left lung. After challenge,
mortality was monitored for 7 days. All the mice challenged with 107-109 cfu of
alginate embedded bacteria and with 108 cfu of free bacteria died within 2-3 days
(figure 3.23). Seven and two mice were alive up to 7 days when challenged with free
bacterial suspension of 106 cfu and 107 cfu respectively. But we could not observe P.
aeruginosa TB cells in the lung homogenate on the seventh day from these mice.
These results indicated that the free bacteria were cleared by the mice in less than 7
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days. In case of alginate embedded P. aeruginosa cells, eight and two mice were
alive up to 7 days when challenged with 105 cfu and 106 cfu respectively. We could
able to detect 1-10 bacteria per mice on the seventh day when they were infected
only with 106 cfu of alginate embedded P. aeruginosa TB. This data suggested that
the optimum dose could be 106 cfu or less of the alginate embedded bacterial cells
with lesser days of incubation period. Since we were interested to test the gain of
function mutants (more virulent than TB wild type from PMN assay) in addition to loss
of function mutants, we decided to use 8 x 105 cfu/mice as a inoculum size in the
further experiments.
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ig. 3.23. Kinetics of killing of 11-12 week old C3H/HeN mice (n=7 or 8) infected intratracheally with
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PAO1 gene (25A12 mutant) to test their virulence in the mouse infection model. All
further experiments were performed with 8 x 105 cfu/mice and they were sacrified on
day 3 and 4 and the following parameters were evaluated.
3.5.2. Leukocyte subpopulation from blood
The mice were challenged with 0.04 ml of 8 x 105 cfu of alginate embedded mutants
and wild type and leukocyte subpopulation was determined from blood on day 3 and
4. We examined the less virulent mutants (flhA, fliK-flagella biogenesis; C47- quorum
sensing; 25A12- non-PAO1 gene) as well as more virulent mutants (pilQ, pilY1- type
IV pili biogenesis) from the PMN phagocytosis assay. On day 3, there were
significantly less number of white blood cells (WBCs) when the mice were challenged
with flhA and C47 mutant as compared to the mice challenged with P. aeruginosa TB
wild type (figure 3.24). The differences were not significant for fliK mutant on day 3
and pilY1 and flhA mutants on day 4. There were less number of WBCs observed on
day 4 when the mice were challenged with pilQ mutant. However, significantly more
number of WBCs were found in the blood when the mice were infected with 25A12
mutant. 
Day 3 Day 4
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Fig. 3.24. The concentration of WBCs in the peripheral blood from C3H/HeN mice on day 3 and 4
after intratracheal installation of 8 x 105 cfu of alginate embedded P. aeruginosa TB wild type and
mutants.
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Fig. 3.25. The concentration of PMNs in the peripheral blood from C3H/HeN mice on day 3 and 4 after
intratracheal installation of 8 x 105 cfu of alginate embedded P. aeruginosa TB wild type and mutants.
The PMNs are normally the first phagocytes to appear in high numbers at the site of
bacterial infections. In the present study, the early involvement of the PMNs in the
antibacterial defense was indicated by the increased number of PMNs in the
peripheral blood. Similar patterns were observed for PMNs from the peripheral blood
with exceptions of high number of PMNs for flik on day 3 and for pilY1 on day 4
(figure 3.25). The high number of WBCs and PMNs in the blood is due to the
inflammatory response exerted by the mice against P. aeruginosa lung infection. The
difference for WBCs and PMNs in the peripheral blood was not significant on day 4
when the mice were challenged with flhA mutant. This finding could be attributed due
to the faster elimination of the flhA mutant as compared to the P. aeruginosa TB wild
type. These results suggests that there was not severe lung inflammation observed
when the mice were challenged with flhA and C47 mutants indicating that these
mutants were unable to persist for longer time in the murine lungs. In contrast, there
could be severe lung inflammation when the mice were challenged with 25A12 and
pilY1 mutants suggesting for the longer persistence in the mice lung as compared to
the TB wild type. From above results it was observed that flhA and C47 mutants are
less virulent and pilY1 and 25A12 mutants are more virulent than the TB wild type in
a murine infection model.
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3.5.3. Leukocyte subpopulation from BAL-fluid
Day 3 Day 4Fig. 3.26. The concentration of WBCs in the BAL-fluid from C3H/HeN mice on day 3 and 4 after
intratracheal installation of 8 x 105 cfu of alginate embedded P. aeruginosa TB wild type and mutants.
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3.27. The concentration of PMNs in the BAL-fluid from C3H/HeN mice on day 3 and 4 after
intratracheal installation of 8 x 105 cfu of alginate embedded P. aeruginosa TB wild type and mutants.
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On day 3 and 4, we found less WBCs in the BAL-fluid when the mice were
challenged with loss of virulence mutants: flik, flhA and C47 as compared to the P.
aeruginosa TB wild type (figure 3.26), however, there were more WBCs found in the
BAL-fluid when the mice were infected with pilY1 and 25A12 mutants. As an estimate
of the intrapulmonary content of PMNs, the number of PMNs in the BAL-fluid were
measured. We found that there were less PMNs in the BAL-fluid when the mice were
challenged with the quorum sensing knockout mutant C47, but more PMNs were
observed when mice challenged with 25A12 and pilY1 mutants (figure 3.27). The
PMNs from BAL-fluid were not significantly different on day 3 and day 4 (figure 3.27)
when the mice were challenged with fliK, flhA and pilQ mutants. These results
support the findings that C47 mutant is less virulent and unable to persist for longer
period, but 25A12 and pilY1 mutants are more virulent and persist for longer time in
the mice lungs than the TB wild type. 
3.5.4. Respiratory burst from BAL-fluid
Day 3 Day 4162
Fig. 3.28. The number of PMNs with spontaneous respiratory burst recovered in the BAL-fluid from
C3H/HeN mice on day 3 and day 4 after intratracheal installation of 8 x 105 cfu of alginate embedded
P. aeruginosa TB wild type and mutants. 
In the BAL-fluid, the number of PMNs with a spontaneous respiratory burst were
increased to 3 and 5 fold on day 4 when the mice were infected with pilY1 and 25A12
mutants as compared to the P. aeruginosa TB wild type (figure 3.28). However, there
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were not significantly different number of PMNs with a spontaneous respiratory burst
for flik, flhA, C47, pilQ mutants as compared to the TB wild type. The more number of
PMNs with spontaneous burst is the sign of bacterial infection in the lung. PMNs are
known to produce oxidative radicals for microbial killing by spontaneous respiratory
burst in the lungs. So above results emphasizes that there could be more number of
bacterial cells for pilY1 and 25A12 mutant persisting for the longer infection as
compared to the TB wild type. The small differences for the other mutants may not be
observed because we had sacrified mice on day 3 and day 4. It would be necessary
to sacrify the mice on day 1 and day 2 to observe the differences in the spontaneous
respiratory burst rate with the less virulent mutants. 
3.5.5. Other Parameters
We also measured the other parameters such as lung bacteriology and pro-
inflammatory response in terms of various cytokines. There were very less number of
bacteria (average 10-100 cfu/lung) recovered from the lung homogenate so we could
not see significantly different number of bacteria when the mice were infected with
mutants and P. aeruginosa TB wild type (data not shown). At the same time we also
measured cytokines such as GM-CSF, KC, IL-12, MIP-2, TNF-α, and IFN- γ from the
lung homogenate on day 3 and 4 (Table 3.20 and 3.21). The cytokines are mediators
of pro-inflammatory response and increased levels of these cytokines provide an
explanation for the faster clearance of the bacteria in the lungs of the C3H/HeN mice.
However, the cytokine levels were not significantly changed when the mice were
challenged with P. aeruginosa TB wild type and mutants. In conclusion, we could not
found the correlation between the cytokine concentration from the mice lung and
bacterial virulence on day 3 and 4. 
 
Table 3.20. The concentration of cytokines in the lungs from C3H/HeN mice on day 3 after
intratracheal installation of 8 x 105 cfu of alginate embedded P. aeruginosa TB wild type and mutants. 
Bacterial
strain/mutant 
GM-CSF IL-12 TNF-α KC MIP-2 IFN-γ
flik 749 1279 1042 649 821 1175
flhA 735 1418 910 690 739 1037
C47 538 1532 1024 585 840 1097
TB wild type 483 1697 892 610 830 1125
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Table 3.21. The concentration of cytokines in the lungs from C3H/HeN mice on day 4 after
intratracheal installation of 8 x 105 cfu of alginate embedded P. aeruginosa TB wild type and mutants. 
Bacterial
strain/mutant 
GM-CSF IL-12 TNF-α KC MIP-2 IFN-γ
pilQ 440 1250 1022 495 736 1097
25A12 460 1369 1070 560 755 1085
wspE 382 1121 947 610 681 1145
flhA 415 1256 976 490 735 1035
TB wild type 373 1146 895 520 787 1117
3.5.6. Conclusions from murine infection experiments
Above results indicated that the loss of function mutants flhA and C47 were found to
be less virulent in the murine lung infection model as compared to the TB wild type.
This suggest that flhA gene is necessary for the P. aeruginosa TB virulence in the ex
vivo PMN assay as well as in the murine lung infection model. It has been reported
that QS is involved in the pathogenesis of P. aeruginosa during lung, corneal and
burn wound infections (Tang et al., 1996; Wu et al., 2001; Rumbaugh et al., 1999).
This C47 mutant is attenuated for nearly all the known lasI-lasR and rhlI-rhlR
regulated genes (see table 3.19). So it was worthwhile to test the pathogenicity of
this mutant in the murine lung infection model. Our finding confirms the results that
quorum sensing regulated gene products are essential for P. aeruginosa virulence in
the mouse infection model. The gain of function mutant pilY1 from PMN assay was
also found to be more virulent in this mouse infection model. These results for flhA,
C47 and pilY1 mutants are consistent with the results obtained from ex vivo PMN
phagocytosis assay. All the parameters from above studies show that the 25A12
mutant is even more virulent than the P. aeruginosa TB wild type and gain of function
mutant pilY1. This mutant is strongly attenuated for intracellular survival in PMN
assay. This discrepancy in the results from two different model systems could not be
explained since both models can use primarily the same mechanisms for microbial
killing. But these results of mouse infection model correlates with the microarray data
obtained for this mutant under various growth conditions. Lots of genes involved in
quorum sensing and QS dependent virulent factors and type III secretion system
were up-regulated in the mutant when grown in presence of hydrogen peroxide and
PMNs (see 3.4.2). The microarray data and mouse infection results indicated that the
mutation in non-PAO1 gene changes the phenotype to the more virulent strain than
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the TB wild type. The pathogenicity of non-PAO1 mutant 25A12 has been examined
in the Caenorhabditis elegans model in co-operation with Dr. Ivo Steinmetz in the
Institute of microbiology at the Medizinische Hochschule Hannover. P. aeruginosa TB
wild type killed 45 % worms, while 98 %  and 60 % of worms were killed by 25A12
and 45A7 mutant in the first 3 h incubation period (data not shown). From these
results, it could observed that 25A12 achieved nematode killing maxima within 3 h
incubation period, while TB wild type took more than 5 hours. This indicated that
25A12 mutant is about two times virulent than the TB wild type in the nematode
worm killing model. The transcriptome data from 25A12 mutant revealed that the type
III secretion and quorum sensing dependent virulence factors were up-regulated in
the 25A12 mutant. This GeneChip experiment uncovered that the 25A12 mutant is
more virulent as compared to the P. aeruginosa TB wild type. The results from the
mouse infection experiments supports the transcriptome finding that the 25A12
mutant alters its phenotype to the more virulent.  
We could not see the same co-relation of PMN phagocytosis assay with a murine
infection model for fliK and pilQ mutants. This could be due to the fact that the subtle
changes in a murine infection model are difficult to notice. The PMN phagocytosis
assay is more sensitive and the signals were enriched several times, so it was
possible to find out the small differences in this assay as compared to the mouse
infection model. 
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4. Conclusions and perspectives
The aim of this study was to identify genes that enable the opportunistic pathogen P.
aeruginosa TB to survive intracellularly. For this, the work presented in this thesis
followed the screening of the STM library for intracellular survival and quorum
sensing, transcriptional analysis of P. aeruginosa TB and knockout mutants and
examination of the virulence attenuated mutants in a murine lung infection model.  
4.1. Screening of STM library for intracellular survival in
PMNs
A previous Ph. D. student had constructed the STM library of P. aeruginosa TB and
he screened 960 transposon mutants for intracellular survival in PMNs during his Ph.
D. studies (Wiehlmann, 2001). The rest of the library consisting of 1344 mutants was
screened during this study. In each assay, 4-5 mutants were found to be attenuated
for virulence, then these mutants were retested in several phagocytosis assays in
different combinations of mutants to make sure that the mutant is attenuated
independent of others. In this way, total 44 mutants were found which significantly
differed in the survival rate in comparison to wild type P. aeruginosa TB. Out of these
44 mutants, 34 were impaired (loss of function) for intracellular survival in PMNs,
while 9 mutants even survived better (gain of function) as compared to the P.
aeruginosa TB wild type. This was the most unexpected finding of gain of function
mutants during the PMN phagocytosis assays. These mutants were subjected to
plasmid rescue to find out the genomic insertions. This was a rather difficult task to
get the transformants from these mutants after genomic DNA restriction digestion
and ligation. But this problem was solved by using highly competent cells (107
transformants/ng DNA). The identified genes were divided into different categories
based on the known or predicted function. The results indicated that most of the
genes identified during the second screening belong to the same metabolic
categories obtained from the first screening. This proves the applicability of the STM
procedure for the identification of habitat specific genes. The major identified
metabolic categories belong to the oxidative stress response, flagella and type IV pili
biogenesis and hypotheticals with unknown function. During this screening, two clone
specific or strain specific genes were identified in addition to the previous clone or
strain specific gene. Complementation of most of the genes is required to rule out the
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possibility of the effect of neighbouring genes. It has been found that many genes
control the complex phenotype of intracellular survival in PMNs and almost all genes
that are needed by the bacterium are present in the sequenced PAO1 core genome,
only very few are strain-or clone-specific. This indicates that subtle shifts in the
genetic repertoire are sufficient to cause a smooth transition from extracellular
lifestyle to intracellular survival and growth in the major antipseudomonal host
defense cell. Unexpectedly, quite a few mutants gained better survival rates due to
transposon insertion. Some of the genes knocked out in these mutants are also the
targets that are modulated in wild type bacteria during the adaptation to the CF lung
habitat (Govan and Deretic, 1996; Tümmler and Kiewitz, 1999).
The genes involved in oxidative stress response and flagella biogenesis were further
characterized. It has been observed that some of the unknown genes (betB, napA,
PA0880, PA1288, PA4621, PA5349) and known genes (recQ, katB) for oxidative
stress response were also identified on hydrogen peroxide agar assay and found
necessary for intracellular survival of P. aeruginosa TB in PMNs. Further biochemical
and genetic characterization of these mutants is required to know their exact
mechanism during the intracellular survival in PMNs. Three mutants carrying defects
in flagella biogenesis were identified during the STM screening. The cellular
morphotypes and structure of flagellum were characterized by electron microscopy.
The flhA mutant was found to be non-flagellated, the fliK mutants showed elongated
flagella, while the fliI mutant was having multiple flagellas. The flagellin monomers of
the fliK mutant were assembled to a flagellar structure with a hook- like relief that
exposes more epitopes on its surface than the wild- type flagella. The cytotoxic assay
showed that the fliK and flhA mutants were less cytotoxic than the TB wild type. All
the three identified flagella genes are located in the center of flagellar export
apparatus. It has been reported that the flagellar export apparatus is not only
involved in the transport of flagellin molecules, but it can also transport virulence
factors in the extracellular environment (Young et al., 1999). Further research on the
identification and characterization of flagellar apparatus dependent export of
virulence factors in TB is required.   
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4.2. Screening of STM library for quorum sensing 
A simple and rapid method of the degradation of casein was used to screen the STM
mutants for defect in quorum sensing. Quorum sensing is involved in the secretion of
virulence factors in the form of extracellular proteases. After screening the 2304 STM
mutants, 21 mutants were attenuated for extracellular protease secretion. Most of
these mutants were further confirmed for defect in quorum sensing by the AHL-
dependent quorum sensing assay. Unfortunately, plasmid rescue for 7 mutants failed
even after successive efforts to find out the genomic disruptions. After sequencing
the disrupted genes from 14 mutants, known quorum sensing dependent gene (rhlR,
gcdH) were identified and others are with unknown function. It will be the next task
for the characterization of their role in quorum sensing cascade. The results indicated
that the screening of mutants for protease secretion is an easy and rapid method for
the identification of quorum sensing dependent genes.   
4.3. Transcriptional analysis of P. aeruginosa TB
The genome-wide transcription profile against the superoxide stress generating
agent paraquat and oxidative stress generating agent hydrogen peroxide was
measured in the P. aeruginosa reference strain PAO1 and the cystic fibrosis isolates
TB and 892 by using the PAO1 GeneChips. One operon encoding four proteins of
previously unknown function (PA0939-PA0942) was 20-200 fold up-regulated in all
three analyzed strains in presence of paraquat. This operon that exhibits the
strongest up-regulation and the constitutively highly expressed manganese-
dependent superoxide dismutase sodB, the catalase katA and the alkyl
hydroperoxide reductase ahpC seem to confer most resistance to paraquat-induced
stress in P. aeruginosa. The next task is the characterization of this operon
(PA0939-PA0942) to uncover how paraquat mediated superoxide stress is handled
by this operon in addition to the other known genes. Upon exposure to hydrogen
peroxide, 23.5, 17.5, 15 % of ORFs were significantly differentially regulated in P.
aeruginosa TB, 892 and PAO1 respectively. The total number of genes expressed in
the chosen condition were about 75 % from all the three strains indicating that most
of the genes were essential to combat the oxidative stress. The up-regulated genes
belong to aerobic energy generation, amino acid metabolism, polyamine transport,
iron-sulfur metabolism, cell rescue/defense and translation machinery. The down-
regulated genes belong to the microaerophilic and anaerobic growth, quorum
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sensing and flagella biogenesis and chemotaxis. The transcriptome data indicated
that more number of genes were significantly modulated against the hydrogen
peroxide mediated oxidative stress response in TB as compared to the 892 and
PAO1 strains.    
The STM screening identified 3 mutants that harbor insertions in non-PAO1 genes
and 2 mutants carrying the transposon in regulatory genes. The sequence from
25A12 mutant was found completely unknown, while the sequence from 45A7 mutant
showed slight homologies with proteins of unknown function. The 25A12 and 45A10
non-PAO1 mutants and 23B9 mutant having insertion in sigma-70 factor was
considered for GeneChip analysis. It was observed that both non-PAO1 ORFs were
expressed in all the tested standard and stress conditions. While the sigma factor
was expressed only in iron limiting condition and in presence of hydrogen peroxide
and PMNs. The transcriptome data from both non-PAO1 mutants revealed that there
were subtle changes in the normal metabolism during standard growth condition.
Only 25A12 mutant showed slight down-regulation in the arginine utilization as
energy source. This indicated that the mutation in the non-PAO1 genes does not
interfere with the P. aeruginosa PAO1 defined core genome under standard growth
conditions. These two non-PAO1 ORFs expressed constitutively and could be
regulated their own without affecting the core metabolism of P. aeruginosa TB. It was
identified that the mutation in the non-PAO1 genes has impact on the denitrification
under hydrogen peroxide and PMNs stimulated growth conditions. This reflects that
the genes involved in energy generation during anaerobic condition are necessary for
the intracellular survival and growth of P. aeruginosa TB. The up-regulation of type III
secretion and quorum sensing systems showed that both mutants are more virulent
than the TB wild type. However, these mutants are impaired for the intracellular
survival and growth in PMNs. This suggested that the transposon insertion in the
strain specific DNA destabilizes the expression of virulence factors but it is necessary
for the intracellular life style of the bacterium P. aeruginosa TB. It was identified that
these two non-PAO1 ORFs have less G+C content (60 %) as compared to the
average G+C content (67 %) of P. aeruginosa. This suggests that they could be a
part of extrachromosomal genetic elements and acquired through the horizontal gene
transfer. It will be interesting to characterize these unknown gene products and their
role for the virulence gene regulation under the stress conditions. The GeneChip data
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from sigma-70 factor showed the down-regulation of the genes involved in aerobic or
anaerobic growth, quorum sensing, type III secretion system, iron homeostasis and
antimicrobial peptide resistance besides the up-regulation of genes involved in
quorum sensing and iron homeostasis as a rescue mechanism. The GeneChip data
revealed that the mutant is hampered for energy generation via aerobic and
anaerobic processes and can be transformed to dormant metabolic stage which is
responsible for the bacterial death. The interesting results obtained was that some of
the quorum sensing dependent genes were down-regulated as well as some were
up-regulated in the mutant. Further work in this direction is necessary to know the
exact function of this sigma factor and its role in quorum sensing cascade under
various environmental conditions.  
The GeneChip experiment from the D8A6 mutant revealed that nearly all the known
quorum sensing dependent genes except lasR and gacA were differentially
regulated. The transcriptome data revealed that the gene regulation for quorum
sensing hierarchy is different in P. aeruginosa TB as compared to the well studied
quorum sensing cascade. Most of the genes were also identified as being quorum
sensing dependent regulated in the microarray experiments by Wagner et al. (2003)
and Schuster et al. (2003). This mutant has been identified during the screening for
defect in protease secretion. The transcriptome data suggest that this gene can get
top hierarchical position in the quorum sensing network. It would be interesting to do
further experiments as how this non-PAO1 gene regulates both quorum sensing
systems and its abundance in other P. aeruginosa strains.
4.4. Examination of P. aeruginosa pathogenicity in murine
lung infection model 
The subset of STM knockout mutants were examined for their pathogenicity in a
murine lung infection model. The mouse infection experiments indicated that some
mutants such as flhA and C47 were also less virulent, while pilY1 and 25A12 were
more virulent than the TB wild type. There was good correlation observed in case of
flhA and pilY1 mutants from the ex vivo PMN phagocytosis assay with the results
from murine lung infection model. The C47 mutant has not been tested in the PMN
assays. But there is lot of literature available on quorum sensing and P. aeruginosa
pathogenesis (Ritchie et al., 2003; Lesprit et al., 2003; Smith and Iglewski, 2003 and
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references cited therein). The monitored parameters during mouse infection
experiments for other mutants were not significantly different than TB wild type
indicating that there could be small difference in the virulence of those mutants and
TB which is difficult to observe in the mouse model. There was large variation in the
experiments suggesting that these mutants should be retested in this murine lung
model. The results from C. elegans showed that 25A12 mutant killed twice the
number of nematodes killed by TB, while 45A7 killed 10 % more than the TB wild
type (data not shown). This supports the results obtained from the mouse infection
model and the GeneChip experiments. 
The transcriptome data together with murine infection model described in the present
study could be useful for well directed experiments to dissect the intracellular survival
mechanisms in P. aeruginosa TB and the biochemical function of the strain specific
(non-PAO1) genes.
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6. Abbreviations
Aa   Amino acid min Minute
bp Base pair MOPS Morpholinopropanesulfonic acid
approx. approximately n nano- (10-9)
oC Degree Celsius OD Optical Density
CDS Coding sequence ORF Open reading frame; possible gene
CF Cystic fibrosis p pico- (10-12)
cfu Colony forming units PAGE Polyacrylamide gel electrophoresis
dATP Deoxyadenosine triphosphate PCR Polymerase chain reaction
dCTP Deoxycytosine triphosphate rpm Revolutions per minute
DEPC Diethypyrocarbonate RNase Ribonuclease
dGTP Deoxyguanosine triphosphate RT Room temperature (23 oC)
DIG Digoxigenin s Second
DNase Deoxyribonuclease SDS Sodium dodecyl sulfate
dNTP Deoxynucleotide triphosphate t Time
dTTP Deoxythymidine triphosphate T Temperature
EDTA Ethylenediaminetetraacetic acid TE Tris-EDTA 
e.g. For example µ micro- (10-6)
et. al., et alteri (and others) Mb Megabases
i.e. That means max. Maximum
FCS Fetal calf serum Tris Tris(hydroxymethyl)aminomethane
x g Centrifugal acceleration TTSS Type III secretion system
h Hour U Unit (unit of enzymatic activity)
I.E. Injection units UV Ultra violet
kBp 1000 Base pairs V Volt
LB Luria-Bertani Vol. Unit volumes
M Molar % v/v Percentage volume per total volume
m milli- (10-3); Meter, Mass % w/v Prcentage by weight per total volume
Max. Maximum 
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7. Appendices
Appendix I
Following are the molecular weight standards used for DNA and RNA agarose gel
electrophoresis and the fragment sizes are given in base pairs.
(1) Lambda DNA-BstE II digest (New England Biolab)
8454 7242 6369 5686 4822 4324 3675
2323 1929 1371 1264 702 224 117
(2) 100 bp DNA ladder (New England Biolab)
1517 1200 1000 900 800 700 600
517 500 400 300 200 100
(3) 0.16-1.77 Kb RNA ladder (Invitrogen)
1770 1520 1280 780 530 400 280
155
Appendix II
The following primer pairs (oligonucleotide sequences) were used for sequencing.
Description Primer sequence
Signal sequence TAG-1: 5‘—GTA  CCC  CAC  TAG  TCC  AAG  C
TAG-2: 5‘—TAC  CTC  CAC  TCA  CCC  AAG C
25A12 25A12GL: 5‘—ATG  TTA  GTG  GCT  TTT  CCC  CG
25A12GRN: 5‘—ATC  TGG  GCC  ATT  TCA  TCA  CC
45A7 45A7GRL: 5‘—GTG  GAA  GAC  GCA  ATG  AAA  GG
45A7GRR: 5‘—AAG  GAC  CGA  GGT  TCT  TGA  TG
23B9 PA2468L: 5‘—GCC  CCG  ATC  CTT  CTC  AGC
PA2468R: 5‘—CGC  AGC  AGG  TAG  CAG  TGG 
D8A6 D8A6L: 5‘—GGC  TTG  CAT  GAT  GTT  GTA  GC
D8A6R: 5‘—GAG  ATG  TTC  AAT  CGC  AAA  GG
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Appendix III
Table 7.1. Differential transcription profile of P. aeruginosa TB, 892 and PAO1 exposed to hydrogen
peroxide. 
PAO No. Average fold changea Protein nameb
TB 892 PAO1
I) Hydrogen peroxide induced genes
A) Energy metabolism
TCA cycle and aerobic respiration
PA0548 2.35 (0.23) transketolase, tktA
PA0552 2.93 (0.20) 2.97 (0.59) 2.53 (0.43) phosphoglycerate kinase, pgk
PA0555 2.07 (0.08) 2.14 (0.00) fructose-1.6-bisphosphate aldolase, fda
PA1580 3.83 (0.60) 3.75 (0.47) 3.11 (0.46) citrate synthase, gltA
PA1588 3.27 (0.41) 2.31 (0.29) 2.56 (0.23) succinyl-CoA synthetase beta chain, sucC
PA1589 2.88 (0.19) 2.59 (0.09) succinyl-CoA synthetase alpha chain, sucD
PA1787 2.32 (0.37) 2.56 (0.23) 2.49 (0.14) aconitate hydratase 2, acnB
PA2023 2.51 (0.09) UTP--glucose-1-phosphate uridylyltransferase,
galU
PA2290 2.11 (0.14) glucose dehydrogenase, gcd
PA2322 3.37 (0.13) 3.06 (0.48) gluconate permease
PA2624 3.88 (0.35) 3.55 (0.83) 4.09 (0.97) isocitrate dehydrogenase, idh
PA2843 2.99 (0.25) 3.63 (0.52) 4.76 (0.19) probable aldolase
PA3131 2.22 (0.09) probable aldolase
PA3181 3.12 (0.57) 2-keto-3-deoxy-6-phosphogluconate aldolase
PA3182 2.80 (0.40) 6-phosphogluconolactonase, pgl
PA3183 3.26 (0.26) glucose-6-phosphate 1-dehydrogenase, zwf
PA3452 5.69 (0.72) 3.59 (1.03) malate:quinone oxidoreductase, mqoA
PA3560 2.44 (0.35) Phosphotransferase system. fructose-specific IIBC
component, fruA
PA3635 2.42 (0.08) enolase, eno
PA4031 2.74 (0.24) 2.89 (0.26) inorganic pyrophosphatase, ppa
PA4333 3.82 (0.44) 3.55 (0.23) 3.05 (0.38) probable fumarase
PA4470 3.75 (0.47) 3.22 (0.48) 5.09 (1.07) fumarate hydratase, fumC1
PA4770 6.93 (2.44) 8.73 (3.16) 2.72 (0.49) L-lactate permease, lldp
PA4771 2.30 (0.13) 3.35 (0.93) L-lactate dehydrogenase, lldD
PA4772 3.12 (0.57) 3.96 (1.32) probable ferredoxin 
PA5046 2.98 (0.10) 3.09 (0.20) 3.54 (0.72) malic enzyme
PA5131 3.67 (0.12) 3.35 (0.63) 3.29 (0.59) Phosphoglycerate mutase, pgm
PA5192 3.11 (0.49) 3.07 (0.55) 3.95 (0.95) Phosphoenolpyruvate carboxykinase, pckA
PA5476 3.32 (0.38) 3.93 (1.17) citrate transporter, citA
Acetyl CoA biosynthesis and acetate degradation
PA0363 4.54 (0.55) 3.14 (0.69) 2.34 (0.15) Phosphopantetheine adenylyltransferase, coaD
PA0887 3.46 (0.62) acetyl-coenzyme A synthetase, acsA
Appendices
192
PAO No. Average fold changea Protein nameb
TB 892 PAO1
I) Hydrogen peroxide induced genes
A) Energy metabolism
Acetyl CoA biosynthesis and acetate degradation
PA4729 2.43 (0.29) 3-methyl-2-oxobutanoate
hydroxymethyltransferase, panB
PA4730 2.43 (0.21) 2.44 (0.35) pantoate-beta-alanine ligase, panC
PA4731 2.74 (0.24) 2.66 (0.39) aspartate 1-decarboxylase precursor, panD
PA5445 3.41 (0.65) 4.81 (1.29) probable coenzyme A transferase
Electron transport and oxidative phosphorylation
PA1317 34.43 (10.84) 38.84 (8.75) 12.14 (2.68) cytochrome o ubiquinol oxidase, cyoA
PA1318 17.79 (1.27) 27.69 (4.91) 19.61 (14.31) cytochrome o ubiquinol oxidase, cyoB
PA1319 21.75 (6.04) 25.49 (5.09) 8.02 (0.64) cytochrome o ubiquinol oxidase, cyoC
PA1320 30.10 (7.72) 37.61 (14.53) 11.91 (6.77) cytochrome o ubiquinol oxidase, cyoD
PA1321 10.72 (2.17) 7.07 (1.43) 3.72 (0.72) cytochrome o ubiquinol oxidase protein, cyoE
PA1552 3.50 (0.44) 2.70 (0.31) probable cytochrome c
PA1553 3.31 (0.12) 2.57 (0.37) probable cytochrome c oxidase subunit
PA1554 2.47 (0.14) probable cytochrome oxidase subunit 
PA2266 2.48 (0.31) probable cytochrome c precursor
PA4133 4.44 (0.18) cytochrome c oxidase subunit (cbb3-type)
PA4429 2.40 (0.39) probable cytochrome c1 precursor
PA5553 2.99 (0.31) 2.40(0.35) ATP synthase epsilon chain, atpC
PA5554 2.72 (0.49) 2.36(0.37) ATP synthase beta chain, atpD
PA5555 2.39 (0.21) ATP synthase gamma chain, atpG
PA5556 2.15 (0.12) ATP synthase alpha chain, atpA
PA5560 2.00 (0.00) ATP synthase A chain, atpB
Fatty acid and phospholipid metabolism
PA1288 2.39 (0.21) 2.51(0.16) probable outer membrane protein precursor
PA1806 2.56 (0.23) 3.37 (0.30) NADH-dependent enoyl-ACP reductase, fabI
PA1846 2.15 (0.22) cis/trans isomerase, cti
PA2015 2.90 (0.41) probable acyl-CoA dehydrogenase
PA2352 4.01 (0.38) 6.34(2.37) probable glycerophosphoryl diester
phosphodiesterase
PA2965 2.61 (0.32) beta-ketoacyl-acyl carrier protein, fabF1
PA2968 2.89 (0.26) 2.75(035) malonyl-CoA-[acyl-carrier-protein] transacylase,
fabD
PA2969 2.26 (0.15) fatty acid biosynthesis protein, plsX
PA3651 3.67 (0.25) phosphatidate cytidylyltransferase, cdsA
PA4693 2.15 (0.22) Phosphatidylserine synthase, pssA
PA4847 3.09 (0.20) biotin carboxyl carrier protein (BCCP), accB
PA4848 3.42 (0.12) biotin carboxylase, accC
PA5174 2.84 (0.32) probable beta-ketoacyl synthase
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I) Hydrogen peroxide induced genes
B) Amino acid biosynthesis and metabolism
Arginine
PA0662 2.43 (0.21) N-acetyl-gamma-glutamyl-phosphate reductase,
argC
PA0895 2.84 (0.23) 2.43(0.21) 3.27 (0.41) N-succinylglutamate 5-semialdehyde
dehydrogenase, aruC
PA0896 2.56 (0.23) arginine/ornithine succinyltransferase, aruF
PA0897 2.69 (0.18) arginine/ornithine succinyltransferase, aruG
PA0898 2.07 (0.15) Succinylglutamate 5-semialdehyde
dehydrogenase, aruD
PA3537 2.38 (0.17) ornithine carbamoyltransferase, argF
PA4756 2.40 (0.39) Carbamoylphosphate synthetase, carB
Glycine and serine
PA0008 2.31 (0.29) 2.27(0.23) glycyl-tRNA synthetase beta chain, glyS
PA0316 2.80 (0.40) D-3-phosphoglycerate dehydrogenase, serA
PA0904 4.47 (0.57) 3.76(0.59) 4.23 (0.43) aspartate kinase alpha and beta chain, lysC
PA2445 2.59 (0.56) 3.88(0.35) glycine cleavage system protein P2, gcvP2
PA2446 5.07 (0.86) 7.42(1.31) glycine cleavage system protein H2, gcvH2
PA3736 3.31 (0.22) 3.57(0.56) 3.93 (1.15) homoserine dehydrogenase, hom
Threonine 
PA0331 2.31 (0.29) threonine dehydratase. Biosynthetic, ilvA1
PA1757 4.45 (0.40) 4.58(0.88) homoserine kinase, thrH
PA3735 3.03 (0.00) 3.20 (0.22) 3.09 (0.28) threonine synthase, thrC
Glutamate and glutamine
PA2202 5.68 (3.71) 5.67(2.40) probable amino acid permease
PA2203 3.46 (0.61) 4.42 (1.25) probable amino acid permease
PA2204 17.81 (1.59) 15.85 (2.27) 4.60 (2.47) probable binding protein component of ABC
transporter
PA3068 2.39 (0.29) NAD-dependent glutamate dehydrogenase, gdhB
PA3134 3.37 (0.30) 3.05 (0.34) glutamyl-tRNA synthetase, gltX
PA5074 3.67 (0.25) 3.59 (1.03) probable ATP-binding component of ABC
transporter
PA5075 3.74 (0.21) 2.94(0.67) probable permease of ABC transporter
PA5076 3.32 (0.38) probable binding protein component of ABC
transporter
PA5203 2.44 (0.37) 2.62 (0.46) glutamate-cysteine ligase, gshA
PA5429 3.70 (0.71) aspartate ammonia-lyase, aspA
PA5479 2.94 (0.26) proton-glutamate symporter, gltP
Alanine and aspartate
PA0903 4.01 (0.32) 3.22 (0.48) 3.02 (0.57) alanyl-tRNA synthetase, alaS
PA2252 4.95 (0.63) 4.47 (0.57) 2.56 (0.23) probable AGCS sodium/alanine/glycine symporter
PA2253 3.62 (0.32) 2.57 (0.37) L-asparaginase I, ansA
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Lysine
PA0904 4.47 (0.57) 3.76 (0.59) 4.23 (0.43) aspartate kinase alpha and beta chain, lysC
PA3700 3.40 (0.56) 2.67 (0.48) 2.70 (0.28) lysyl-tRNA synthetase, lysS
PA4628 4.76 (1.04) 3.58 (1.24) 3.41 (1.30) lysine-specific permease, lysP
PA5278 2.04 (0.07) diaminopimelate epimerase, dapF
Leucine, isoleucine and valine
PA1587 2.11 (0.14) lipoamide dehydrogenase-glc, lpdG
PA1971 2.50 (0.51) branched chain amino acid transporter, praZ
PA3834 3.05 (0.34) 2.52 (0.35) 2.72 (0.51) valyl-tRNA synthetase, valS
PA3987 2.55 (0.17) leucyl-tRNA synthetase, leuS
PA4560 2.30 (0.18) 2.80 (0.40) isoleucyl-tRNA synthetase, ileS
PA4694 2.19 (0.20) ketol-acid reductoisomerase, ilvC
PA4695 2.30 (0.13) acetolactate synthase isozyme , ilvH
PA4696 2.19 (0.23) acetolactate synthase, ilvI
PA5308 3.13 (0.64) 3.04 (0.71) leucine-responsive regulatory protein, lrp
Proline 
PA0782 5.55 (1.11) 5.66 (0.00) 3.70 (0.53) proline dehydrogenase, putA
PA0783 5.81 (0.90) 5.77 (0.52) 3.57 (0.50) sodium/proline symporter, putP
PA0789 4.70 (0.54) 3.70 (0.53) probable amino acid permease
PA0956 2.31 (0.29) 2.63 (0.47) prolyl-tRNA synthetase, proS
Histidine
PA3151 2.26 (0.19) imidazoleglycerol-phosphate synthase, cyclase
subunit, hisF2
PA4448 2.43 (0.21) 2.27 (0.23) histidinol dehydrogenase, hisD
PA4449 2.83 (0.16) 2.75 (0.37) ATP-phosphoribosyltransferase, hisG
PA5140 2.22 (0.09) 2.26 (0.19) imidazoleglycerol-phosphate synthase. cyclase
subunit, hisF1
PA5141 2.42 (0.08) 2.70 (0.28) phosphoribosylformimino-5-aminoimidazole
carboxamide, hisA
Tryptophan and phenylalanine
PA0037 2.72 (0.49) 2.14 (0.00) transcriptional regulator, trpI
PA0649 2.23 (0.20) 2.35 (0.27) anthranilate synthase component II, trpG
PA1750 4.72 (0.74) 4.10 (0.58) 3.35 (0.61) phospho-2-dehydro-3-deoxyheptonate aldolase
PA2739 2.39 (0.29) phenylalanyl-tRNA synthetase, pheT
PA2740 2.28 (0.33) 2.07 (0.08) phenylalanyl-tRNA synthetase, pheS
PA3164 3.70 (0.56) 2.78 (0.60) still frameshift 3-phosphoshikimate 1-
carboxyvinyltransferase prephenate
dehydrogenase
PA3165 3.56 (0.41) 2.80 (0.14) histidinol-phosphate aminotransferase, hisC2
PA4439 2.18 (0.14) 2.61 (0.32) 2.44 (0.37) tryptophanyl-tRNA synthetase, trpS
 PA4447 2.64 (0.00) 2.75 (0.37) histidinol-phosphate aminotransferase, hisC1
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C) Biosynthesis of cofactors, prosthetic groups and carriers
Folic acid biosynthesis
PA0342 2.34 (0.08) thymidylate synthase, thyA
PA0350 2.99 (0.25) 2.56 (0.23) dihydrofolate reductase, folA
PA0582 3.50 (0.35) dihydroneopterin aldolase, folB
PA1674 2.95 (0.43) 2.81 (0.50) GTP cyclohydrolase I precursor, folE2
PA1796 2.65 (0.30) 2.11 (0.14) 5.10-methylene-tetrahydrofolate dehydrogenase /
cyclohydrolase, folD
PA2444 6.00 (2.38) 18.29 (8.92) serine hydroxymethyltransferase, glyA2
PA2964 2.43 (0.25) 4-amino-4-deoxychorismate lyase, pabC
PA4314 2.42 (0.08) 2.51 (0.22) 2.38 (0.10) formyltetrahydrofolate deformylase, purU1
PA4602 2.95 (0.43) 2.62 (0.65) serine hydroxymethyltransferase, glyA3
PA4664 3.42 (0.12) 2.98 (0.64) 4.40 (0.68) probable methyl transferase, hemK
PA5415 2.57 (0.33) serine hydroxymethyltransferase, glyA1
Cobalamin biosynthesis
PA1271 2.49 (0.44) 2.86 (0.51) probable tonB-dependent receptor
PA1272 2.18 (0.14) 2.34 (0.08) cob(I)alamin adenosyltransferase, cobO
PA1273 2.26 (0.15) cobyrinic acid a.c-diamide synthase, cobB
PA1274 3.44 (0.35) 3.33 (0.47) conserved hypothetical protein
PA1275 2.18 (0.14) 2.30(0.18) cobalamin biosynthetic protein, cobD
PA1276 5.11 (0.46) 3.80 (0.25) cobalamin biosynthetic protein, cobC
PA1277 2.76 (0.45) cobyric acid synthase, cobQ
PA1278 4.15 (0.95) 3.08 (0.17) cobinamide kinase, copP
PA1279 9.14 (2.51) 3.51 (0.55) nicotinate-nucleotide—dimethylbenzimidazole
phosphoribosyltransferase, cobU
PA1281 3.03 (0.69) cobalamin (5'-phosphate) synthase, cobV
PA2903 8.89 (0.59) 5.16 (2.16) precorrin-3 methylase, cobJ
PA2904 2.43 (0.25) precorrin-2 methyltransferase, cobI
PA2948 4.13 (0.77) precorrin-3 methylase, cobM
Vitamin B6 biosynthesis
PA0593 2.89 (0.30) pyridoxal phosphate biosynthetic protein, pdxA
PA1375 2.54 (0.47) erythronate-4-phosphate dehydrogenase, pdxB
PA2062 2.23 (0.20) probable pyridoxal-phosphate dependent enzyme
D) Polyamine biosynthesis and transport
PA0293 2.85 (0.36) N-carbamoylputrescine amidohydrolase, aguB
PA0301 2.45 (0.43) polyamine transport protein, spuE
PA0303 2.23 (0.20) polyamine transport protein, spuG
PA0304 2.82 (0.61) polyamine transport protein, spuH
PA0654 10.25 (1.23) 5.55 (1.59) S-adenosylmethionine decarboxylase proenzyme,
speD
PA1687 3.94 (0.26) 3.77 (0.64) spermidine synthase, speE
PA3607 5.58 (1.26) polyamine transport protein, potA
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I) Hydrogen peroxide induced genes
D) Polyamine biosynthesis and transport
PA3609 3.26 (0.26) polyamine transport protein, potC
PA3610 5.80 (0.82) 3.02 (0.90) polyamine transport protein, potD
PA4839 2.81 (0.50) biosynthetic arginine decarboxylase, speA
E) Iron-sulfur metabolism
Iron acquisition
PA0929 2.23 (0.20) two-component response regulator
PA3812 2.15 (0.17) probable iron-binding protein, iscA
PA3813 2.26 (0.19) probable iron-binding protein, iscU
PA3901 6.09 (2.57) 30.74 (29.69) Fe(III) dicitrate transport protein, fecA
PA4221 3.62 (0.32) 13.66 (2.71) 20.22 (12.39) Fe(III)-pyochelin receptor precursor, fptA
PA4222 3.98 (1.09) probable ATP-binding component of ABC
transporter
PA4223 4.23 (0.36) 8.31 (0.74) 2.85 (0.36) ATP-binding component of ABC transporter
PA4224 5.81 (1.98) 5.29 (0.42) 4.83 (0.96) pyochelin biosynthetic protein, pchG
PA4225 4.08 (0.92) 5.11 (0.46) 14.71 (9.30) pyochelin synthetase, pchF
PA4226 4.25 (0.61) 11.49 (7.51) 26.00 (13.98) dihydroaeruginoic acid synthetase, pchE
PA4227 2.43 (0.21) 2.98 (0.63) 2.26 (0.15) transcriptional regulator, pchR
PA4228 3.44 (0.35) 10.22 (2.35) 7.93 (3.48) pyochelin biosynthesis protein, pchD
PA4229 3.62 (0.41) 10.58 (0.85) 6.52 (0.66) pyochelin biosynthetic protein, pchC
PA4230 2.49 (0.40) 10.23 (0.91) 7.48 (0.16) salicylate biosynthesis protein, pchB
PA4231 3.03 (0.67) 9.49 (3.29) 14.72 (9.30) salicylate biosynthesis isochorismate synthase,
pchA
PA4358 3.31 (0.12) probable ferrous iron transport protein
PA4514 3.08 (0.62) probable outer membrane receptor for iron
transport
PA4687 5.22 (0.67) 7.61 (0.50) ferric iron-binding periplasmic protein, hitA
PA4688 2.62 (0.46) 4.29 (0.24) 3.57 (1.38) iron (III)-transport system permease, hitB
PA4710 3.45 (0.49) 3.09 (0.28) 5.17 (3.33) haem/haemoglobin uptake outer membrane
receptor PhuR precursor, phuR 
PA5217 2.64 (0.15) probable binding protein component of ABC iron
transporter
PA5531 2.79 (0.24) 5.05 (0.67) TonB protein, tonB
Sulfur metabolism
PA0280 4.64 (0.74) 5.90 (0.85) sulfate transport protein, cysA
PA0281 17.17 (0.97) 24.31 (16.0) sulfate transport protein, cysW
PA0282 4.27 (0.77) 4.36 (0.15) sulfate transport protein, cysT
PA0283 5.77 (1.34) 6.83 (2.40) sulfate-binding protein precursor, spb
PA0390 3.15 (0.28) 3.32 (0.38) homoserine O-acetyltransferase, metX
PA1493 3.22 (0.48) 2.43 (0.29) 2.74 (0.24) sulfate-binding protein of ABC transporter, cysP
PA1795 2.28 (0.33) cysteinyl-tRNA synthetase, cysS
PA1838 6.73 (0.27) 7.69 (2.14) sulfite reductase, cysI
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E) Iron-sulfur metabolism
Sulfur metabolism
PA3809 3.04 (0.24) ferredoxin [2Fe-2S], fdx2
PA3814 2.15 (0.17) L-cysteine desulfurase, iscS
PA4442 12.49 (2.27) 15.77 (3.55) 4.46 (0.56) ATP sulfurylase GTP-binding subunit/APS kinase,
cysN
PA4443 12.01 (1.67) 12.32 (3.69) 4.68 (0.31) ATP sulfurylase small subunit, cysD
F) Transcription, RNA processing and degradation
PA1161 3.10 (0.36) rRNA methyltransferase, rrmA
PA3246 3.36 (0.71) pseudouridine synthase, rluA
PA3308 2.76 (0.45) RNA helicase, hepA
PA3743 2.65 (0.34) tRNA (guanine-N1)-methyltransferase, trmD
PA3861 2.35 (0.25) 2.85 (0.41) ATP-dependent RNA helicase, rhlB
PA4269 3.80 (0.13) 2.40 (0.39) DNA-directed RNA polymerase beta* chain, rpoC
PA4270 4.71 (0.67) DNA-directed RNA polymerase beta chain, rpoB
PA4275 2.22 (0.09) transcription antitermination protein, nusG
PA4742 2.73 (0.11) tRNA pseudouridine 55 synthase, truB
PA4755 2.47 (0.14) transcription elongation factor, greA
G) Translation and post-translational modification
PA0018 2.07 (0.15) methionyl-tRNA formyltransferase, fmt
PA0067 2.43 (0.21) oligopeptidase A, prlC
PA0538 2.23 (0.20) 2.40 (0.39) disulfide bond formation protein, dsbB
PA0579 2.57 (0.37) 30S ribosomal protein S21, rpsU
PA0594 3.00 (0.36) peptidyl-prolyl cis-trans isomerase, surA
PA0767 2.71 (0.38) GTP-binding protein, lepA
PA0768 2.64 (0.15) signal peptidase I, lepB
PA1793 2.56 (0.23) 2.51 (0.22) peptidyl-prolyl cis-trans isomerase B, ppiB
PA1805 2.83 (0.00) 3.20 (0.22) 2.62 (0.39) peptidyl-prolyl cis-trans isomerase D, ppiD
PA2748 3.26 (0.76) probable methionine aminopeptidase
PA2851 2.55 (0.10) 2.44 (0.35) translation elongation factor P, efp
PA2970 2.47 (0.20) 2,.40 (0.35) 50S ribosomal protein L32, rpmF
PA3262 3.17 (0.52) 3.52 (0.56) 2.63 (0.51) probable peptidyl-prolyl cis-trans isomerase 
PA3653 2.18 (0.08) ribosome recycling factor, frr
PA3655 3.80 (0.25) 3.08 (0.66) 3.47 (0.67) elongation factor Ts, tsf
PA3656 2.94 (0.26) 3.24 (0.62) 30S ribosomal protein S2, rpsB
PA3717 2.11 (0.14) probable peptidyl-prolyl cis-trans isomerase 
PA3737 2.28 (0.33) 2.28 (0.33) thiol:disulfide interchange protein, dsbC
PA3742 2.43 (0.21) 50S ribosomal protein L19, rplS
PA3831 2.36 (0.33) leucine aminopeptidase, pepA
PA3903 3.34 (0.56) peptide chain release factor 3, prfC
PA4237 3.49 (0.20) 2.58 (0.43) 2.71 (0.38) 50S ribosomal protein L17, rplQ
PA4239 2.72 (0.51) 2.40 (0.39) 30S ribosomal protein S4, rpsD
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G) Translation and post-translational modification
PA4244 2.31 (0.26) 2.65 (0.21) 50S ribosomal protein L15, rplO
PA4245 2.27 (0.23) 50S ribosomal protein L30, rpmD
PA4250 2.26 (0.19) 2.40 (0.35) 30S ribosomal protein S14, rpsN
PA4252 2.45 (0.47) 2.82 (0.78) 50S ribosomal protein L24, rplX
PA4254 2.47 (0.28) 30S ribosomal protein S17, rpsQ
PA4255 3.83 (0.54) 2.69 (0.61) 50S ribosomal protein L29, rpmC
PA4256 2.14 (0.00) 50S ribosomal protein L16, rplP
PA4257 2.40 (0.35) 30S ribosomal protein S3, rpsC
PA4266 2.19 (0.23) elongation factor G, fusA1
PA4268 2.23 (0.20) 30S ribosomal protein S12, rpsL
PA4271 3.20 (0.22) 2.23 (0.27) 3.70 (0.53) 50S ribosomal protein L7 / L12, rplL
PA4272 2.94 (0.26) 3.72 (0.72) 50S ribosomal protein L10, rplJ
PA4273 2.89 (0.30) 50S ribosomal protein L1, rplA
PA4432 2.88 (0.10) 2.40 (0.39) 30S ribosomal protein S9, ssb
PA4483 2.44 (0.34) Glu-tRNA(Gln) amidotransferase, gatA
PA4484 2.43 (0.25) Glu-tRNA(Gln) amidotransferase, gatB
PA4558 2.53 (0.39) 2.93 (0.10) probable peptidyl-prolyl cis-trans isomerase
PA4567 2.64 (0.15) 2.34 (0.15) 50S ribosomal protein L27, rpmA
PA4568 2.04 (0.07) 50S ribosomal protein L21, rplU
PA4665 3.20 (0.22) 2.74 (0.63) 3.50 (0.44) peptide chain release factor 1, prfA
PA4671 3.21 (0.39) 2.31 (0.29) 3.30 (0.67) probable ribosomal protein L25
PA4672 3.99 (0.77) peptidyl-tRNA hydrolase
PA4741 3.04 (0.31) 2.49 (0.42) 3.67 (0.12) 30S ribosomal protein S15, rpsO
PA4743 3.34 (0.52) ribosome-binding factor A, rbfA
PA4744 2.22 (0.16) translation initiation factor IF-2, infB
PA4768 2.31 (0.29) 2.37 (0.43) SmpB protein, smpB
PA4850 2.74 (0.63) ribosomal protein L11 methyltransferase, prmA
PA4932 3.68 (0.38) 2.81 (0.50) 50S ribosomal protein L9, rp1I
PA4934 2.34 (0.15) 2.52 (0.29) 30S ribosomal protein S18, rpsR
PA4935 2.60 (0.17) 2.55 (0.54) 30S ribosomal protein S6, rpsF
PA5049 2.69 (0.09) 2.62 (0.46) 2.88 (0.10) 50S ribosomal protein L31, rpmE
PA5117 6.58 (1.17) 3.87(0.86) 4.02 (0.51) regulatory protein, typA
PA5129 2.89 (0.33) 2.77 (0.55) 2.57 (0.37) glutaredoxin, rgx
PA5134 2.15 (0.17) probable carboxyl-terminal protease
PA5240 2.14 (0.00) 2.39 (0.21) thioredoxin, trxA
PA5256 2.62 (0.39) disulfide bond formation protein, dsbH
H) Cellular organisation and biogenesis
PA0973 2.42 (0.08) peptidoglycan associated lipoprotein, oprL 
PA1812 2.27 (0.23) membrane-bound lytic murein transglycosylase D
precursor, mltD
PA1959 3.56 (0.37) bacitracin resistance protein, bacA
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H) Cellular organisation and biogenesis
PA2272 3.02 (0.54) penicillin-binding protein 3A, pbpC
PA3047 2.51 (0.16) 2.35 (0.32) probable D-alanyl-D-alanine carboxypeptidase
PA3243 2.79 (0.34) 2.44 (0.35) cell division inhibitor, minC
PA3245 2.55 (0.10) 2.31 (0.26) cell division topological specificity factor, minE
PA3643 3.43 (0.29) 3.04 (0.71) lipid A-disaccharide synthase, lpxB
PA3644 2.79 (0.24) UDP-N-acetylglucosamine acyltransferase, lpxA
PA3646 2.71 (0.38) UDP-3-O-[3-hydroxylauroyl] glucosamine N-
acyltransferase, lpxD
PA3652 3.04 (0.17) undecaprenyl pyrophosphate synthetase, uppS
PA3659 2.26 (0.15) 2.34 (0.15) probable aminotransferase
PA3666 2.27 (0.23) 2.65 (0.21) 2.89 (0.26) Tetrahydrodipicolinate succinylase, dapD
PA3984 3.62 (0.32) 2.79 (0.29) 2.07 (0.08) apolipoprotein N-acyltransferase, lnt
PA3999 2.11 (0.14) D-ala-D-ala-carboxypeptidase, dacC
PA4002 2.65 (0.27) rod shape-determining protein, rodA
PA4003 2.53 (0.39) 2.74 (0.24) penicillin-binding protein 2, pbpA
PA4450 2.15 (0.17) 3.00 (0.36) UDP-N-acetylglucosamine 1-
carboxyvinyltransferase, murA
PA4479 2.78 (0.19) rod shape-determining protein, mreD
PA4480 2.86 (0.51) rod shape-determining protein, mreC
PA4481 2.51 (0.09) rod shape-determining protein, mreB
PA4512 3.25 (0.18) lipopolysaccharide biosynthetic protein, lpxO1
PA4662 3.19 (0.11) glutamate racemase, murI
PA4668 2.99 (0.25) 2.89 (0.33) 4.48 (0.74) probable lipoprotein localization protein 
PA4930 2.15 (0.12) biosynthetic alanine racemase, alr
PA5009 2.56 (0.23) 2.31 (0.22) lipopolysaccharide kinase, waaP
PA5549 4.22 (0.28) 3.21 (0.39) glucosamine—fructose-6-phosphate
aminotransferase, glmS
PA5562 2.26 (0.15) chromosome partitioning protein, spoOJ
II) Hydrogen peroxide repressed genes
A) Quorum sensing 
PA0996 5.81 (1.57) probable coenzyme A ligase, pqsA
PA0999 5.06 (1.72) 3-oxoacyl-[acyl-carrier-protein] synthase III, pqsD
PA1003 4.88 (0.70) 6.03 (2.12) 6.54 (3.88) transcriptional regulator, mvfR
PA1246 3.95 (0.95) 2.19 (0.20) alkaline protease secretion protein, aprD
PA1247 3.42 (0.69) alkaline protease secretion protein, aprE
PA1248 2.30 (0.13) alkaline protease secretion protein, aprF
PA1249 7.75 (0.69) 5.66 (0.32) alkaline metalloproteinase precursor, aprA
PA1250 3.19 (0.68) 3.16 (0.46) alkaline proteinase inhibitor, aprI
PA1430 2.65 (0.27) transcriptional regulator, lasR
PA1431 4.93 (1.09) 5.82 (2.16) regulatory protein, rsaL
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PAO No. Average fold changea Protein nameb
TB 892 PAO1
II) Hydrogen peroxide repressed genes
A) Quorum sensing 
PA1871 19.31 (3.8) 7.77 (0.97) 6.54 (5.48) LasA protease precursor, lasA
PA1901 16.50 (3.0) phenazine biosynthesis protein, PhzC2
PA1902 4.83 (1.9) phenazine biosynthesis protein, PhzD2
PA1904 11.13 (4.3) probable phenazine biosynthesis protein, phzF2
PA1985 2.47 (0.23) 2.30 (0.13) 7.84 (5.05) pyrroloquinoline quinone biosynthesis protein A,
pqqA
PA1986 2.59 (0.52) pyrroloquinoline quinone biosynthesis protein B,
pqqB
PA1987 2.71 (0.40) pyrroloquinoline quinone biosynthesis protein C,
pqqC
PA1988 2.43 (0.21) pyrroloquinoline quinone biosynthesis protein D,
pqqD
PA2193 13.11 (4.4) 16.66 (5.38) hydrogen cyanide synthase, hcnA
PA2194 17.02 (4.5) 14.41 (6.76) hydrogen cyanide synthase, hcnB
PA2195 19.40 (5.9) 10.85 (1.69) hydrogen cyanide synthase, hcnC
PA2586 2.15 (0.22) response regulator, gacA
PA2587 2.51 (0.22) probable FAD-dependent monooxygenase, pqsH
PA3006 2.83 (0.62) 6.08 (2.57) transcriptional regulator, psrA
PA3476 2.07 (0.08) 4.09 (0.43) autoinducer synthesis protein, rhlI
PA3477 5.48 (0.49) 8.19 (2.03) 4.01 (1.47) transcriptional regulator, rhlR
PA3478 28.70 (5.2) 19.20 (5.01) rhamnosyltransferase chain B, rhlB
PA3479 34.50 (4.3) 35.00 (8.13) rhamnosyltransferase chain A, rhlA
PA3724 8.02 (3.39) elastase, lasB
PA4209 4.76 (0.19) 3.11 (0.48) probable phenazine specific methyltransferase,
phzM
PA4211 5.73 (1.02) 6.43 (1.64) probable phenazine biosynthesis protein, phzC1
PA4217 3.00 (0.42) flavin-containing monooxygenase, phzS
PA5499 2.36 (0.37) transcriptional regulator, np20
B) Flagella biogenesis and chemotaxis
PA0173 23.79 (12.3) 31.55 (16.5) 9.11 (4.86) probable methylesterase
PA0175 15.37 (5.2) 12.36 (2.79) 8.20 (2.04) probable chemotaxis protein methyltransferase
PA0176 24.54 (4.3) 22.52 (6.24) 16.06 (1.52) probable chemotaxis transducer
PA0177 22.76 (2.8) 25.60 (10.5) 12.33 (5.79) probable purine-binding chemotaxis protein
PA0178 17.31 (2.7) 16.33 (3.79) 12.68 (1.92) probable two-component sensor
PA0179 20.55 (2.9) 35.34 (9.97) 13.66 (2.73) probable two-component response regulator
PA0180 8.35 (1.20) 8.47 (2.03) 7.43 (1.34) probable chemotaxis transducer
PA1077 2.62 (0.39) 8.20 (1.16)  flagellar basal-body rod protein, flgB
PA1078 2.72 (0.49) 8.33 (1.00) flagellar basal-body rod protein, flgC
PA1079 5.97 (0.40) flagellar basal-body rod modification protein, flgD
PA1080 2.00 (0.00) 6.19 (0.65) flagellar hook protein, flgE
PA1081 5.90 (1.35) flagellar basal-body rod protein, flgF
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PAO No. Average fold changea Protein nameb
TB 892 PAO1
II) Hydrogen peroxide repressed genes
B) Flagella biogenesis and chemotaxis
PA1082 2.59 (0.09) 5.42 (1.47) flagellar basal-body rod protein, flgG
PA1083 2.51 (0.09) 5.72 (0.97) flagellar L-ring protein precursor, flgH
PA1084 2.52 (0.26) 4.72 (0.74) flagellar P-ring protein precursor, flgI
PA1085 2.26 (0.15) 3.45 (0.49) flagellar protein, flgJ
PA1086 2.30 (0.00) 5.55 (1.11) flagellar hook-associated protein 1, flgK
PA1087 2.47 (0.14) 6.78 (0.98) 2.39 (0.21) flagellar hook-associated protein type 3, flgL
PA1088 3.05 (0.38) 5.57 (0.37) hypothetical protein
PA1089 2.27 (0.27) 5.48 (0.49) conserved hypothetical protein
PA1092 3.09 (0.11) 5.72 (0.97) 2.93 (0.12) flagellin type B, fliC
PA1093 5.31 (0.67) 10.23 (0.9) 4.38 (0.51) hypothetical protein
PA1094 4.40 (0.62) 10.66 (2.8) 3.75 (0.47) flagellar capping protein, fliD
PA1095 3.00 (0.36) 8.47 (1.02) 2.65 (0.21) hypothetical protein
PA1098 2.34 (0.21) 3.28 (0.93) two-component sensor, fleS
PA1099 2.74 (0.24) 4.87 (1.63) two-component response regulator, fleR
PA1100 2.67 (0.48) 4.62 (1.74) flagellar hook-basal body complex protein, fliE
PA1101 2.56 (0.23) 4.77 (1.10) flagellar M-ring protein, fliF
PA1102 2.19 (0.23) flagellar motor switch protein, fliG
PA1105 2.27 (0.27) flagellar protein, fliJ
PA1423 4.61 (0.37) probable chemotaxis transducer
PA1452 3.70 (0.56) flagellar biosynthesis protein, flhA
PA1453 2.43 (0.29) 3.78 (1.10) flagellar biosynthesis protein, flhF
PA1455 2.18 (0.14) 2.90 (0.45) sigma factor, fliA
PA1456 2.31 (0.29) 3.02 (0.54) two-component response regulator, cheY
PA1457 2.65 (0.21) 3.05 (0.38) chemotaxis protein, cheZ
PA1458 2.51 (0.16) 3.75 (0.47) 2.26 (0.15) probable two-component sensor
PA1459 3.25 (0.00) 4.40 (0.69) 2.51 (0.16) probable methyltransferase
PA1460 2.55 (0.17) 3.61 (0.14) probable chemotaxis transmembrane proton
channel
PA1461 2.44 (0.37) 3.74 (0.21) probable chemotaxis protein
PA1464 2.47 (0.14) 2.85 (0.45) probable purine-binding chemotaxis protein
PA1561 5.58 (0.47) 12.28 (6.1) 2.98 (0.20) aerotaxis receptor, aer
PA1608 3.70 (0.51) 3.06 (0.49) probable chemotaxis transducer
PA1930 26.09 (2.6) 19.06 (8.01) 16.67 (2.15) probable chemotaxis transducer
PA2561 2.63 (0.47) probable chemotaxis transducer
PA2573 28.24 (8.2) 19.11 (5.99) 9.75 (1.36) probable chemotaxis transducer
PA2652 2.90 (0.45) 2.59 (0.51) probable chemotaxis transducer
PA2654 2.47 (0.20) 4.53 (0.39) 2.53 (0.43) probable chemotaxis transducer
PA2788 13.70 (0.4) 23.03 (4.8) 4.10 (1.03) probable chemotaxis transducer
PA2920 9.01 (1.80) 9.75 (1.40) 5.77 (0.52) probable chemotaxis transducer
PA3348 2.90 (0.42) 3.57 (0.50) probable chemotaxis protein methyltransferase
PA3349 3.37 (0.30) 5.08 (0.95) 2.15 (0.12) probable chemotaxis protein
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TB 892 PAO1
II) Hydrogen peroxide repressed genes
B) Flagella biogenesis and chemotaxis
PA3708 2.39 (0.21) 2.86 (0.48) probable chemotaxis transducer, wspA
PA4117 4.29 (0.24) 3.02 (0.54) probable bacteriophytochrome
PA4307 2.53 (0.39) chemotactic transducer, pctC
PA4309 5.38 (0.35) 10.84 (1.6) 5.33 (1.42) chemotactic transducer, pctA
PA4310 2.78 (0.19) 10.04 (0.6) 2.96 (0.52) chemotactic transducer, pctB
PA4520 2.59 (0.09) 3.05 (0.38) probable chemotaxis transducer
PA4633 5.77 (0.52) 9.66 (1.93) 4.96 (0.64) probable chemotaxis transducer
PA4915 13.72 (4.2) 14.82 (5.0) 6.41 (0.66) probable chemotaxis transducer
a: Values are means (SD) of four independent RNA preparations.
b: Gene names are indicated in Italics.
Table 7.2. Genes down-regulated from arginine metabolism in 25A12 mutant when grown in LB
medium up to late exponential phase1,2.
PAO No. Average fold change Protein name3
PA0888 1.60 arginine/ornithine binding protein, aotJ
PA0889 1.81 arginine/ornithine transport protein, aotQ
PA0890 1.52 arginine/ornithine transport protein, aotM 
PA0892 1.52 arginine/ornithine transport protein, aotP 
PA0893 1.45 transcriptional regulator, argR 
PA0895 1.02 N-succinylglutamate 5-semialdehyde dehydrogenase, aruC
PA0896 2.07 arginine/ornithine succinyltransferase, aruF 
PA0897 1.94 arginine/ornithine succinyltransferase, aruG 
PA0898 2.34 succinylglutamate 5-semialdehyde dehydrogenase, aruD
PA0899 1.59 succinylarginine dihydrolase, aruB 
PA1544 1.50 transcriptional regulator, anr
PA5171 1.42 arginine deiminase, arcA
PA5172 1.52 ornithine carbamoyltransferase, arcB
PA5173 1.70 carbamate kinase, arcC
1: No down-regulated genes observed in mutant 45A7 under the same condition.
2: No down-regulation of genes from this category were observed when both the mutants were grown
   in presence of hydrogen peroxide and PMNs.
3: Gene names are indicated in italics.
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